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ABSTRACT
Epidemiological studies have failed to show any important impact of human 
immunodeficiency virus (HIV) infection and disease on leprosy, in contrast to the well documented 
increase in incidence and morbidity with other mycobacteria in these patients, notably Mycobacterium 
tuberculosis. The early events following exposure and repeated exposure to Mycobacterium leprae 
(ML) have not still been studied. Previous studies of first inoculations of ML in the sldn of rhesus 
monkeys have indicated delayed recruitment of CD4+ cells and delayed interleukin (IL) 2 secretion in 
skin inoculation sites in simian immunodeficiency (SIV) positive animals.
The development of the secondary immune response against a challenge of ML was studied 
over a period of 2 months in the sldn of 9 rhesus macaques, all inoculated previously with ML, 3 of 
which were SIV positive slow progressors. Cell recruitment and types of cytokine response in the skin 
and draining lymph nodes (LN) were investigated using flow cytometry (FC), immunohistochemistry, 
and reverse transcription polymerase chain reaction to detect relative levels of messenger ribonucleic 
acid (mRNA) expression for IL2, IL4, interferon gamma (DFNy) and IL10. Results were analyzed 
according to SIV status and persistence of ML infection.
An early vigorous expression of IL2 and IFNy mRNA, indicative of a strong T helper (Th) 1 
cytokine profile, was seen in the skin of macaques that cleared ML infection. Animals that developed 
persistent ML infection (ML+) had delayed, weak Thl response, and no evidence o f early Th2 response 
in the sldn. In contrast, early up regulation of IL4 was only observed in the LN of ML+ macaques. 
Recruitment of CD4+ lymphocytes into the sldn was significantly lower and delayed in ML+ animals. 
CD4-.CD8 ratio were significantly lower in the blood in SIV+ monkeys. However, no significant 
differences in CD4+ lymphocyte recruitment or expression o f cytokine mRNA were observed between 
SIV- and SIV+ monkeys.
Despite evidence o f systemic immunodepression, the slow progressing SIV+ rhesus macaques 
are still capable o f mounting an adequate response to ML re-inoculation in the sldn. A Th2 response is 
not generated in die sldn early after re-infection in animals which developed progressive infection.
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1 INTRODUCTION
“ Different forms of clinically established (‘determinate’) disease are 
associated with different type of immune reactivity, but it is not completely 
known to what extent these differences have been of primary importance for 
the course after exposure to M. leprae or a consequence o f the development 
of the infection.” Morten Harboe, ‘Leprosy’, 1994.
In mycobacterial diseases in general and in leprosy in particular, both the ‘natural’ and 
‘acquired’ arm of cellular immunity are believed to be important. Their respective importance, 
however, remains, to most leprosy investigators’ knowledge, largely speculative and difficult to define 
since proper cooperation between different cell types and coordination of macrophages and 
lymphocytes are critical to the development of strong cell-mediated immunity (CMI).
Rodent animal models, such as nude (nu/nu) or ALY (alymphoplasia) mice, teach us that T- 
cell mediated adaptive immunity is important when coping with mycobacteria (Orme, Andersen et al. 
1993) and Mycobacterium leprae (Yogi, Endoh et al. 1998). In the clinical fields, there are rare reports 
of renal transplantation in leprosy patients who developed relapse of the disease after 
immunosuppressive regimens (Adu, Evans et al. 1973; Teruel, Liano et al. 1985). However, with a few 
exceptions (Borgdorff, van den Broek et al. 1993), increased incidence o f leprosy and down-grading of 
leprosy has not been observed in immuno-compromised, human immunodeficiency virus (HIV)- 
infected individuals (Pdnninghaus, Mwanjasi et al. 1991; Frommel, Tekle-Haimanot et al. 1994; 
Munyao, Bwayo et al. 1994; Lienhardt, Kamate et al. 1996).
Previous studies have shown that the T cell subsets in tuberculoid (paucibacillary) versus 
lepromatous (multibacillary) lesions (Modlin and Rea 1994), and the type of cytokine secretion 
associated with these lesions are different (Yamamura, Uyemura et al. 1991). Those valuable studies in 
human patients with fully developed lesions however, probably represent only the emerged portion of 
the iceberg, at a stage in pathogenesis when limited immunomodulatory interventions can be taken in 
addition to poly-chemotherapy. For obvious ethical and practical reasons, it is impossible to study 
longitudinally the early, silent phase of leprosy, before lesion development, after documented exposure.
I
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The exact documented tune o f exposure is seldom known. Likewise, the incubation period of leprosy, 
believed to be quite long, is not precisely known. Some studies are currently under way to characterize 
the cytokine profile and inflammatory infiltrate composition from single lesions of leprosy, believed to 
be early lesions, in leprosy patients in Brazil (T. Gillis, personal communication) and in India. 
However, only animal models can help to provide insights concerning the initial host response soon 
after exposure or re-exposure.
It was recently discovered that helper T lymphocytes do not up-regulate cytokines important 
for an immune response in a random and / or an independent manner but mature into two main types of 
secreting lymphocytes, termed type 1 and type 2, which are defined by the secretion of consistent sets 
of cytokines (Mosmann, Cherwinslri et al. 1986). The type 1 T helper lymphocyte (Thl) cytokine 
response is characterized by the recruitment of lymphocytes secreting a defined array of cytokines, i.e. 
interleukin (IL) 2, interferon gamma (IFNy) lymphotoxin (LT / TNFP) and granulocyte macrophage 
colony stimulating factor (GM-CSF). In contrast, the type 2 helper T lymphocyte cytokine response 
(Th2) is characterized by the secretion of IL-4, IL-5, IL-3, IL-6 and IL-10. These T cells evolve from 
immature precursor T cells able to secrete a non-committed array o f cytokines and is termed 
‘ThO’(Mosmann, Cherwinski et al. 1986). However, when T cells are engaged in one of the 2 types of 
cytokine secretion, they are in an irreversible manner, at least at the clonal level. A debate still exist as 
to the existence of a mature ThO subset (Lucey, Clerici et al. 1996). The 2 types of T cells provide help 
for different cell subsets and favor maturation of immune cells in a different manner, resulting in 
different types of immune response and are thought to regulate each other (Mosmann and Coffman 
1987), although this is still matter of debates (Muraille and Leo 1998).
The Thl cytokine response, otherwise called ‘type 1’response when the cytokine response is 
studied from inflammatory cells, has been demonstrated to play an important role in controlling most 
mycobacterial infections (reviewed in (Daugelat and Kaufinann 1996; Lucey, Clerici et al. 1996)). Type 
1 cytokines contribute to the control and elimination of Mycobacterium tuberculosis and M. avium 
through activation of the macrophages. In tuberculosis, the initial response to a respiratory challenge 
with M. tuberculosis is a type 1 response that subsequently evolves into a type 0 response characterized 
by die apparition o f IL-4 mRNA expression in the lung with progression o f disease towards pneumonia
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(Hemandez-Pando, Orozcoe et al. 1996). Interestingly, there is correlation between lesion type and 
severity and intensity of down-regulation of type 1 cytokine and up-regulation o f type 2 cytoldnes.
In leprosy where the disease evolution is very slow, it would be desirable to know the cytokine 
profile of microscopic lesions before they are grossly visible, at the primary site of infection, to know 
whether this is determinant for the subsequent expression of the disease or is independent of it. That is 
where the value of performing longitudinal studies on primate animal models becomes most obvious. 
With such models, it is theoretically possible to study the kinetic of the local cytokine response from the 
time of inoculation and to generate inferences on the importance of the type of cytokine response on the 
subsequent outcome after exposure. Such studies might indicate whether early lesions all have a type 1 
cytokine milieu or an uncommitted type 0 mixture of cytokines with similar levels of expression. Do 
type 2 cytokine responses appear at the beginning of a primary or a secondary exposure to M. leprae? 
Are there shifts from type 1 to type 2 or vice-versa in the same animals inoculated over time? Is the 
type 2 cytokine milieu causative for developing a lepromatous multibacillary disease or a consequence 
of it, being part of a specific immune down regulation system (i.e., T helper 2 lymphocytes might be the 
long sought “suppressor” T lymphocytes)? Does the type of cytokine milieu correlate with any 
preferential recruitment of T cells or T cell subsets?
Kinetic studies of cytokine expression are critical to the understanding of leprosy because two 
cases can theoretically exist. First, it may be that the initial cytokine milieu at the site of inoculation 
might be appropriate and the same in intensity and timing, regardless o f the outcome after 
Mycobacterium leprae infection or the existence of an immunocompromising chronic viral infection. In 
that case, if only the animals thereafter developing a persistent infection do shift to a type 2 cytokine 
milieu, then further studies of initial cytokine milieus are no longer critical to understand the immuno- 
pathogenesis of Hansen’s disease. Rather, focusing on defects in macrophage recruitment, macrophage 
activation and macrophage-lymphocyte interaction (such as antigen presentation, and immune response 
(MHC) genes) and lymphocyte activation and recruitment, would be more desirable. The second 
possibility is that the animals that encounter the leprosy bacillus either have an initial non-committed or 
a variably committed cytokine milieu. In that case, understanding what determines the type of cytokines 
that will be initially secreted will be o f great importance to fight Hansen’s disease. In inoculated
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animals, the effect of variable immunosuppressive agents, including immunosuppressive 
chemotherapeutic agents and immuno-compromising infectious agents such as the lentiviruses that 
induce immuno-deficiency should also be studied in terms of type and timing o f lymphocyte 
recruitment and the nature o f the cytokine response.
In mycobacterial diseases, in particular tuberculosis and diseases secondary to opportunistic 
mycobacteria of humans, such as Mycobacterium avium, there is a striking acceleration of the evolution 
and a worsening of the clinical signs of tuberculosis in human immunodeficiency virus (HIV) infected 
individuals (Havlir and Barnes 1999) and an increased incidence of the opportunistic mycobacteriosis in 
HIV patients (Benson and Ellner 1993). A debate is still present among leprosy researchers as to 
whether HIV has any effect on the incidence, evolution and spectrum of dually infected HIV-M leprae 
patients (Pfinninghaus, Mwanjasi et al. 1991). Epidemiological studies and immunological studies thus 
far have failed to show any impact o f HIV infection and disease on leprosy (Pdnninghaus, Mwanjasi et 
al. 1991; Frommel, Tekle-Haimanot et al. 1994; Sampaio, Caneshi et al. 1995). However the question is 
still matter of some debates, especially concerning the incidence of immuno-pathological reeactions to 
leprosy (Borgdorff, van den Broek et al. 1993; Bwire and Kawuma 1994). The controlled experimental 
model o f rhesus macaques (Macaca mulatto) dually infected with M. leprae and SIV might help to 
clarify the situation of human leprosy in the context of HIV infection.
These thoughts, arising from the review of the CMI against M.leprae and the interactions of 
mycobacteria with immunosuppressive lentiviruses, are the basis for the hypothesis of this study that 
can be formulated as follow:
“The immunodeficiency resulting from the chronic progressive infection 
with the simian immunodeficiency virus (SIV) is responsible for an 
inappropriate T-lymphocyte response against mycobacteria, including 
Mycobacterium leprae in rhesus macaques (Macaca mulatto)"
There are additional reasons to study the early immune response in rhesus macaques after 
exposure to M. leprae in SIV- and SIV + animals. There is a need to better characterize the immune 
response to M. leprae in rhesus macaques (Macaca mulatto), where thus far only pathologic (Baskin 
1990) and disease outcome (persistent M. leprae infection with nerve lesions versus rejection of the 
infection), lymphocyte proliferative assays and antibody levels in the peripheral blood have been
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performed (Gormus, Muiphey-Corb et al. 1998; Gonnus, Xu et al. 1998). There are also renewed 
interests in studying the CMI to mycobacterial disease since the HIV/AIDS pandemic. In addition, 
leprosy research suffers from the scarcity of experimental animal models that exhibit the spectrum of 
leprosy (i.e. tuberculoid and lepromatous) and is fully characterized immuno-pathologically, regardless 
of their similarity and discrepancy with the human disease.
In this context, my research goals are:
1 -  Objective 1: to ascertain that the rhesus monkeys (Macaca mulatto) can effectively mount 
a cellular immune response locally and regionally against Mycobacterium leprae.
2 -  Objective 2: to compare the kinetics of T lymphocyte recruitment at cutaneous inoculation 
sites and the fluctuation of T lymphocyte subsets in the regional lymph nodes draining the inoculation 
sites and in the peripheral blood.
3 -  Objective 3: To assess the mRNA expression of 4 important cytokines in the developing 
lesions in the skin and mRNA up-regulation or down-regulation of these same 4 cytokines in the 
regional draining lymph nodes.
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2 REVIEW OF THE LITERATURE ON THE IMMUNO- 
PATHOLOGY OF LEPROSY
2.1 CELL MEDIATED IMMUNITY (CMI) TO MYCOBACTERIA, 
WITH PARTICULAR REFERENCE TO MYCOBACTERIUM 
LEPRAE
2.1.1 C u r r e n t  D e f in i t io n  o f  a n d  C o n c e p ts  a b o u t  C e l l  M e d ia te d  Im m unity  
(CMI)
Cell mediated immunity (CMI) has been classically defined as the protective functions and 
structural changes of a host directed against an invading harmful micro-organism, primarily mediated 
by macrophages and lymphocytes that matured in the thymus, the T lymphocytes, all recruited at site or 
at the vicinity of the invading micro-organism. The structural microenvironment where CMI takes place 
is called a granuloma. It is composed predominantly of macrophages and T lymphocytes that interact 
either through surface receptors and cytokines in order to kill or at least contain the invading 
microorganism (Kaufmann 1994).
Cells acting in a granuloma can be arbitrarily divided into 2 main categories. First, the effector 
cells, the function of which is to kill the pathogenic parasitic organism (the pathogen) or the infected 
cell and second, the orchestrating cells, whose function is to increase (help) or diminish (suppress) the 
inflammatory and immune response through various surface signals and soluble mediators directed at 
the effector cells. The relative importance of the effector cell versus the orchestrating cell is difficult to 
assess. In a perfect world, the function of the effector cell would be 100% effective, without any help 
provided by other cells. However, due to evading strategies employed by most pathogen of medical 
importance, adaptive immunity and helper T cells are important to successfully contain intracellular 
parasites. The orchestrating ‘helper’ immune cell is in charge to tune the efficacy of the cellular immune 
primary and secondary response, and to a certain extent modulate the launch of the humoral response, 
without excessive toxicity to the host, against a given pathogenic organism. These various signals 
themselves are believed to be elicited by the invading microorganism and the effector cells from the 
first line of defense coping with the invader. They may also be dependant upon the degree of tissue 
injury elicited by the invading microorganism (“non-self element”) and the first line of defense 
represented by granulocytes, mast cells and macrophages (Matzinger 1994). Also the degree and type of 
antigen presentation and other factors of innate immunity, such as the chemoldnes and cytoldnes
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secreted by the inflammatory cells are important Another consideration is the difference in the 
repertoire of ligand receptor between acquired and innate immunity: whereas the ligand-receptor 
diversity is very high in adaptive immunity, innate immunity is characterized by a more limited array of 
recognition patterns of invading micro-organism. The first consequence is that the primary handling of 
invading micro-organisms by effector cells of innate immunity is rarely optimal when this micro­
organism is a pathogen for a specified host. The second consequence is that any genetic weakness in 
handling and managing a pathogenic organism by a host is more likely to occur during the primary 
infection, before the lymphocytes with specifically selected T cell receptors come into play.
2.1.2 H e lp e r ,  S u p p re s s o r  a n d  E f f e c t o r  Im m une C e l l s  -  C u r r e n t  C o n c e p ts
Classically, in a granuloma, macrophages and perforin-containing cytotoxic CD8+ T 
lymphocytes were considered the main effector cells, and the CD4+ T helper cells were believed to be 
the main orchestrating cells. This was mainly because CD4+ lymphocytes together with the professional 
antigen presenting cells (APC) (i.e. having MHC class 2 on their surface) are the main actors of the 
afferent phase of the CMI against particulate antigens. Antigen presentation and selection of specific 
clones of T lymphocytes were viewed as the cornerstones of adaptive cellular immunity, enabling the 
host to specifically recognize the invading microorganism, thereby tremendously augmenting the 
efficacy o f the CMI response.
However, this correct but relatively simple classic view is no longer tenable because of the 
more recent data showing that both the CD8 T lymphocytes and the macrophages are fully capable of 
secreting complex arrays of mediators that increase or diminish the CMI: they are part of the 
immunoregulatory network (Kemeny, Noble et al. 1994). For example, not only can CD8+ cytotoxic T 
lymphocytes produce the same array of cytokines as CD4+ T cells, they can be grouped into the same 
sub-groups of cytokine secretion pattern as CD4+ T cells namely type 1 and type 2 helper CD8+ T 
lymphocytes, which very importantly are also cytotoxic through perforin secretion (Sad, Marcotte et al. 
199S). These two subsets termed TCI and TC2 can both induce delayed type hypersensitivity reactions, 
the latter with more eosinophils (Li, Sad et al. 1997). Similarly, the macrophage is also a critical cell in 
up-regulation of CMI locally and generally, by secreting important cytokines such as interleukin (IL)- 
12, IL-18, tumor necrosis factor (TNF)-a, IL-1 and the different types o f interferons (IFN). On the 
other hand, it is now clear that CD4+ T lymphocytes are also capable of cytolytic activities in vitro and
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in granulomas (Hancock 1989; Pithie, Rahelu et al. 1992) therefore showing that at least some CD4+ T 
lymphocytes have effector cell capabilities.
Another important debate deals with suppressor T lymphocytes, a topic of important confusion 
and controversy until recently (Kaufmann 1994). Suppression is defined as the decrease of proliferation 
in standard lectin-induced lymphocyte stimulation tests (LST) after the introduction of lymphocyte 
subsets responding to particular antigens (Mehra, Mason et al. 1979). Using this method, however, there 
is no indication of the mechanism of suppression. Several possible mechanisms may be mediated by 
different lymphocyte subsets. In the granuloma, two levels of suppression are theoretically possible: the 
first one is at the level o f innate immunity and the inflammatory effector cells, most commonly through 
apoptosis, but also possibly through unresponsiveness, as in the foamy macrophages of lepromatous 
leprosy. The second level involves defective T cell presentation leading to tolerance through apoptosis 
or anergy of specific T cell clones. This is now believed to be through the lack of an appropriate 
secondary co-signal, either through a cell surface co-stimulatory signal, such as CD 86 (B7-1) - CD28 
engagement, or through the appropriate array of cytokine.
These suppressor cells do exist (see the lepromatous leprosy section, page 24) but have never 
been conclusively and clearly identified. They were first believed to be of CD8+ phenotype (Modlin, 
Mehra et al. 1986), but it now appears that these are in fact only one component of a broader group of 
cytolytic and secretory cells of various phenotypes. These cells would be able to induce apoptosis or 
inhibit the activation of other immune cells through a range of ligand-receptor mechanisms and/or 
secretion of critical mediators, respectively.
Macrophages can also secrete suppressor factors under specific states of maturation and/or 
types of infection. For example, secretion of prostaglandin E2 (PGE2) is important in the suppression of 
macrophage activation: it induces IFN-y unresponsiveness, down modulate the MHC class 2 expression 
and the oxydative burst (Krahenbuhl 1994). EL-6 has been recently identified as a potent suppressor of 
T lymphocyte activation secreted by bone marrow derived macrophages infected with mycobacteria 
such as Mycobacterium bovis strain ‘bacille de Calmette et Guerin’ (BCG) and M. avium (Van 
Heyningen, Collins et al. 1997). Interestingly, this high level o f IL-6 secretion was characteristic of 
infection with mycobacteria. Listeria monocytogenes and Leishmania mexicana infected macrophages
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did not secrete this suppressor factor. This interesting finding need to be confirmed by further studies 
exploring the mechanisms of up-regulation of expression of IL-6 in macrophage-infected macrophages 
(Russell, Sturgill-Koszycki et al. 1997). In addition, IL-4, secreted by mast cells and both CD4 and CD8 
T cells, can provoke apoptosis of stimulated, but not resident, monocytes, being qualified of “major 
monocyte deactivating factor*' by these authors (Mangan, Robertson et al. 1992). This apoptosis- 
promoting action is mediated through the down regulation of CD 14, which is the receptor for complexes 
of lipopolysaccharides (LPS) and LPS binding proteins that are required for monocyte activation 
(Heidenreich, Schmidt et al. 1997). Interestingly, LPS, macrophage colony stimulating factor (M-CSF), 
TNF-a and EL-ip are all factors capable of activating monocytes/macrophages, with prolonged survival 
and inhibition of apoptosis (Mangan, Welch et al. 1991).
Depending upon the system studied, it appears that the apoptosis inducing mechanisms are 
independent of specific cell surface markers previously thought to be important, such as CD4 or CD8, 
but rather to the up-regulation of key factors such as, for example, the Fas/Fas ligand under the 
appropriate cytokine milieu. Markers of suppressive activity may exist, but they remain to be identified, 
as do markers of memory state of lymphocytes (London, Perez et al. 1999), (see also section S page 60). 
In the granuloma, IL-10, (which is currently identified as a prime cytokine in down-modulating the 
immune response) (Muraille and Leo 1998) and TGF-(3, the main anti-inflammatory cytokine, are now 
believed to be very important mediator of the down-regulation of the immune response including CMI. 
More specifically, it is now proven that this cytolytic activity (i.e. induction of apoptosis) is not specific 
of any lymphocyte sub-population and is in fact part of a more general mechanism of tissue homeostasis 
in multi-cellular organisms (Cohen 1999).
In conclusion, it appears that in efficient CMI, several cell types can have the orchestrating and 
effector function, depending on the nature of the infectious process. It should also be stressed that the 
helper, suppressor and effector activities are loosely dependant, not to say independent of the CD4 and 
CD8 molecules, whose main function remains the stabilization of the TCR/CD3 -  MHC/foreign 
molecule fragment during antigen presentation. Responses characterized by dominant CD4 and CD8 
lymphocytes will depend on the dominance of phagocytized particulate antigens (Ag) versus 
intracytoplasmic Ag, respectively. In mycobacterial infections in humans, it is to be expected to observe
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predominant CD4 T lymphocytes due to presentation of processed phagocytozed bacteria. In this 
system, CD4 T cells have been shown to have both helper, cytotoxic functions and, more rarely, 
suppressor function (Modlin, Mehra et al. 1986). CD8 T cells are also present in lesser numbers in 
mycobacterial infection, either because mycobacteria escape in the cytoplasm or secrete proteins, the 
peptide fragments of which can be presented with MHC class I molecules. CD8 have been shown in 
this system to have cytotoxic, suppressor and, less frequently, helper activities (Modlin, Mehra et al. 
1986; Li, Sad et al. 1997).
To illustrate the role of CD4 and CD8 molecules in CMI and open further thoughts and 
discussion, CD4/CD8 double knockout mice have been generated and tested in intracellular infections. 
These mice have a larger granulomatous response against heat killed BCG and heat killed 
Corynebacterium parvum than did control mice. However, CD4/CD8 KO mice challenged with live 
BCG showed initially fewer and smaller granulomas but later more and larger granulomas than control 
mice. Interestingly, the level of IFN-y mRNA was similar in CD4/CD8 knockout and control mice. 
Inoculation of live BCG resulted in progressively larger granuloma with higher bacterial loads within 
these lesions (Senaldi, Saklee et al. 1999). Therefore, and to generalize these findings, CD4 and CD8 
are not essential to elicit a granulomatous response against intracellular bacteria and adequate cytokine 
response such as the secretion of IFNy, but contribute to improve the host defense against live 
mycobacteria. This latter finding is not surprising in light of the critical role played by CD4 and CD8 
for a successful antigen presentation and subsequent adaptive CMI with efficient acquired and memory 
cell immunity.
2.1.3 How C a n  CMI B e  S tu d ie d ?
One important drawback in studying CMI is that relatively few in vivo tests and in vitro means 
and techniques are presently available, and even fewer methods were successful before recombinant 
DNA technology and molecular definition of cytokines became available. Similarly, at the local 
microenvironment (i.e. the granuloma), functional tests are still impossible to perform because in vitro 
reconstitution of granulomas has not yet been achieved. The standard in vitro test for acquired CMI is 
the lymphocyte stimulation test (LST), which is a development of the former, which measures cell 
proliferative response through incorporation of tritiated thymidine in mononuclear cells stimulated with
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specific antigens. In vivo, CMI may be measured through injection of cocktails o f antigens able to elicit 
delayed-type hypersensitivity (DTH) reaction in the patient. However, DTH is not synonymous of CMI 
but rather represent an extreme, or better said, a polarized aspect o f CMI (see next section). DTH may 
also be interpreted as the memory side of adaptive CMI and the phenomenon is probably highly 
dependant on the rapid secretion of appropriate chemokines.
New means to explore factors regulating CMI is to assess KO mice, to perform longitudinal 
studies using cytokine probes and markers either at the mRNA level or the protein level, respectively, in 
ex vivo or in situ studies. Those means have already permitted the achievement of tremendous advances 
in leprosy and mycobacterial research. The results of some of these new means will be presented in the 
next sections.
2 .1 .4  P r e s e n t a t io n  o f  N o n -P r o t e in  F r a g m e n t s  t o  T  C e l l s
This breakthrough in the understanding of antigen presentation of non-peptide antigens has 
been recently characterized. These non-peptide antigens are mainly complex lipids (lipids and 
glycolipids) with phosphate residues, which are mostly presented with CD1 molecules, a recently 
characterized third lineage of antigen-presenting molecules (Porccili, Morita et al. 1992; Tanaka, Sano 
et al. 1994; Grant, Degano et al. 1999) (reviewed by (Sugita, Moody et al. 1998)). In humans, several 
CD1 molecules have been identified, which are capable to mediate the generation of strong CMI to 
various microbial antigens (Fairhust, Wang et al. 1998), including the mycobacteria (Beckman, Melian 
et al. 1996). Importantly for leprosy, CD1 expression, similar to other MHC molecules, is up-regulated 
in patients with tuberculoid leprosy and reversal reaction whereas there was an absence of 
CDlexprcssion in lepromatous leprosy (Modlin and Rea 1994) (Sieling, Jullien et al. 1999). During 
culture of blood monocytes from both categories of leprosy patients, however, CD1 molecules could be 
induced at similar levels. This suggested that the lack of CD1 expression locally in the skin of 
lepromatous patients is related to local factors rather than defective CD1 expression in leprosy patients 
(Sieling, Jullien et al. 1999). The situation is quite similar in tuberculosis, whereby CD1+ antigen 
presenting cells (APC) down-regulated CD1 surface expression after infection with live Mycobacterium 
tuberculosis. This effect is not due to secretion of cytokine, requires live bacteria and is unique to CD1 
since MHC molecules were not down-regulated (Stenger, Niazi et al. 1998). This new escape 
mechanism described in vitro with M. tuberculosis fairly matches the in vivo situation in leprosy since
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MHC class II Ag are present and not down-regulated in patients with lepromatous leprosy (Codings, 
Tidman et al. 1985). However, in vivo, it is not known whether this is a direct effect of M. leprae or a 
consequence of the cytokine milieu, since GM-CSF, a cytokine highly expressed in tuberculoid leprosy 
can up-regulate CD1 expression on APC, whereas IL-10 down-regulates CD1 expression (discussed and 
reviewed in (Yamamura, Uyemura et al. 1991).
2.1.5 C y to k in e  N e tw o r k  a n d  C y to k in e  F u n c t io n s  in  t h e  G r a n u lo m a  
2.1.5.1. Important Cytokines Secreted by Macrophages Composing the Granuloma
All ceds in a granuloma can secrete cytokines. Notably, eosinophils and other inflammatory
cells, which are characteristicaUy present in certain types of granuloma elicited by parasites such as 
Schistosoma mansoni, do secrete cytokines and other mediators. The classical view is usually that 
granulocytes are present earlier than the mononuclear cells at site of inflammation due to invading 
micro-organisms. This classic view has been challenged by recent kinetic studies, in which 
accumulation o f granulocytes does not always precede, but sometimes follows the recruitment of 
mononuclear cells, depending on the type of injury elicited by the injurious agent (Buchanan and 
Murphy 1997). Therefore, the hypothesis implying that other cell types would be important in ‘pre­
defining’ a cytokine milieu in which lymphocytes and macrophages would mature is not universally 
applicable or accepted in every bacterial or fungal disease.
The paragraphs below will focus on the cytokines secreted by macrophages (M4>) within the 
granuloma. Macrophages (M4>) can secrete two types of cytokines: on the one hand they may secrete 
IL-1, TNF-a, EL-12 and IL-18 and on the other hand they can secrete IL-10, IL-6 and TGF-p. These 2 
groups of cytokines have pro-inflammatory and anti-inflammatory properties, respectively. Using the 
various models of inbred mice, Mills recently proposed and defined M-l and M-2 types of 
macrophages, following the model of T helper lymphocytes and stressed their importance since, in 
many models o f intracellular infections, M4> are in the first line of defense against an infectious agent 
(Mills 1999), although this cannot be generalized for all infections, such as cryptococcosis where 
lymphocytes are recruited slightly before monocytes/M® (Buchanan and Murphy 1997). Mills showed 
that resident peritoneal M<X> from strains of inbred mice which secrete higher amounts o f IL-12 and y- 
IFN, and those which secrete TGF-P, have a corresponding difference in activation potential in response
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to y-IFN and LPS (Milk 1999). Similarly, cultured dendritic cells (DC) can be induced to mature into at 
least 3 sub-types termed DCO, DC1 and DC2 depending of the relative amounts of IFNy + IL12 and IL- 
4 cytokines in the culture media in addition to GM-CSF and IL-3. Those that matured with IL-12 and 
IFNy in the medium (DC1) ako secreted the highest levek of IL-12 (Sato, Iwakabe et al. 1999). 
Whether this dichotomy will prove to be valid in a heterozygous outbred population of humans and 
other animals is worth of testing, especially with correlation with important markers of natural 
resistance to intracellular infection, such as the beg / Nrampl gene. This is also a strong invitation to 
study the pattern of cytokine secretion of antigen presenting cells (APC) , which might enable 
identification of the genetic factors responsible for allergic responses to common antigens.
The disruption of murine genes by specifically targeted vectors to obtain gene deficient 
homozygous mice, otherwise called knockout (KO) mice, is a very powerful tool to investigate whether 
a certain mediator is critical or not (i.e. can be replaced by redundant mediators) during granuloma 
formation and development of a protective CMI. Results of these in vivo experiments in mice are 
compelling, especially concerning cytokines in the M. tuberculosis model: IFN-y is absolutely critical in 
the defense against mycobacteria since IFN-y gene KO mice are incapable to handle Mycobacterium 
tuberculosis and rapidly die from the infection (Cooper, Dalton et al. 1993; Flynn, Chan et al. 1993). IL- 
18 and IL-12 are also essential for the establkhment of a strong CMI with efficient clearance of 
pathogenic bacteria, and both act through the action of IFN-y (Cooper, Magram et al. 1997; Mastroeni, 
Clare et al. 1999; Sugawara, Yamada et al. 1999). TNF-a is ako important for granuloma formation and 
clearance of pathogenic M. tuberculosis (Kaneko, Yamada et al. 1999). In addition, T cell activation, as 
measured by DTH, was markedly reduced in IL-12 -/- mice (Cooper, Magram et al. 1997), highlighting 
the crucial role of this cytokine in this model system. IL-1 knockout mice have recently been produced 
(Horai, Asano et al. 1998) but, to the author’s knowledge, have not been tested in mycobacterial 
infection systems.
The case of IFNy deserves special consideration because of its critical function in granuloma 
formation, clearance o f intracellular bacteria through activation of MO (reviewed by (Krahenbuhl 1994) 
and the fact that it k  believed to be primarily secreted by T lymphocytes and natural killer (NK) cells. 
Of important note, MO can ako secrete y-IFN (reviewed in (Gessani and Belardelli 1998). The in vivo
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biological relevance of y-IFN secreted by macrophage is still unclear, but the possibility that y-IFN may 
have a more important role than previously thought in early phase of host response to infectious agent 
through NK and M4> secretion is interesting. It would also explain the profound deficiency in hand ling  
intracellular pathogen such as Mycobacterium tuberculosis by y-IFN knockout mice (Cooper, Dalton et 
al. 1993; Flynn, Chan et al. 1993), which somewhat differs in severity with CD4 and/or CD8 KO 
(Myers Caruso, Serbina et al. 1999; Senaldi, Saklee et al. 1999). However, the situation may be 
different in murine models and humans.
Fine dissection o f the promotion of y-IFN gene expression in T cells, the major source of this 
cytokine, indicates that the strongest up-regulation of y-IFN secretion in CD4+ T cells occur when there 
is TCR activation through antigen presentation. However, recently, it has been shown in vitro that 
another way of inducing prolonged y-IFN production independently of antigen presentation was through 
IL-18 and IL-12 added together in the culture medium (Yang, Murphy et al. 1999). This finding is 
interesting in view of the recent in vivo results obtained in CD4/CD8 double KO mice, in which levels 
of g-IFN mRNA were similar to levels in control mice after infection with intracellular bacteria 
(Senaldi, Saklee et al. 1999).
As stated above, studies in KO mice may reveal compensatory mechanisms. Are there any IFN 
and/or IL12 deficient humans with disseminated intracellular infections? If none has been found and 
characterized so far, it is not the case concerning the receptors to these two critical cytokines. In contrast 
to cytokines, cytokine receptors may have less redundancy than the former. In man, children have 
recently been identified with IFN-y and IL-12 receptor deficiencies, and diagnosed with disseminated 
mycobacterial and severe Salmonella sp. infection (Newport, Huxley et al. 1996; Altare, Durandy et al. 
1998). Because there is now an intensive search for cytokine gene deficiencies in humans, it is likely 
that if a severe disease had been linked to a cytokine deficiency, it would have already been reported. It 
is therefore likely that cytokine mutations inducing mild or moderate cytokine malfunction with more 
insidious clinical consequences exist in nature and will be characterized in the future. This has already 
been shown for cytokine receptor deficiencies, where mild or severe clinical consequences are a 
function of the mutation sites (Altare, Durandy et al. 1998).
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2.1.5.2 The Potential Complexity of Cytokines and Other Mediators Regulating the 
Granuloma
In an attempt to draw parallel models between T lymphocytes and macrophages, there is an 
important common concept: immune cell activation and maturation. There is a striking parallel between 
T cell clones which can mature from a uncommitted ThO phenotype to mature, irreversibly polarized T 
cell clones (see part 2 of sme chapter, page 26-28), and monocytes, which can irreversibly mature either 
towards specialized phagocytic or specialized dendritic antigen presenting cells. They can exhibit a 
different morphology, such as epithelioid M4> or dendritic cells (DC), and different surface receptors 
and cytokine secretion patterns. Increasingly, data show that monocytes, mature macrophages, 
activated/ epithelioid macrophages and other antigen presenting cells differ not only in their function 
and their relative expression of surface markers, but also in their responsiveness to cytokines. For 
example, human synovial fluid macrophages and human blood monocytes differ in their response to IL- 
4 (Hart, Ahem et al. 1993). Whereas IL-4 can suppress the release of both IL-12 and IL-10 by freshly 
cultured monocytes stimulated by lipopolysaccharides (LPS), synovium-derived mononuclear cells 
from the joints o f patients with rheumatoid arthritis and LPS-stimulated monocyte-derived macrophages 
that had matured in vitro, down-regulate only IL-12, but not IL-10, when treated with IL-4. This 
difference may be attributable to a reduction in mRNA expression of the yc subunit (IL2Ry) of the IL-4 
receptor in the M4>, which diminishes over time and correlates with a loss of IL-10 down regulation. 
This finding is compatible with an increase o f the suppressor activity of IL-4 in the granuloma 
composed of mature macrophages (Bonder, Finlay-Jones et al. 1999) and offers a glimpse at the 
potential differences between monocyte or non stimulated, resident histiocytic cells and stimulated, 
mature phagocytic cells such as epithelioid MO and lepromatous MO.
In culture, bone marrow-derived dendritic cells can be induced to mature to different types of 
DC, depending on the composition of cytokines added to the culture medium. Specifically, adding IL- 
12 and IFNy to the medium elicits DC, termed DC1, with high presentation capability as assessed by 
high expression of MHC molecules and co-stimulatory markers. In contrast, adding IL-4 to the medium 
favors the maturation of another type of DC, termed DC2. They can in turn favor the maturation / 
differentiation of T lymphocytes into Thl and Th2 (see later section page 28), respectively, in a specific
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manner (Sato, Iwakabe et al. 1999). The responsiveness o f these different sub-types of DC to various 
cytokine milieus is currently being studied.
2.1.5.3 Mycobacterial Granulomas
Granulomas elicited by various mycobacteria do not present with the same morphology. The
prototype of mycobacterial granuloma is the one elicited by M. tuberculosis in humans. It is 
characterized by focal lesion containing a large central area of caseous, sometimes m in era lised  necrosis 
surrounded by a wide mantle of epithelioid macrophages and a few multinucleate giant cells (MGCs), 
with nuclei at their periphery called Langhans’ MGCs. Within and at the periphery of this mantle of 
M4> are lymphocytes, mostly T cells. The granulomas seen in patients with tuberculoid leprosy are very 
similar to granulomas elicited by agents causing tuberculosis in mammals and birds, except that central 
necrosis is rarely if ever seen (Job 1994). If granulomas elicited by Mycobacterium infections are often 
discrete entities with low numbers of organisms in the lesions, other forms of mycobacterial disease 
exist in which the granulomas coalesce, forming sheets of macrophages loaded with an large numbers of 
mycobacteria. Examples are paratuberculosis of ruminants (Barker, van Dreumel et al. 1993; Jones, 
Hunt et al. 1997), and, in man, the lepromatous forms of leprosy (Job 1994)and mycobacterial 
infections in persons with the acquired immunodeficiency syndrome (AIDS).
A fascinating recent approach concerns the partial reproduction of different types of 
mycobacterial granulomas through the use of inbred strains of mice (Veazey 199S) and more recently 
through the study of gene-knockout mice. Targeted inactivation of critical genes coding for cytokines 
and other products believed to be important in CMI and granuloma formation have resulted in 
unorganized granulomas with fewer lymphocytes and uncontrolled replication of mycobacteria. For 
instance, no necrosis was seen in the granuloma of IL-18 deficient mice infected with mycobacteria 
(Sugawara, Yamada et al. 1999).
In a murine model of tuberculosis, aggregation of bone marrow macrophages was shown to be 
mediated by TNF (Barnes, Abrams et al. 1993). The study of TNF-a-deflcient mice showed that TNF-a 
has an important role in protection against mycobacteria but plays an indirect role in granuloma 
formation (Kaneko, Yamada et al. 1999).
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2.1.5.4 Conclusion
Studies of the cytoldnes secreted during intracellular infections indicate that an array of
cytokines, e.g. IFN-y, TNF-a, IL-1, IL-12 and IL-18, secreted by both lymphocytes and macrophages,
are critical for an effective granulomatous response capable of eradicating or at least containing the
invading micro-organisms. Up-regulation or suppression of the activation state of macrophages
composing a granuloma is of uppermost importance to the successful management of intracellular
infections, and is mediated by the helper and suppressor activity of cytokines secreted not only by T
lymphocytes, but also by other cell types, including the macrophagic cells.
However, many critical points in granuloma formation and successful eviction of intracellular
infection are still poorly understood, primarily due to the fact that the study of activated and manure
macrophages in vitro remains quite difficult Macrophages apparently die rapidly after isolation from a
granuloma (J. Kraenbuhl, personal communication) whereas lymphocytes survive more easily in
standard culture conditions. Pre-culturing blood-derived monocytes in culture medium containing
defined sets of recombinant mediators for an appropriate interval before undertaking functional studies
at the protein and mRNA level o f the macrophages may help to unravel the complexity of immuno-
regulatory mediators acting on the evolving granuloma (Hart, Jones et al. 1995).
2 .1 .6  D a t a  o n  CMI o f  M. le p r a e  E x p o s e d  P e r s o n s  a n d  ‘I n d e t e r m i n a t e ’
L e p r o s y  P a t ie n t s
Considerable debate still exists concerning the pathogenesis of Hansen’s disease. Evidence 
from the epidemiology of the disease suggests that the vast majority of exposed individuals will never 
develop the disease (reviewed by (Harboe 1994)). The incubation time is also believed, without proof 
due to the present lack of reliable test of exposure, to be quite long, possibly decades (Fine 1982). 
Alternatively, healthy contacts may be exposed several times and during a possible weakening of innate 
or acquired immunity, those individuals might eventually develop leprosy. There is virtually no data 
and hence no evidence of difference of CMI in individuals recently exposed to M. leprae, which would 
predict whether an individual will or will not develop leprosy.
The situation is further complicated in leprosy where very few pure, specific M.leprae antigens 
are presently available to test CMI. CMI in leprosy has been classically studied through the injection in 
the skin of killed whole M. leprae of armadillo or nude mouse footpad origin (lepromin), called the
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Mitsuda test This test measures the ability of an individual to generate a granulomatous response 
against extract of M. leprae after 2-3 weeks. In a proportion of patients, however, there is a DTH-like 
reaction within 2*3 days after injection of lepromin, called the “early Fernandez reaction”, sim ila r to 
what is seen after injection ofM. tuberculosis protein purified derivative (tuberculin) in M. tuberculosis- 
exposed or M. bovis BCG-vaccinated individuals. Disrupted, purified mixtures o f proteins have been 
developed from the leprosy bacillus, called leprosin, in an attempt to produce early Fernandez reaction 
without late development of granulomas at site o f lepromin injection, with variable results. However, 
several drawbacks exist using those reagents. First, it is well established that mycobacteria share 
numerous antigens and epitopes, complicating the interpretation of any positive result. Second, due to 
the lack of in vitro culture of M. leprae, one cannot be completely sure that the CMI is not directed 
against antigens of mouse or armadillo origin, even though this seems quite unlikely (reviewed in 
(Harboe 1994).
2.1.6.1 Indeterminate Leprosy
Indeterminate leprosy is characterized grossly by a usually unique discrete slightly
depigmented lesion that is often overlooked or considered unimportant by the patient. Microscopically, 
the skin has sparse, pcri-adnexial and peri and intra-neural mononuclear infiltrates of predominantly 
lymphocytes but no granuloma present. Neural infiltrates with nerve damage are sometimes seen. Rare 
acid fast bacteria are found in nerves, arrector pili muscles or in the region immediately beneath the 
basal layer of the epidermis (Job 1994). These cases are unfortunately too rare and unpredictable to 
allow systematic sampling and collection of enough cases to study surface markers in situ in those 
lesions. With such a low level of inflammation, the only technology enabling the study of cytokines 
with sufficient sensitivity is the powerful reverse transcriptase- polymerase chain reaction (RT-PCR) 
technology. To the author’s knowledge, none of these studies have been performed so far.
2.1.6.2 Healthy Contacts
Healthy contacts with demonstration of exposure to M.leprae have been denonstrated in 1972
by positive lymphoblast transformation tests (Godal, Ldfgren et al. 1972) . Lymphocyte stimulation 
tests (LST) confirmed these results and showed increased specificity using purified protein antigens 
from M. leprae (Closs, Reitan et al. 1982). Considerable variation is seen in these healthy contacts, as a 
group, and it is not known whether the lowest responders might develop the disease and the highest
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responders (in the range of tuberculoid patients) will remain disease free. In addition, there is so far no 
report o f a recombinant M. leprae protein that does not cross-react serologically or with LST after 
exposure to other mycobacteria. Such peptide or lipid antigens would be o f the greatest importance to 
compare the epidemiology of the leprosy infection versus leprosy disease.
One test may however provide an indication of developing multibacillary lepromatous leprosy. 
This is when a healthy contact does not present with a positive Mitsuda reaction (testing the ability to 
mount a CMI), even though he/she has been in contact with (a) leprosy patient(s) for years. It has been 
shown that these individuals are at higher risk to develop lepromatous leprosy (reviewed in Harboe 
1994, page 95). If a sensitive and specific test for exposure existed (requiring antibodies raised 
specifically against an antigen unique of M. leprae), an important question concerning M. leprae 
pathogenesis could be answered. Specifically, it would indicate whether these individuals are already 
showing a strong down modulation of CMI (type 2 milieu -  see section 2 page 40) with detectable 
antibodies or are unable constitutively (without priming by infection) to mount any innate and acquired 
immunity against the pathogen with a complete absence of acquired immunity.
2 .1 .7  F u l l y  E s t a b l is h e d  ‘D e t e r m in a t e ’ L e p r o s y
Fully developed, ‘determinate’ leprosy is characterized by several clinical and pathologic 
manifestations that correspond to markedly different immunological features, which have been linked 
and integrated by the classification of Ridley and Jopling (Ridley and Jopling 1966) (Figure 2.1), fully 
establishing the concept of a clinical, pathologic and immunological spectrum. This spectrum has two 
polarized, rather stable manifestations: Polar lepromatous (LL) and polar tuberculoid (TT) of Hansen’s 
Disease. In between those two extremes are intermediate manifestations named borderline lepromatous 
(BL), borderline leprosy (BB) and borderline tuberculoid (BT) leprosies. Strong CMI is the important 
feature o f the polar tuberculoid patients. Conversely, the lepromatous patients, both BL and LL are 
characterized by a moderate and marked deficiency of cell mediated immunity, respectively. The 
different borderline leprosy manifestations are typically unstable and most frequently subjects to burst 
of increased cellular immunity called reversal reactions (RR) or increased immunity seen in 
lepromatous patients called erythema nodosum leprosum (ENL). ENL is believed to be a type III 
hypersensitivity reaction with vasculitis. These immunolo-pathological reactions result in various
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sequelae, the most important being nerve damage. Figure 2.1 summarizes the salient features of the 
immunological spectrum o f leprosy.
The main classification (Ridley and Jopling 1966) describes S categories (Figure 2.1) and is 
primarily for research use. Follow-up biopsies indicate that those patients in the borderline spectrum 
evolve towards either the lepromatous side or the tuberculoid side of the spectrum, if  left untreated. 
Since a RR is an upgrade o f cellular immunity, the consequence of a RR is often regarded as a shift to 
the left side o f the spectrum (Figure 2.1) corresponding to a position in the spectrum closer to the 
tuberculoid pole.
ibact. load;
AD
severity, distr 
of lesions
"PAUCIBACILLARY" "M U LTIB AC ILLARY"
Figure 2.1: Immunological spectrum of leprosy. This diagram summarizes the salient features 
of the spectrum of Leprosy as defined by Ridley and Jopling. TT = polar tuberculoid, BT = 
borderline tuberculoid, BB = borderline, BL = borderline lepromatous, LL = polar lepromatous.
Since there is so far no evidence o f any genetic diversity by restriction length fragment 
polymorphism or other methods amongst M.leprae obtained from diverse geographic areas (Williams, 
Gillis et al. 1990; de Wit and Klatser 1994), it is currently believed that the leprosy bacillus is 
phylogenetically represented by one strain with no variation in pathogenicity. If so, then it is assumed 
that the clinico-pathologic and immunologic variations observed in Hansen’s disease patients may only 
represent the ability o f the host to cope with the microbe. It is thought that differences in innate and 
acquired immunity are the key to the understanding of die leprosy spectrum.
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2.1.7.1 CMI in Tuberculoid Patients
Tuberculoid leprosy is characterized by a few limited, well demarcated lesions in the skin
containing well formed and organized granulomas resembling the granulomas in tuberculosis except for 
an absence of central necrosis. Epithelioid macrophages, which are thought to be strongly activated 
Md>, are most common cell in the granuloma together with lymphocytes with a CD4-.CD8 ratio of ~ 2:1 
(Modlin, Hofman et al. 1983; Modlin and Rea 1994). In tuberculoid granulomas, immunohistochemistry 
from frozen biopsies shows that the CD4 positive cells are distributed in the center of the granuloma in 
close association with the macrophages and the CD8+ T cells are primarily distributed at the periphery. 
Double immunofluorescence labeling and flow cytometry show the large majority of CD4+ T cells to be 
CDw29+ and CD45RO+, suggesting that the CD4+ cells are of the activated/memory phenotype 
(Modlin, Melancon-Kaplan et al. 1988). The majority of CD8+ T cells are CD28 positive, a prime 
marker of positive co-stimulation following TCR engagement CD28 is an important costimulatory 
marker necessary to up-regulate T cell activation upon T cell presentation. The antigen presenting cells 
(APC) in the epidermis, the Langherans’ cells, as assessed by the CD1 marker by 
immunohistochemistry, are numerous in the overlying epidermis as well as at the periphery of the 
granuloma (Modlin, Hofman et al. 1983). Numerous CD1 positive dendritic cells are also present in 
granulomas of patients suffering from Reversal Reaction.
In tuberculoid lesions, there are 100 times more lymphocytes capable of proliferation in 
response to M.leprae antigen than in the blood of the same patient, as assessed by T cell precursor 
frequency analysed by limiting dilutions of T cells (Modlin, Melancon-Kaplan et al. 1988). T cell lines 
generated from these lesions are mostly of helper phenotype (Modlin, Mehra et al. 1986) and they 
secrete a predominance of type 1 cytokines, independently of whether the cells are of CD4 and CD8 
phenotype. The lesions have a strong ex vivo amplification signal for y-IFN, IL-2 and lymphotoxin 
(TNF-3) after relative RT-PCR standardized on CD3-5 (Yamamura, Uyemura et al. 1991). T 
lymphocyte lines (T cell clones) extracted from these tuberculoid lesions have the same characteristics, 
that is y-IFN, IL-2 and GM-CSF production, with little or no secretion of IL-4, IL-5 or IL-10 (Salgame, 
Abrams et al. 1991). Similar results are found in the blood, assessing M. leprae stimulated total PBMC 
as well as T cell clones, except that such a polarization and clear cut results are not found. Notably, half
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of the tuberculoid patients has, directly or from T lymphocyte clonescultured from petpheral blood, co­
expression o f IL-4 and IFNy messenger RNAs (mRNA) (Salgame, Abrams et al. 1991; Misra, Murtaza 
et al. 199S). Messenger RNAs encoding cytokines mainly secreted by macrophages, such as II-1 p, TNF- 
a , GM-CSF and IL-6, were found at high levels in tuberculoid lesions. Notably, the highest expression 
of y-IFN in situ and ex vivo has been found in reversal reaction (Cooper, Mueller et al. 1989).
2.1.7.2 CMI in Lepromatous Patients
Lepromatous leprosy is characterized by numerous poorly demarcated and sometimes nodular
cutaneous lesions conposed of sheets of foamy macrophages with ill defined cell boundaries, containing 
myriads of acid fast bacilli. The lymphocytes are scattered throughout the lesion and are not statistically 
significantly in reduced numbers compared to TT lesions. The CD4:CD8 ratio is lower, however, in the 
range of 0.5:1 and the macrophages/lymphocytes ratio has not been examined and compared to 
tuberculoid lesions. The majority of CD8+ lymphocytes are devoid of the CD28 co-receptor of T cell 
activation, but express high levels of CTLA-4 (CD152) (Schlienger, Uyemura et al. 1998). This co­
stimulatory molecule is transiently expressed in activated T cells, is believed to deliver a negative 
immuno-regulatory signal and is suspected to be able to induce anergy and acquired tolerance (recently 
reviewed by (Sayegh 1999). The proportion of memory/activated CD4+ T cells, as assessed by the 
CDw29+ and the CD45RO+ markers is lower than the one observed in the tuberculoid patients, with 
notably more CD4+ T cells devoid of CDw29 and expressing the isoform of CD45 (CD45RA) 
associated with naive T cells (Modlin, Melancon-Kaplan et al. 1988). CD 1-positive antigen presenting 
cells are infrequent in lepromatous patients (Modlin, Hofman et al. 1983; Sieling, Jullien et al. 1999). 
Recently, the discovery of CD1 mediated antigen presentation has been emphasized (Porcelli 1995) 
(Maher and Kronenberg 1997). CD1 is a family o f non-polymorphic transmembrane proteins that 
associate with beta-microglobulin, resemble MHC class I molecules structurally and are prominently 
expressed on APCs. The unique feature of CD1 restricted presentation is the ability to present non­
peptide, lipid and lipid-containing antigens to CD4 negative T cells (Porcelli, Morita et al. 1992; Grant, 
Degano et al. 1999; Sieling, Jullien et al.1999). This third lineage of presentation molecules (Grant, 
Degano et al. 1999) have been shown to play a significant role in immunity against mycobacteria and 
M. leprae since (1) the CD1 molecules are down-regulated in lepromatous leprosy in vivo (Sieling,
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Jullien et al. 1999), (2) there is down regulation o f CD1 on APC following in vitro infection with 
virulent M. tuberculosis, suggesting a new escape mechanism (Stenger, Niazi et al. 1998) and (3) there 
is abrogation of M. tuberculosis induced y-IFN production by 0 )1  restricted T cell lines with CD lb 
monoclonal antibodies in vitro (Gong, Stenger et al. 1998). Lipid and glycolipids such as lipo-arabino- 
mannan (LAM) are typical antigens that are CD1 restricted and presented to a|3 double negative CD4-, 
CD8-, T cells. It also appears that CD1 mediated presentation is rather broad and also involves 
presentation of non-peptide antigens from gram negative bacteria. It has already been shown for 
Haemophilus influenzae type B (Fairhust, Wang et al. 1998).
The T cells in lesions of lepromatous leprosy have been shown to exhibit significant 
suppressive activity, as evidenced by the inhibitory effect of the addition of Dharmendra lepromin after 
lectin-induced proliferation (Modlin, Mehra et al. 1986). These suppressive activities were found 
mostly, but not exclusively, in CD8+ T cell lines. The lesions have a strong ex vivo amplification signal 
for IL-4, IL-S and IL-10 after relative RT-PCR standardized on CD3-5 (Yamamura, Uyemura et al. 
1991). In addition, after analysis of cytokine production profiles of isolated T cell clones, these CD8+ 
suppressor cells from lepromatous lesions have a strong expression of IL-4 and lower amounts of IL-S 
(Salgame, Abrams et al. 1991). Following this landmark discovery, several experiments were designed 
to demonstrate the suppressive role o f IL-4 in lepromatous lesions. Interestingly, IL-4 was shown to 
selectively augment the proliferative potential of PBMC from lepromatous patients, but not tuberculoid 
patients (Salgame, Abrams et al. 1991; Sieling, Abrams et al. 1993). These data together with other 
important findings of this important role o f IL-4 will be developed in the next section (page 36). The 
other important player of the down modulation of CMI in lepromatous lesions turned out to be IL-10 
and TGF-P which are mainly secreted by macrophages. Interestingly, M. leprae stimulated PBMC from 
patients and healthy donors secrete abundant IL-10. In this system, IL-10-blocking monoclonal 
antibodies significantly increased the secretion and proliferation o f T cells. These T cells have 
augmented y-IFN, TNF-a and GM-CSF (Sieling, Abrams et al. 1993). Lastly, and very importantly, 
recombinant cytokines such as IL-2 and IFNy injected in the site of lepromatous lesions produced 
significant clearing of Af. leprae bacilli and recruitment of large numbers o f T cells, most of them being 
o f “helper” phenotype, with minimal side effects (reviewed by (Kaplan and Cohn 1991). These
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therapeutic trials are in any case fundamental because they indicate that the ‘primary defect’ of the 
specific anergic state and lepromatous leprosy research is not at the T lymphocyte level because the 
lesions are almost fully reversible if the right milieu is artificially recreated. The “defect” may rather be 
during antigen presentation or in an as yet not described deficient macrophage function (or a 
combination of defective functions). A very interesting opening in the direction of antigen presentation 
has been quite recently observed by Dr. Modlin’s group: they found a profound down regulation of B7- 
1 (CD80), a slight down-regulation of B7-2 (CD86) and a marked down-regulation of CD28 mRNA 
expressions in skin lesions of lepromatous patients, whereas CTLA-4 mRNA expression was up- 
regulated in lepromatous patients compared to tuberculoid patients, which had expressions of B7-1, B7- 
2, CTLA-4 and CD28 mRNA, in relatively similar levels. Moreover, in vitro, they showed that the B7-1 
(CD80), but not CD28, is crucial for the maintenance o f the CD4+ T cell response in tuberculoid 
leprosy (Schlienger, Uyemura et al. 1998). This finding points strongly towards APCs, on which the 
different types of B7 molecules are usually expressed at high levels. Importantly, the kinetics of the 
expression of the B7 molecules are important during an immune response. Elucidation of factors 
regulating the expression of B7-1 (CD80) and B7-2 (CD86) molecules over time on APC and 
macrophages in leprosy, and in particular indeterminate leprosy and evoluting borderline leprosy might 
enable leprosy investigators to gain insight into differences in antigen presentation in this disease. 
Longitudinal studies following M. leprae inoculations in animal models might also be critical in that 
regard.
2 .1 .8  C o n c l u s io n  o n  C M I  a n d  L e p r o s y
In conclusion, there has been a tremendous effort in the last 20 years to carefully study and
contrast the immuno-pathologic features of established leprosy, especially by Modlin and collaborators
(Modlin and Rea 1994). Careful review of CMI in leprosy leads to formulate the two following
statements and associate questions:
1 - Contrary to classic opinion, cell mediated immunity (CMI) mediated by T cells does exist
throughout the leprosy spectrum, even though it is greatly reduced in the lepromatous pole of the
spectrum, most probably contributing to the uncontrolled replication o f the organism. In contrast,
delayed-type hypersensitivity (DTH), is totally abrogated in lepromatous leprosy. The important
question is then whether this CMI down-regulation is critical and at the origin of the initial development
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of LL or accompanies and limits the consequences of a defect located elsewhere in the immune and 
defense system of the lepromatous patient
2- Likewise, it is an established fact that CMI is relatively high in tuberculoid pole of the 
disease spectrum. This CMI is not completely efficient since the organism does persist What is 
different between the CMI of an individual that rejected M.leprae and never had the disease and a CMI 
of a tuberculoid patient? And is there any difference at all? These are the crucial questions that might be 
answered only through animal models. One can, however, propose that CMI is higher in asymptomatic 
exposed individual as compared with tuberculoid patients but this has not been demonstrated by TTL 
and LST tests and thus remains to be proven.
2.2 TYPE I AND TYPE IIT LYMPHOCYTE HELP PARADIGM 
AND ITS APPLICATION IN LEPROSY
2 .2 .1  In t r o d u c t io n
This review focuses on the recent publications on the topic from leprosy research and other 
mycobacteria research and a few other diseases and animal models that can help to comprehend the 
consequences of the type 1 / type 2 T cell help paradigm in the understanding of the immune response 
to Leprosy, as Modlin and collaborators have done (Modlin 1994). Also mentioned will be the puzzles 
that still remain in this finely tuned network of cytokine cross regulations. Some important experimental 
results that are useful for the understanding of the research results published in this volume will also be 
developed and discussed.
2 .2 .2  O v e r v ie w  o f  t h e  T h I /T h2  P a r a d ig m
Recently, it has been established that CD4 positive T-helper lymphocytes are committed to 
secrete certain sets of cytokines that have been originally characterized from cloned cultured T 
lymphocytes of murine origin (Mosmann and Coffman 1987) and have differing functions in immune 
regulation (Lucey, Clerici et al. 1996).
At the clonal level, T lymphocytes bearing the ap  T cell receptor can be divided into at least 3 
subsets with regard to the pattern of cytokine secretion, as initially defined by murine CD4+ T cell 
clones cultured in vitro: The T helper type 0 (ThO), Thl and Th2 (Mosmann, Cherwinsld et al. 1986). 
This finding was subsequently shown to apply to humans (Romagnani 1991) and other animal species, 
in particular non-human primates (Ansari, Mayne et al. 1994). T helper type I cells mainly secrete IFN-
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y, TNF-P (lymphotoxin -  LT), GM-CSF and IL-2. They may also secrete under appropriate conditions 
low levels of IL-15. T helper 2 cells mainly produce IL-4, IL-S, IL-6, IL-10 and IL-13. Under 
appropriate conditions and depending on the species studied, Thl cells may also produce IL-10 
(Muraille and Leo 1998). ThO can produce a combination of IL-4, IFN-y and any of the cytolrines 
mentioned above. In T lymphocyte cultures (T cell clones), it appears that the ThO phenotype may be 
unstable and gradually evolves towards one pole or the other. Other researchers consider that unstable 
precursors of T cell clones subsequently mature to stable Thl, Th2 and stable ThO clones. Differences 
between groups and species of mammals are possible (Lucey, Clerici et al. 1996).
After extensive studies of Thl and the Th2 system applied in vivo and in vitro, several facts 
came to light: First, the most critical cytokines secreted by T lymphocytes with a defined, stable, 
“mature” cytokine pattern are y-IFN and IL-4, for Thl and Th2, respectively. Second, the Thl and Th2 
dichotomy also includes cells other than populations of CD4+ T lymphocytes, including also CD8+ T 
lymphocytes, termed Tel and Tc2 (Sad, Marcotte et al. 1995) and macrophages secreting IL-12 + IFNy 
and IL10, respectively. However, whereas IL-12 is an early, critical cytokine shifting the response 
towards type 1 cytokine secretion, IL-10 is a late cytokine that down-regulates inflammation and does 
not influence early type 2 differentiation (Muraille and Leo 1998).
2.2.3 T h e  A n ta g o n i s t i c  A c t io n s  o f  IL-4 a n d  IFN-y
IL-4 and IFN-y have antagonistic, but not symmetrical regulatory actions in the acquisition and 
maintenance of type 2 and type 1 CMI, respectively (Muraille and Leo 1998; Paludan 1998). Whereas 
IL-4 can drive the differentiation towards a type 2 response, IFN-y appears be dependant upon the 
secretion of IL-12 to be secreted by T lymphocytes. Both IL-4 and IFNy are then critical in the 
maintenance of their respective type of immune response and the inhibition o f the other type of 
response. Whereas the trigger of secretion of type 1 cytokines in the innate stage o f the immune 
response is now well established to be IL-12, in synergy with IL-18, secreted by the macrophages and 
APC, the early trigger of the type 2 response, believed so far to be early secretions of IL-4 is still ill- 
defined and subject to considerable debates (Haas, Falcone et al. 1998). Although it is suspected that 
mast cells and basophils, which are strong producers of IL-4, might be also early producers of IL-4 
driving outbred mammals to mount type 2 immune responses in vivo, this has not yet been formally
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demonstrated (reviewed in (Haas, Falcone et al. 1998). Another uncertainty is whether some subsets of 
antigen-presenting cells (APC), such as dendritic cells (DC), could be early producers of IL-4 or 
another, as yet not characterized, cytokine (i.e. the homologous of IL-12 for type 2 response).
Interleuldn-4 and IFNy can inhibit each other’s production quite strongly at the level of T cell 
clones, findings that are not true for any other cytolcinea such as IL-2 and IL-13, for example. IL-4 and 
IFNy also have antagonistic actions on macrophages. IL-13 has down regulatory actions very similar to 
IL-4. However, in contrast to IL-4, which has it main action on T cells, IL-13 acts predominantly on 
monocytes and M4>, where it has differing actions (de Vries 1996). In monocytes, IL-13 promotes 
differentiation towards a dendritic APC. In macrophages, it inhibits some key markers of macrophage 
activation after exposure to LPS, including as down modulation of CD 14 and of the receptors of the 
constant region of immunoglobulins (FcyR) and reduction of effector functions such as the generation 
of nitric oxide (NO) (de Vries 1996). In the macrophage, these actions are closely similar to those seen 
with EL-4 and may contribute to the deletion by apoptosis of the incoming monocytes in inflammatory 
sites via down regulation of CD 14 (Heidenreich, Schmidt et al. 1997).
The two key cytokines IL-4 and IFN-y can activate widely different pathways of second 
messengers and transcription factors (recently reviewed by (Paludan 1998). Reviewing the fine 
molecular events responsible for the activation of specific sets of genes is beyond the scope of this 
review. It suffices here to say that, according to the present state of knowledge, there are no shared 
receptors or even second messengers and transcription factors between the 11-4 and the y-IFN mediated 
activation pathway, which are through die signal transducer and activator of transcription (STAT) 4 and 
STAT 1, respectively.
2.2.4 T h e  D ic h o to m y  o f  T H e l p e r  1 a nd  T H e l pe r  2 C y t o k in e  Secretion  
Pa ttern s  Is  B ey o n d  t h e  T L y m pho cytes  S u bsets
2.2.4.1 Introduction
This grouping of T cell derived cytokines and other critical ones predominantly produced by
other cell types such as APC and MO can be found in less stringent in vitro systems and in vivo
systems. This corresponds to the preferential development o f strong cell mediated immunity or a strong,
predominant humoral immunity. From the observations made on in vivo immune responses came the
concept of type 1 and type 2 nomenclature (Lucey, Clerici et al. 1996) and the important concept of
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cytoldne milieu. However, whereas cross regulation between Thl and Th2 was clearly established at the 
cloned T cell level, the cross regulation of type 1 and type 2 cytoldne expression in complex cellular 
systems and tissues turned out to be far more difficult to decipher than originally hoped (Muraille and 
Leo 1998). Nevertheless, this pattern of cytokine secretion corresponds to clinical and pathologic 
entities and fully establishes the model at a central pivotal position o f up regulation (helper) and down 
regulation (suppressor) o f the immune and inflammatory (i.e. immuno-pathologic) response.
2.2A.2 Tentative Model of Cross Regulation of the Type I and Type 2 Cytoldne 
Systems: Application to Immuno-Pathologic Conditions
Assuming that the T lymphocytes are the leaders in an immune reaction, what factors are
driving T cells towards a “mature” pattern of secretion of cytokines? Does this dichotomy of cytokine 
secretion and trans-regulation exist in any other cell types, such as mononuclear phagocyte (MNP) 
system and the granulocytes? It may be hypothesized that M<X> and APC, notwithstanding of their 
suggested variations related to their tissue/organ homing, might be viewed as two different cell types, 
dendritic cell and activated epithelioid macrophages could represent type 2 and type 1 APCs, with a 
common precursor, the monocyte. Even though this is not firmly established, there are a few recent 
studies that suggest that it may be the case, at least in vitro (Mills 1999; Sato, Iwakabe et al. 1999). 
Likewise, eosinophils/ basophils/ mast cells on one side and neutrophils on the other side may be 
viewed as type 2 and type 1 cells, respectively. A more established theory is that the mast cell/basophils 
may drive type 2 response (Haas, Falcone et al. 1998) and the APC/DC/ M4> drive the type 1 response 
(Lucey, Clerici et al. 1996).
The difficulty in describing an integrated model of Type 1 and Type 2 cross regulation is 
related not only to the different cellular levels of secretion, but also in the tuning of various cytokine 
secretions and the up-regulation of their receptors that peak, wax and wane while an immune reaction 
takes place in vivo. This may be different from isolated cells and lymphocytes that proliferate in vitro in 
response to cytokines and other mediators. This timing has not been extensively investigated yet 
because of repetitive analysis required. However, as various technologies mature to measure levels of 
cytokines and other mediators more easily and reliably, more immunologic studies will be generated 
regarding this important parameter.
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It is now well established that an early peak of IL-12 is secreted by macrophages and/or NK 
cells upon entry of a pathogenic microorganism and activation of recruited inflammatory cells. This 
peak is critical for the subsequent elevated sustained secretion o f IFN-y that will strongly drive 
appropriate CMI and inflammation (O'Garra and Murphy 1996). As with any strong agonist, down 
regulatory mechanisms must exist to avoid excessive CMI and tissue damage, both up-stream (tissue 
cells such as epithelial cells, mesenchymal cells, endothelial cells, etc...) and down-stream 
(lymphocytes). In this regard, in humans, IL-10 secreted by Th2 lymphocytes and MNP cells and TGF- 
P secreted by various cells from an inflammatory site may play an important immuno-regulatory and 
anti-inflammatory role. Also, it seems that IL-18, secreted mainly by M<D, which is structurally like IL- 
1 and functionally acts as a strong co-inducer of IL-12 to drive the immune response towards a type 1 
cytokine milieu (reviewed by (Kohno and Kurimoto 1998), might play an important role. Recent results 
in CD3+ T lymphocytes and NK1.1 cells in mice indicate that IL-18 is a potent co-inducer of IL-2 for 
the secretion of IL-13, especially in the absence of IFN-y (Hoshino, Wiltrout et al. 1999). Therefore, in 
a strong type 2 environment or in an uncommitted cytokine milieu with no or low levels of secretion of 
IL-12, IL-18 secreted by certain subsets of APC or M4>, enhances a type 2 milieu, instead of driving 
towards IFN-y production and a type 1 response. This appears to operate through IL-13 production that 
in turn promotes the differentiation of monocytes into dendritic APC and IgA and IgE production by B 
cells (Table 2.1).
Beside cytokines secreted by M4>, the relative expression of co-receptor molecules on APC 
and M4> seems also to play a role in the differential activation and / or the maturation of Type 1 versus 
Type 2 T helper lymphocytes in the development of immune responses. For example, one group showed 
recently that CD28 with B7-1 versus B7-2 controlled Thl versus Th2 development based in the 
experimental auto-immune encephalitis in mice and in in vitro assays (Kuchroo, Das et al. 1995). 
However, this field is still young and apparent paradoxes existFor example and to illustrate further this 
field o f co-receptors, there are studies of transgenic and knockout mice that suggest that CD28 co­
stimulation can promote the production o f Th2 cytokines (Rulifson, Sperling et al. 1997).
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Table 2.2: Type 2 and type 1 cytoldne milieu/network elicited against invading micro-organisms, 
dissected by cell types, dose, antigen presentation and accessory molecules.
Cytokine milieu
Type 1 Type 2 Type 0
Cell type Differentiation
t
Secretion Differentiation
t
Secretion Secretion
Granulo­
cytes
IL-3, GM-CSF 
Neutrophils?
? IL-3, GM-CSF 
IL-S eosinophil 
IL-4 basophils
IL-5
IL-4
N/A
APC/M«Df Monocytes 
IL-3, GM-CSF 
IL-12 
LPS§
Macrophages 
IL-12+++ 
TNF-a 
IL-18 
IL-1
Monocytes 
IL-3, GM-CSF 
IL-4 
IL-13
Dendritic cells 
? IL-4?
IL-18
IL-1?
T lympho­
cytes
Naive T cells 
IL-12
Thl cells
IFN-Y+++
IL-2
TNF-P (LT) 
GM-CSF
Naive T cells 
IL-4
Th2 cells
IL-4+++
IL-5
IL-13
IL-6
IL-10
ThO cells
IFN-y
IL-4
Maturing?
Other stimuli (Ag presentation)
Type 1 Type 2 TypeO
Cell type Differentiation
t
Secretion Differentiation
t
Secretion Secretion
Peptide-
MHC
High affinity Intermediate
affinity
?
Dose low low high low Intermediate?
Accessory
molecules
APC*
Anti B7-2? 
B7-1(CD80)
B7-1(CD80) Anti-B7-1 
B7-2 (CD86)?
Accessory 
molecules 
T cells*
CD28 CD28f CD28 CTLA-4 
(CD 152)? t
§Lipopolysaccharide; LPS also blocks differentiation of DC (Palucka,
Taquet et al. 1999).
f  Antigen presenting cells / macrophages
{ In the differentiation columns, the cytokines/ factors mentioned favor or 
increase the given cytokine milieu and CMI type.
* (Kuchroo, Das et al. 199S; Ranger, Das et al. 1996; Rulifson, Sperling et 
al. 1997; Schlienger, Uyemura et al. 1998).
fCD28 and CTLA-4 appear to be associated with up and down regulation, 
respectively, o f CMI rather than favoring type 1 and type 2 response, 
respectively. The CTLA-4-dependent inhibition of cytokine production 
(both IFN-y and IL-4) in all types of T cells in mice is mediated by TGF-P 
(Chen, Jin et al. 1998).
IL-10, initially shown to be highly produced by Th2 murine lymphocytes, and also by 
macrophages, has been proposed to contribute in the development of the type 2 immune reaction. 
However, in humans, both Thl and Th2 cell clones can produce IL-10 (reviewed in (Muraille and Leo
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1998). Since many o f IL-10 actions are similar to IL-4, one may suggest that IL-10 is more a down 
regulator of the inflammatory response than a strong promoter of a type 2 immune response like IL-4, 
thus confirming the initial name of this latter cytokine, namely cytoldne synthesis inhibitory factor 
(CSIF). IL-10 turns out to be a cytoldne with complicated actions, probably inhibiting APC migration in 
mice through the down-regulation o f TNF-a and of IL-1 production (Wang, Zhuang et al. 1999) 
(reviewed in (Wang, Amerio et al. 1999), down modulating the Md> activation system and cytotoxicity 
(Nabioullin, Sone et al. 1994) while at least partially promoting lymphocyte responsiveness by the up- 
regulation of CD25, the a  chain o f the IL-2 receptor (IL2Ra) of T cell clones in vitro in humans 
(Cohen, Katsikis et al. 1994).
At another level, it is established that IL-2 shares one and two common receptor subunit(s) 
with IL-4 and IL-15 , respectively, including the IL-2 receptor gamma (IL-2R y or yc) (de Jong, Famer 
et al. 1996). At the cellular level o f T cells in vitro, as well as ex vivo in lesions, there are no notable 
differences between IL-2 and IL-15, especially concerning the function, even though the main in vivo 
cell sources are different: IL-15 is mainly secreted by epithelial cells whereas IL-2 is the prototypic 
lymphokine. This example, which is probably frequent in the cytokine network, may in part explain 
some in vivo results found using cytokine gene knockout mice, which suggest variable levels of 
redundancy in the functions of cytokines: compensatory mechanisms are often shown when cytokine 
genes are inactivated. Studies of human genetic defects predisposing them to severe infection suggest 
that receptors rather than mediators may be limiting factors for adequate immune response (Newport, 
Huxley et al. 1996; Altare, Durandy et al. 1998; de Jong, Altare et al. 1998). Differential expression of 
these receptor sub-units in a particular cell type in vitro and discrete populations of cells in an 
inflammatory site in vivo ate often tightly regulated by the early cytokine milieu (O'Garra and Murphy 
1996).
Sharing of one receptor sub-unit of IL-4 and IL-2 would suggest that engagement of these 
cytokines would potentially activate, with variable efficiency, similar sets o f transcription factors in the 
cells. This is puzzling since, at first analysis, IL-2 and IL-4 should have opposite actions. This can 
probably be reconciled by considering that IL-2 is probably an earlv autocrine growth factor mainly 
secreted transiently at high levels in precursor T cells that are not still committed into going towards any
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type of cytoldne profile. In a sense, IL-4, since it is closely related structurally to IL-2 and is also a 
cytokine with a high autocrine up-regulation, may be considered as an evolution of IL-2 that may down 
regulate this latter, whereas IFN-y is from a radically different group of mediators, the interferons. 
Actors o f innate immunity such as NK cells and macrophages predominantly secrete this group of 
structurally mediated molecules and this must be kept in mind when analyzing the type 1 cytokine 
environment.
To summarize, in the type 1 cytokine milieu, M4> and NK cells play a key role by secreting IL- 
12 and IFN-y, respectively, whereas the type 2 milieu would be the responsibility of Th2 lymphocytes 
or mast cells and basophils rapidly secreting high levels of IL-4. Cytotoxic NK cells and properly 
activated M4> secrete a significant amount of IL-12 and IL-18 to drive the helper T cells which in turn 
secrete strong, sustained Thl cytokines, while M4>/APC present antigens to T cells, another strong 
inducer of IFN-y by T cells. However, in the mononuclear phagocyte (MNP) system, IL-18 (and IL-1) 
may be the equivalent of IL-2 in T cells, since IL-18, depending on the initial cytokine milieu, may 
subsequendy enhance a type 1 or type 2 cytoldne milieu. On the other hand, IL-12 can be proposed as 
being the equivalent of IFN-y at the MNP level. Although IL-10, mainly secreted by macrophages, has 
been proposed to be a strong driver of the type 2 cytokine milieu, the data, at least in humans, do not 
support this hypothesis. Rather IL-4, by virtue of its autocrine mode o f action, seems to be able to 
perform this function. However, it is still possible that an additional mediator, stimulating type 2 
response, possibly secreted by the dendritic (DC) cells and other APC/phagocytic cells will be soon 
characterized.
With the large numbers of studies exploring the function, the cell source, the regulation of 
cytoldnes, it may sometimes be fruitful to try to delineate where and when a cytokine is not produced. 
For example, careful analysis of primary data on cytokine mRNA expressions ex vivo in leprosy skin 
tuberculoid lesions reveals that the type 1 milieu has a low but detectable amount of IL-4 and IL-10 as 
detected by relative (semi-quantitative) R.T-PCR, albeit in much lower amount, as compared to 
lepromatous patients. Conversely, with the detection limits of RT-PCR, absolutely and uniformly no 
signal for IFN-y and IL-2 has been detected in lepromatous patients (Yamamura, Uyemura et al. 1991; 
Modlin 1994). Knowing that this relative RT-PCR was standardized on the amount of CD38 cDNA,
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even if  we take into account differences of priming and hybridization efficiency between these primer 
pairs and probes (that have been checked by serial dilution of plasmid positive controls (Yamamura, 
Uyemura et al. 1991)), these differences may teach one about the type 1/type 2 cross regulation and 
leprosy disease. First it may be that IL-4 is a down regulator of y-IFN and IL-2 in a type 1 lesion 
whereas the latter 2 cytokines may not be strong down regulator of die former in a type 2 milieu. In 
other words, it might be that type 0/type 2 milieu are the default, less effective immune response in 
intracellular parasite infections, including mycobacteria, if the APC/macrophages fail to secrete key 
cytokines early after encounter of the invading organism, such as IL-12, TNF-a, IL-18, and IL-1, by 
decreasing order of importance. In fact, in vivo data from inoculations of animal models by pathogenic 
microorganisms and parasites is now accumulating showing that this is the case (reviewed by (Lucey, 
Clerici et al. 1996; O'Garra and Murphy 1996). That is also supported by in vitro data showing Thl/Th2 
cross-regulation in lymphocyte culture systems. IL-4 can down regulate Thl cell differentiation whereas 
IFN-y cannot (O'Garra and Murphy 1996). At the clinical level of the leprosy disease, this subtle feature 
of the type 1 cytokine milieu provides a basis to the observation of certain patients on the tuberculoid 
side (BT) going progressively to the lepromatous side of the spectrum, especially before multidrug 
therapy was available.
2 .2 .5  T y p e s  o f  C y t o k in e  S e c r e t io n  a n d  M y c o b a c t e r ia l  D is e a s e s , w it h  
E m p h a s is  o n  L e p r o s y
In intracellular infections with predilection to the mononuclear phagocyte system (MNP), such 
as leishmaniasis and mycobacteriosis [reviewed in: (Lucey, Clerici et al. 1996)]. Th 1/type 1 immune 
responses are associated with protection against disease development whereas Th2/type 2 immune 
respnses are clearly linked to inadequate handling o f the pathogen and progresson to disease. However, 
the unique situation of leprosy as an example of mycobacterial disease is that the Thl/Th2 paradigm 
seems to exquistely match with the spectrum of the disease (Figure 2.2).
2.2.5.1 Type 1 Immune Response in Leprosy and Other Mycobacteriosis
Type 1 cytokines, such as IFNy nd IL-2 secreted by the T lymphocytes and IL-12 secreted by
M<D correlate with usually strong inflammatory responses and CMI in mycobacterial diseases, including 
leprosy. Type 1 cytokines are typically found in patients in the tuberculoid side of the immuno-
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pathological spectrum (Figure 22). Interestingly, these T lymphocyte responses are driven by IL-12, 
mainly secreted by cells of the MNP system.
Th1/type1 Th2/type2
i  'CMI'
11 \  I___________j
c i rcu la t in g
Ab
severity, distr 
of lesions
BT BB
"PAUCIBACILLARY” "MULTI BACILLARY"
Figure 2.2: Immunological spectrum of leprosy and Thl/Th2 paradigm. This diagram is 
similar to the one schown in figure 2.1., except that it shows the types o f cytokine secreted 
at site of leprosy skin lesions along the spectrum. Thl/type 1 and Th2/type2 stand for the 
type 1 and type 2 cytokine milieu driven by type 1 and type 2 T cells, respectively.
In tuberculosis, tuberculous pleurisy, considered to be a response with favorable outcome in 
tuberculosis (Ferrer 1997), has high amounts of IL-12 in the inflammatory pleural fluid (Zhang, Gately 
et al. 1994). The factors that determine IL-12 secretion are still ill defined, but it likely follows 
phagocytosis and presentation of antigens from the leprosy bacillus. The dose and pattern o f enzymatic 
antigen processing before antigen presentation appear to be important (Maekawa, Himeno et al. 1998; 
Power, Wei et al. 1998). It may be that overloading of die phagocytic cells impedes the proper mRNA 
up-regulation of IL-12 but this has not been proven. In addition to the secretion of IL-12, which seems 
to be the key early driver to the type 1 cytokine milieu, IL-18, TNF-a, and also to a lesser extent by, IL- 
lseem to be important, or at least to participate in the promotion of a type 1 response (Garcia, Uyemura 
et al. 1999). At the same time of this appropriate cytokine environment secreted by the key actors of the 
innate immunity, cells from the adaptive immunity, mainly the CD3+ T lymphocytes, relay by secreting 
high levels of IFNy and GM-CSF (O'Garra and Murphy 1996). Some kinetic studies indicate that the
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recruitment of numerous lymphocytes before the monocytes may be critical for an early strong type 1 
cytokine milieu and development of an adequate primary CMI, at least in leprosy (Lathrop, Scollard et 
al. 1996) as well as in other models of intra-cellular infection (Buchanan and Murphy 1997). In this 
regard, the role o f IL-2 seems crucial in the amplification o f the recruitment and multiplication of 
lymphocytes at sites of invasion of microorganisms. Type 1 cytokines and chemotactic cytokines 
(chemokines) such as the a-chemokine MIG (monokine induced by IFN-y) and IFN-y induced protein- 
10 (IP-10) (Kaplan, Luster et al. 1987) and (3-chemokines such as monocyte chemotactic protein (MCP) 
and macrophage inflammatory protein (MIP) are also important in mycobacterial disease to recruit more 
activated lymphocytes at sites of invasion [reviewed by (Luster 1998) and (Schluger and Rom 1997)]. 
Type 1 cytokines also favor granuloma formation; IL-12 enhances survival in long term (10 day) 
cultures of adherent human monocytes (Estaquier and Ameisen 1997).
In summary, a type 1 cytokine milieu in leprosy favors strong CMI with low, often 
undetectable levels of particular subtypes of immunoglobulin (Ig). This strong CMI is reminiscent of, 
but not identical to DTH, the prototype of which is tuberculin test after purified protein derivative 
(PPD). This also exists to a lesser degree in tuberculoid patients after injection of lepromin and is called 
the Fernandez reaction (reviewed by (Harboe 1994)). CMI with a type 1 cytokine secretion is 
recognized as the most efficient immune response against intracellular parasites, notably mycobacteria.
2.2.S.2 Type 2 Immune Response in Leprosy and Other Mycobacteriosis
The second type of CMI, the type 2/Th2, generally observed when dealing with extra-cellular
organisms, is not characterized by prominent granulomatous response (see previous section on CMI), 
but rather favors humoral immunity and is characterized by the secretion of alternate subtypes of Ig, 
including IgA and IgE (Lucey, Clerici et al. 1996). A type 2 response therefore limits the advene 
consequences of marked granulomatous response. Type 2 immune response also favors mucosal 
immunity and is therefore very useful for protective immunity against several infectious agents. It also 
favors eosinophilic granulomatous responses, also useful against metazoal parasites.
In mycobacterial diseases, and in tuberculosis in particular, this type of T cell help is not 
associated with protection, and is at first analysis detrimental to the host. However, nobody knows 
exactly to what extent type 2 /Th2 immune responses are detrimental in these diseases.
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In leprosy, type 2 T cell help is found in the lepromatous / multibacillary side o f the spectrum, 
where IL-4, IL-5 and IL-10 are more expressed than type 1 cytoldnes (Figure 2.2). In contrast to a few 
infectious agents where type 2 response may be associated with some degree of protection against 
disease, such as schistosomiasis (Lucey, Clerici et al. 1996), the type 2 cytokine milieu in mycobacterial 
diseases suggests a problem in handling the pathogen, such as in lepromatous leprosy, or in tuberculosis 
(Yamamura, Uyemura et al. 1991; Hemandez-Pando, Orozcoe et al. 1996).
But the question remains why more IL-4 and other type 2 cytokines are produced in 
lepromatous patients. Is it due to an initial, vigorous and aberrant secretion of IL-4 shortly after 
encounter with M. leprae, as it may be the case after exposure to parasite nematodes such as 
Schistosoma mansoni eggs or filarial species (Haas, Falcone et al. 1998)? Or is IL-4 progressively and 
secondarily produced in maturing lesions evolving towards lepromatous lesions either after an initial 
adequate strong Thl response (down-regulation hypothesis) or after an initial, weak, uncommitted ThO 
milieu or a weak and delayed type 1 milieu? This question cannot be simply answered by assuming that 
some external source of IL-4 is responsible, such as from basophils, mast cells or neutrophils recruited 
at granuloma sites since that has not been observed in microscopic tissue sections of mature or 
indeterminate leprosy lesions (Job 1994). However the morphology of lesions in human leprosy after 
initial exposure is essentially unknown.
Important data have been recently published on the kinetics of cytokine mRNA expression of 
IL-4, IFNy and IL-12 in a model of tuberculosis in susceptible BALB/c mice (Hemandez-Pando and 
Rook 1994). This study showed that the initial cytokine response in this model is a Thl environment 
with rapid high mRNA expression of both IFNy and IL-12 within approximately 14 days after 
inoculation of M. tuberculosis in the lung. After 60 days, signals for IL-4 was detected and at high 
levels and increased thereafter, indicating the evolution towards a type 0 cytokine milieu at site of 
infection. Interstingly, the emergence of the type 0 cytokine milieu at site o f disease correlated with 
progression from limited granulomatous pneumonia to disseminated, severe pneumonia (Hemandez- 
Pando and Rook 1994). This kinetic study in a mouse model of pulmonaty tuberculosis correlated with 
the situation in tuberculosis patients versus healthy PPD-positive individuals, where a Th2 versus a Thl, 
respectively, was observed (Sanchez, Rodriguez et al. 1994; Surcel, Troye-Blomberg et al. 1994)
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reviewed in (Cooper and Flynn 1995). Therefore, these studies suggest that, in tuberculosis, the initial 
response is developed in a type 1 cytokine environment that may progressively shift to a type 0/type 2 
milieu with development of pneumonia. Whether this scenario is also true or different in human patients 
after exposure to M. leprae when developing progressive lepromatous leprosy is still unknown.
Recent studies have focused on secreted proteins of M. leprae using molecular methods and 
have shown that these proteins were very close the proteins secreted by M. tuberculosis (Harboe and 
Wiker 1998). However, whereas several secreted proteins of mycobacteria, such as the heat shock 
protein 60 (hsp60), have been demonstrated to be major immunogenic antigens, there have been no 
studies exploring whether M. leprae or M. tuberculosis proteins or non-peptide antigens may elicit a 
Th2 response in mice or humans (Orme, Andersen et al. 1993). Even though it is likely that the type of 
cytokine response may be variable depending on the antigen presentation for same mycobacterial 
antigens, this whole area of research is worth exploring, especially in the light of recent studies 
indicating that CD1 antigen presenting molecules are not as polymorphic as MHC class I and class II 
molecules. This raises the possibility that the early human response to mycobacterial non-peptide 
antigens may be more stereotyped than the MHC-H-restricted response to protein antigens (Maher and 
Kronenberg 1997; Sugita, Moody et al. 1998).
There are no reports of studies exploring the cytokines secreted within hours days or weeks 
following an inoculation/exposure of M. leprae either in humans or in animal models. Differences in 
bacterial load and/or in the capability of M<t> to degrade and kill mycobacteria offer an alternate 
hypothesis to explain an initial absence of type 1 response or a slow shift from the type 1 to the type 2 
cytokine milieu over long period o f time. Experimentally, it is well established that dose, together with 
route and type of antigen administration, determine a mutually exclusive predominance of antibody or 
DTH response. This aspect of type 1/type 2 determination, besides the pre-existing cytokine milieus, 
has been reviewed several times recently (O'Garra and Murphy 1996; Constant and Bottomly 1997). 
Very few data are published from mycobacterial and leprosy research. However, two important studies 
have been reported recently, one on BCG and inoculation doses and route, the other on pre-existing 
cytokine environment A landmark paper studying BCG infection and disease in susceptible mice 
(Balb/c mice) showed that the dose of M. bovis strain BCG was critical to the development of a type 1
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and a type 2 cytokine response, independently of the route of administration of the organism (Power, 
Wei et al. 1998) (Table 2.1). High doses of inoculation are associated with a type 2 response whereas a 
low dose is consistently associated with a type 1 response, regardless of the route of infection. In 
leprosy, there are numerous epidemiological data demonstrating a higher risk to develop leprosy in 
healthy contact o f lepromatous leprosy patients, which excrete higher numbers of leprosy bacilli (Doull, 
Guinto et al. 1945; Fine 1982). It is unfortunately more difficult to establish a link between a high 
exposure situation and subsequent development of higher rates of lepromatous leprosy as compared 
with tuberculoid leprosy (Doull, Guinto et al. 1945). Even though it would be foolish to confuse 
bacterial dose and bacterial load, augmenting bacterial load in lesions secondary to defective bacterial 
killing by M4> might result in the same end-point as a high initial dose in an experimental setting 
(Power, Wei et al. 1998). Interestingly, the production of IL-4 by CD4+ T lymphocytes from already 
sensitized allergic patients is also down regulated when high dose of allergen is used (Secrist, De Kruyff 
et al. 1995), suggesting that the secondary high doses down-regulate the type 2 as well. From these 
results, it may be hypothesized that the already sensitized Thl lymphocytes may behave similarly: if 
dose of antigen increase dramatically in the host, type 1 cytokines (IFN-y and IL-2) may be down 
regulated, but this hypothesis has not been tested.
The other important studies concerning pre-existing cytokine milieu as predisposing factors to 
develop tuberculosis in children, the T cells of which have been shown to produce lower levels of IFNy. 
Using high serum IgE as a marker of prominent Th2 response in a community with a high incidence of 
tuberculosis, it was shown that high IgE correlated with tuberculosis incidence (Beyers, van Rie et al. 
1998). A similar study has been performed investigating any correlation between atopy, IgE serum 
levels and leprosy. Leprosy patients had significantly higher levels of IgE, regardless of whether they 
were atopic or not (Yong, Grange et al. 1989; Smith, Bahna et al. 1990). However, to our knowledge, 
no prospective study has been performed to assess the predictability of markers o f high Th2 milieu in 
contacts and compare tuberculoid versus lepromatous patients in a region with high leprosy prevalence 
and incidence. One study found no significant difference between the mean serum IgE levels of 
tuberculoid and lepromatous leprosy patients (Saha, Dutta et al. 1975).
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Another aspect that is of value in studying the skewing of cytokine secretion patterns is the 
study of antigen presentation. Two approaches have been very fruitful in understanding the contribution 
of APC in driving type 1 versus type 2 immune responses: the generation of “altered peptide ligands” 
(APL) and the generation o f specific inhibitors o f enzymes involved in antigen processing by the APC.
It is known that in MHC restricted presentation of small peptides, certain amino-acid (AA) 
residues are critical for successful TCR engagement and specific recognition. APL are peptides from 
antigens, the critical residues o f which have been substituted by residues resulting in a lower affinity 
between the MHCII/peptide and the TCR. Results indicate that the MHC class n  genotypes in mice 
were important in an in vivo immunization against a protein antigen (reviewed by (Constant and 
Bottomly 1997). Low affinity between APL and MHCII favored a Th2 response whereas higher affinity 
resulted in a Thl response (Table 2.1). An intermediate affinity result in T cells secreting a mixture of 
type 1 and type 2 cytokines as assessed by intracellular staining and flow cytometry. Using transgenic T 
cells bearing a single TCR and peptides differing in affinity for this particular TCR, it has been recently 
shown that the degree of affinity of the immunogenic peptides, the dose and the timing correlate with 
the initial stimulation levels and Thl and Th2 differentiation. Over the short term, IFN-gamma- 
producing cells were induced by lower levels o f stimulation than IL-4-producing cells, although optimal 
induction o f both was seen with the same high level of stimulation. Over the long term, high affinity and 
high dose favor a high stimulation level o f T cells and Thl cell clones with type 1 cytokine 
differentiation, whereas moderate dose of high affinity peptides resulted in the development o f Th2 cell 
clones. Low affinity at any concentration resulted in the failure to develop either Thl or Th2 long term 
T cell clones. Therefore, dose and peptide-TCR affinity influence the level of signalling and the timing 
(i.e. the kinetic) of Th differentiation, which seem to be equally critical for successful Thl and Th2 
differentiation (Rogers and Croft 1999). These in vitro results differ from, but are not contradicting the 
results in the in vivo mouse study with BCG challenge (Power, Wei et al. 1998).
Another important result that is probably related to the APL findings concerns the effect of an 
inhibitor of cathepsin B, an enzyme involved in the processing of particulate antigens (Maekawa, 
Himeno et al. 1998). Cathepsin B is a lysosomal cystein protease involved in antigen processing. In a 
leishmania model of infection in mice, these authors showed that mice, which are normally susceptible
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to the disease and secrete type 2 cytokines, treated with the inhibitor shifted to high production of IFN-y 
and become resistant to the L. major infection (Maekawa, Himeno et al. 1998).
In summary, in addition of the cytokine environment such as the roles o f IL-12 and IL-4 
produced by cells of the inflammatory response and innate immunity, antigen presentation, antigen 
processing and other as yet poorly defined APC-T cell interactions are turning out to be very important 
for the evolution towards a type 1 or type 2 cytokine secretion and corresponding immune response. 
This may also be the case in leprosy.
2.2.S.3 Application of the Thl/Th2 Paradigm to Studying the Healthy Leprosy 
Contacts.
Recently, the cytokine response of circulating blood mononuclear cells (PBMC) stimulated by 
whole and recombinant proteins of M. leprae were studied in seven healthy volunteers who had been in 
contact with leprosy patients for over 3 years (Misra, Murtaza et al. 199S). The healthy contacts (HC) 
showed a pattern very similar to that of tuberculoid patients, with notably similar proportions of 
ThO/Type 0 and Thl/Type 1 responses, as well as anecdotal Th2/Type 2 (Table 2.2). Based on these 
limited results, the types of cytokine profile are not different from tuberculoid patients and support the 
idea that tuberculoid patients are closer to the disease-free status. However, there is at present no 
prospective study of the cytokine profile of M. leprae stimulated PBMC from a large number of healthy 
contacts, as a predictive indicator for subsequently development of Hansen’s disease as has been done 
for the lepromin test.
Table 2.2: Comparison of the cytokine profiles of the healthy contacts and leprosy 
patients in the blood. Number (percentage) of leprosy patients and healthy contacts, the 
stimulated PBMC of which exhibit a type 0 (co-expression of IFNy and IL-4), a type 1 
(expression of ylFN only) and a type 2 (expression of IL-4 only) cytokine profile as 
measured by relative RT-PCR. In the group secreting IL-4 and IFNy, 2 lepromatous 
patients and one healthy contact had a higher level of IL-4 compared with IFNy. Adapted 
from Misra, et al. 1995.
Healthy Contacts Tuberculoid Lepromatous
y IFN and IL-4 3 (43%) 6(46%) 8 (42%)
ylFN 3 (43%) 4(31%) 0
IL-4 1 (14%) 1 (08%) 8 (42%)
None 0 2(15%) 3 (16%)
Total 7 13 19
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2 .2 .6  G e n e r a l  C o n c l u s io n  O n  t h e  T h 1 /T h 2  P a r a d ig m
Type 1 and type 2 cytokines provide differential help both in the magnitude o f CMI and the 
magnitude and type o f humoral immunity such as immunoglobulin isotype switching and the level of 
secretion of immunoglobulins by B lymphocytes.
The secretion of type 1 and type 2 cytokines by cells of adaptive immunity is determined, at 
least in part, by the type of cytokines secreted by different subsets of inflammatory cells of the innate 
side of immunity. The cytokines secreted by T cells, and probably also B cells, also reciprocally 
influence the differential priming and activation of cells o f the innate side of immunity.
Similar concepts may apply to chemokines secreted at the site of inflammation or injury caused 
by an invading “non self element”. The concept of type 1 and type 2 chemokine is now emerging 
(Boring, Gosling et al. 1997; Lukacs, Chensue et al. 1997; Schlugerand Rom 1997; Luster 1998).
Finally, important parameters external to the cytokine milieu that are thought to play a role in 
determining the type of cytokine response include at least the amount o f invading microorganisms (dose 
of inoculum) (Power, Wei et al. 1998) and the antigen presentation process (Maekawa, Himeno et al. 
1998).
2.3 CMI, TH1/TH2 HYPOTHESIS AND IMMUNOSUPPRESSIVE 
LENTIVIRUSES
The early, specific deficiency of CMI as indicated by DTH and LST assays in human immuno­
deficiency vims (HIV)-infected persons has led to the “Thl/Th2 switch” hypothesis to tentatively 
explain the progressive evolution towards Acquired immunodeficiency syndrome (AIDS). This part 
focuses on the experimental data from which the hypothesis has been developed and the results of some 
of the experiments that tested it
2.3.1 F u n c t i o n a l  D e f e c t s  in  t h e  M e m o r y  S id e  o f  CMI
2 .3 .1.1 In the Early Stages of the Disease (CDC stage n / m )
It seems logical to associate the loss of immunological competence in HIV infected individuals
only with the concomitant decline of the CD4+ T lymphocytes. However, HIV infection elicits cell 
mediated immunity defects well before any abnormal CD4:CD8 ratio or any symptoms of advance 
disease are detected.
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It is the important work o f Frank Miedema and colleagues and the team lead by Gene Shearer 
that put forth evidence of an early, progressive crippling of CMI in asymptomatic HIV-1 infected 
individuals with normal CD4+ lymphocyte counts (Miedema, Petit et al. 1988; Clerici, Stocks et al. 
1989). This loss of CMI was assessed by LST with PBL stimulated by CD3 monoclonal antibodies and 
an in vitro assay of IL-2 production following stimulation with PHA, alloantigens and two common 
recall antigens, tetanus toxoid and influenza. There is a progressive, sequential loss of response to these 
stimuli, starting with the loss of recall antigens, followed by the loss o f response to alloantigens, and 
Anally to lectin stimulation (PHA). These findings were independent of clinical staging and CD4+ 
counts (Clerici, Stocks et al. 1989). In fact, loss of T cell function in vitro predicts progression to 
acquired immune deficiency syndrome (AIDS) and a decrease of survival time (Dolan, Clerici et al. 
199S; Roos, Miedema et al. 199S).
DTH skin test responsiveness to various products such as tuberculin PPD were also sometimes 
lost in healthy HTV+ individuals previously known to be responders. In one study, HIV-1 seropositivity 
was the strongest predictor of DTH anergy (Markowitz, Hansen et al. 1993). However, it is the use of 
antigens (Ag) having a high proportion of reactivity in the general population, such as Candida albicans 
Ag (98% responders), mumps Ag (83%) and tetanus toxoid (83%), that are most useful for assessing 
asymptomatic HIV+ individuals (Birx, Brundage et al. 1993). These studies indicate that partial DTH 
anergy (a few negative responses) is a strong, independent predictor o f progression to AIDS in 
asymptomatic patients (Birx, Brundage et al. 1993; Blatt, Hendrix et al. 1993). In those conditions, 
combined loss o f skin test reactivity is associated and declining CD4+ T cells, is a more accurate 
predictor of progression to AIDS than CD4+ T cell counts alone (Birx, Brundage et al. 1993).
2.3.1.2 In the Late Stages of the Disease (CDC stage IV-V)
In symptomatic patients, the immunodeficiency is more profound and less speciflc for CMI
and the loss of the memory function. PBMCs are impaired in their proliferative response to lectins that 
activate both T and B lymphocytes. At those stages, anergy to the complete panel of antigens is often 
observed, and is a direct predictor of development of opportunistic infections such as thrush, for 
example. Complete anergy is also predictive of development of tuberculosis when compared with PPD- 
negative, non-anergic patients, but not with PPD+ non-anergic HIV+ individuals (Moreno, Baraia- 
Etxaburu et al. 1993).
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2 .3 .2  T h e  ‘T h 1 /T h2  H y p o t h e s is ’ in  HTV In f e c t io n
2.3.2.1 Why a Thl/Th2 Hypothesis in AIDS?
Cytokines are closely linked to the history of the discovery of HIV as the etiological agent of
AIDS, since recombinant IL-2 was a necessary factor for HIV replication in cultures of lymphoblasts 
(Barre-Sinoussi, Chermann et al. 1983; Popovic, Sarnagadharan et al. 1984). This indicated that 
cytokine mediated lymphocyte stimulation is a necessary requirement for productive HIV replication in 
CD4+ T lymphocytes.
Also, some of the clinical features o f recently HIV-infected persons and AIDS patients are 
believed to be cytokine mediated. For example, high serum IL-6 and TNF-a in HIV-infected patients 
without evidence of overt secondary opportunistic infection(s), in the AIDS related complex stage 
(ARC / CDC stage m) and terminal AIDS (CDC stage IV) may be at least partly responsible for the 
weight loss and other symptoms observed in these patients (Manetti, Annunziato et al. 1996).
The previous observations on reduced memory and CMI response early in the course of HIV 
infection led one group of investigators to propose that progressive HIV infection and subsequent 
crippling of the immune system is due to a progressive preferential absence of the type 1 T 
lymphocytes, leading to an impaired type 1 immune response and a shift to a Th2 ineffective response 
leading to the development of AIDS (Clerici and Shearer 1993; Clerici and Shearer 1994). This would 
be logically due to the crippling and death o f the CD4+ Thl clones, with dominance of type 2 T helper 
lymphocytes, as an ineffective compensatory mechanism. It would also take into account the differences 
between AIDS in developing countries and industrialized nations, since individuals in the former have 
higher levels of parasite infestation with a dominant Th2 milieu. This environment, in him, would favor 
more rapid evolution towards immuno-deficiency and AIDS. This attractive theory would also account 
for the high level of immunoglobulins in the serum of HIV-infected patients, with occasional hyper-IgE 
syndromes that have been described previously (Paganelli, Scala et al. 1993; Raiteri, Sinicco et al.
1993).
2.3.2.2 Cytokines Secreted by Macrophages in HIV Infected Patients:
Several studies have shown an imbalance in the secretion o f cytokines secreted by M4>
(monokines) during the course o f HIV infection. Several monokines such as TNF-a , IL-1, GM-CSF 
and IL-3 have long been known to favor HIV replication in human monocytes and M<D (reviewed in
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(Manetti, Annunziato et al. 1996). In contrast, IFN-a and TGF-P would exert a suppressive activity on 
HIV replication in cells of the mononuclear phagocyte system. Also, it was found that IL-10 is produced 
constitutively (i.e. without stimulation) both in vivo and in vitro by HIV-infected macrophages. 
Subsequently, it was shown that PBMC from HIV-infected patients had defective secretion of IL-12, 
and this defect could be detected early, during the asymptomatic phase of HIV infection (Chehimi, Starr 
et al. 1994). By testing various cell culture systems of PBMC, monocytes and M4>, including human 
hybridoma cell lines (Yoo, Chen et al. 1996), it was shown that upon exposure and infection by various 
strains and fragments of HIV, the envelope glycoprotein (gp) 120 evoked rapid (within 4 hours) and 
severe down regulation of IL-12 mRNA indirectly through up-regulation of IL-10 mRNA (Taoufik, 
Lantz et al. 1997).
In parallel with these findings in vitro, the study of identical monozygotic twins discordant for 
HIV infection revealed that epidermal APC (Langerhans’ cells) are not ability in their function to 
present recall antigens in HIV-infected individuals (Blauvelt, Clerici et al. 199S; Blauvelt, Chougnet et 
al. 1996). They are, however, impaired in their ability to generate a primary immune response, as 
assessed by proliferation following allogeneic stimulation (Blauvelt, Clerici et al. 199S). Also, even 
though Langerhans’ cells (LC) from HIV+ twins were able to induce IL-2 production comparable to LC 
from HIV- individuals when T cells from HIV- persons were added, IL-2 production was markedly 
decreased in cultures containing T cells from HTV+ patients. This points towards a defect in T 
lymphocytes themselves. However, since it is estimated that only ~ 1 % of these cells are infected by 
HIV and that the reservoir of HIV is believed to be in dendritic cells in the germinal centers of the 
lymph nodes, these findings should not be generalized. More studies are necessary to decipher the exact 
contribution of APC to cytokine dysregulation in HIV infected patients progressing to disease. The 
results of these studies are so far contradictory (Fan, Huang et al. 1997; Fidler and Rees 1999; Sapp, 
Engelmayeretal. 1999).
Addition of recombinant human IL-12 (rhIL12) enhanced endogenous Ag-specific IL-2 
production by T cells from 2 patients with relatively high CD4+ counts (>600/pl). In contrast, blocking 
anti IL-10 monoclonal antibodies (mABs), but not rhIL12, enhanced IL-2 production by T cells in 
influenza virus stimulated cultures in patients with very low CD4 cell counts (<20/pl) (Blauvelt,
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Chougnet et al. 1996). These results indicate that APC are important in m o d u la tin g  the im m u n e  
response in HIV patients, and that the response to cytokines and cytokine blockers are variable, and 
probably related to the clinical phase of HIV disease. In fact, recent reports have indicated little benefit 
in terms of viral load of short-term treatment with rhIL-12 in rhesus monkeys chronically infected with 
virulent stains of SIV (Watanabe, Sypek et al. 1998). This result must be interpreted in light o f the 
knowledge of the stage o f SIV infection and the fact that even if rhIL12 is bio-active in rhesus monkeys, 
it may not be as potent in this species as in humans.
2.3.2.3 Cytokines Secreted by Lymphocytes During HIV Infection
The hypothesis of a possible Thl/Th2 switch during the evolution of HIV infection was
extensively tested shortly after the theory had been put forth. Cytokine profiles in T lymphocyte
populations from both peripheral blood and lymph node during the evolution of HIV infection and
disease have been shown to be equivalent, without a of shift towards a strong or at least frank type 2
cytokine profile (Graziosi, Pantaleo et al. 1994; Maggi, Mazetti et al. 1994). Rather, there was an
unquestionable shift to a predominant type 0 profile and a weakening of type 1 responses in T cell
clones stimulated by PPD and Toxoplasma gondii antigens. Importantly, type 2 and type 0 T
lymphocyte clones are more permissive to HTV-1 replication than type 1 T cell clones (Maggi, Mazetti
et al. 1994). Careful analysis of data generated from these experiments on T cells reveal some features
unique to HIV-infected patients as compared to HIV-negative individuals, such as impaired IL-2
secretion even though y-IFN is elevated (Graziosi, Pantaleo et al. 1994). In vivo, the dominant cytokines
present in the plasma, and constitutively at the m-RNA level in lymphocytes in HIV-infected patients
are TNF-a, IFN-y, IL-6 and H-10, while IL-2 is consistently low (reviewed by (Oyaizu and Pahwa
199S). Since in most disease systems IFN-y and IL-2 are classically considered to be dually and
concomitantly regulated, deciphering the mechanisms of this difference could be of the great interest in
understanding the immune dys-regulation in HTV infected individuals and AIDS patients. It might also
be that, in contrast with strong Thl and Th2 responses requiring robust T  cell responses and fully
competent CMI, HIV infection globally weakens the T helper response at the cytokine level, regardless
of its type. This is shown very clearly in the report by Maggi (Maggi, Mazetti et al. 1994). It has also
been very recently confirmed using the enzyme-linked immunospot assay (ELISPOTXByl, Gerard et al.
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1999). Whereas the numbers of IFN-y secreting cells were equivalent between HIV+ and HIV- cells 
stimulated with PHA, there was a significant decrease o f both IFN-y secreting cells and IL-4 secreting 
cells derived from HIV+ patient as compared with control when cells were stimulated with tetanus 
toxoid. PHA-induced secretion of IL-4 was also less frequent in HIV+ patients than controls. It was also 
shown that this decreased number of secreting cells was related to CD4+ T cell impairment of secretion 
(Byl, Gerard et al. 1999).
The situation has been further clarified recently following kinetic studies measuring the 
number of HIV-1 RNA copies in the blood with ultra-sensitive quantitative RT-PCR methods. These 
studies revealed detectable levels of HIV-1 in plasma during all stages of infection (Piatak, Saag et al.
1993). They also revealed a gigantic struggle between HIV replication and CD4+ T cells: a high rate of 
CD4+ cell death and regeneration occurs, with an insidious, slight advantage to the former (Ho, 
Neumann et al. 199S; Wei, Hosh et al. 1995).
Augmented T cell death, both in CD4 and CD8 positive lymphocytes, occurs early in HIV 
infection (reviewed by (Oyaizu and Pahwa 1995), which is believed to involve gpl20, up-regulation of 
Fas antigen (CD95) and Fas ligand and down regulation of the bcl-2 family of proteins. So where is the 
link with the cytokine world? Several investigators have independently shown that type 1 cytokines, 
such as IL-2, IFN-y, and IL-12, can rescue from apoptosis resting and activating T cells from HIV+ 
patients and activated T cells from HIV- donors (Clerici 1994; Estaquier, Idziorek et al. 1995). IL-4 and 
IL-10 have no effect or are detrimental . Interstingly, IL-12 can restore or augment antigen-specific 
immune responses in vitro, such as against influenza and env-antigen (gpl20), in asymptomatic HIV- 
infected patients (Clerici, Lucey et al. 1993). However, this restoration of responsiveness may be a 
double-edged sword since it is well documented that T lymphocyte activation during episodes of 
common viral infection(s) in vivo may be detrimental and favor progression to AIDS (reviewed by 
(Copeland and Heeney 1996). Similarly, vaccinations, albeit not detrimental, do promote a transiently 
higher viral burden and direct cytolysis (apoptosis) of pre-activated T cells (Farber, Barath et al. 1996), 
but without a net loss of CD4 T cells (O'Brien, Grovit-Ferbas et al. 1995; Staprans, Hamilton et al. 
1995; Stanley, Ostrowsld et al. 1996). These in vivo results are also supported by in vitro results 
(Weissman, Barker et al. 1996). Since memory T cells are more prone to be activated, through
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mechanisms still not entirely understood (see next section on memory T cells page 59), it is logical to 
assume that these cells are the preferential targets o f direct cytolysis and/or apoptosis during an immune 
reaction. This fact would readily explain why the memory side of CMI is preferentially affected early, 
even in apparently healthy HIV-infected individuals.
More recent studies, analyzing type 1/ type 2 cytokines from specific sites, such as the saliva 
from HIV+ and HTV- individuals with or without oropharyngeal candidiasis, reveal a more clear cut 
deviation towards the type 2 milieu (Leigh, Steele et al. 1998). Similarly, mucosal vaccine studies in 
mice have indicated for the first time the importance of mucosal cytotoxic T lymphocytes and the 
adjuvant effect o f IL-12 delivered with the vaccine. Interestingly, these vaccines were HIV peptide 
immunogen and HIV-1 gp 160-expressing vaccinia live virus (Belyakov, Ahlers et al. 1998).
2.3.2.4 Dynamics of the Thl/Th2 Balance and Progression to AIDS
HIV kills the very cells that could support a thorough switch to a type 2 cytokines milieu. Th2
CD4+ cells preferentially support replication of HIV-1 (Maggi, Mazetti et al. 1994). HIV-1 requires 
certain types o f chemokine receptors to gain entry in the cell (reviewed by (Levy 1996). CXCR4 and 
CCR5 are 2 chemokine receptors that have been shown to be necessary for HTV entry in lymphocytes 
and macrophages, respectively (Alkhatib, Combadiere et al. 1996; Feng, Broder et al. 1996). More 
recently, it has been found that type 2 T lymphocytes producing high levels o f IL-4 had up-regulation of 
the CXCR4 chemokine receptor, thereby favoring the preferential entry and replication of HTV in these 
cells (Galli, Annunziato et al. 1998; Wang, Harada et al. 1998). Very recently, Suzuki et collaborators 
showed that macrophage-tropic strains of HIV-1, which depend on CCR5 for virus entry, can replicate 
in IL-12 stimulated Thl cell cultures from normal donors more efficiently than T cell lines. In contrast, 
T-tropic strains o f HTV can more efficiently replicate in IL-4 stimulated Th2-type culture cells (Suzuki, 
Koyanagi et al. 1999). Taken together, these findings provide mechanisms reponsible the switch from 
Thl to ThO cytokine profiles in CMI responses in HIV-infected patients.
If, then, the ongoing infection with HIV does not clearly switch CMI responses from a type 1 
to a type 2 milieu, but rather to a weakened type 0 environment, what does a pre-existing polarized type 
2 milieu due to ongoing parasitic infections before HTV infection? This would be especially detrimental 
for the lymphocyte population present in die mucosae, such as die gastro-intestinal (GI) tract. In fact, 
recent experiments in rhesus monkeys have indicated that very early during die acute syndrome, before
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the time of sero-conversion, the worst loss of CD4+ T cells occurs among lymphocytes in the lam ina 
propria of the GI tract (Veazey, De Maria et al. 1998). Similarly, studies of the viral and proviral load 
present in biopsies of the GI tract from HIV-infected patients revealed the GI tract to be a reservoir of 
viral production, as assessed by p24 ELISA (Fackler, Schafer et al. 1998). These latter findings provide 
a pathogenesis support to the following epidemiological observations. In individuals with an over­
expression of type 2 cytolrines due to genetic causes (asthmatic and atopic individuals) or due to 
environmental causes (mainly multicellular parasites infections), the likelihood to rapidly develop AIDS 
after HIV exposure is worse (Manetti, Annunziato et al. 1996). This hypothesis has been put forth to 
take into account the differences between rate of HIV infections and features of AIDS progression in 
developing countries such as Africa and AIDS in highly industrialized countries (Bentwich, 
Kalinkovich et al. 1995).
2 .3 .3  T h e  N o n -P r o g r e s s o r  H IV -In f e c t e d  In d iv id u a l s
In recent yean, a few individuals at high risk for exposure to HIV, but with non-detectable or 
very low viremia have been found. They have normal CD4+ counts, vigorous cell mediated immunity, 
mild humoral immunity (Haynes, Pantaleo et al. 1996) and present with extremely robust CMI against 
HTV antigens such as p24, as assessed by LST (Rosenberg, Billingsley et al. 1997) (reviewed by 
(Shearer and Clerici 1996)). They also have quite high responses to envelope antigens. This CMI is 
mainly mediated by CD4 + T lymphocytes that secrete high to very high levels of IFNy. The p24- 
speciffc response was not associated with the production of IL-4 and IL-10 and was abrogated by the 
addition of recombinant human IL-10. Therefore, these rare individuals have evidence of protective 
immunity mediated by a very strong, specific, memory type 1 CMI response, indicating that HTV makes 
no exception to the model of protection by type 1 CD4 T lymphocyte-mediated cellular immunity. 
Moreover, in the same report, the study of CMI in 3 patients diagnosed with the acute HIV-1 syndrome 
(Stage 1 of HIV infection) and rapidly put on aggressive combination antiretroviral therapy, 
demonstrated that the lowering of plasma viremia was accompanied by the generation of a p24-specific 
proliferative response (Rosenberg, Billingsley et al. 1997). This suggests that, during primary infection, 
it is the very destruction o f the protective type 1 helper T lymphocytes whose TCR are specific for HIV- 
1 antigens by direct virus-replication-cytolysis and/or activation-induced cell death by apoptosis, that is 
responsible for the viral persistence and possibly the progression to generalized immunodeficiency.
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2 .3 .4  C o n c l u s io n
It appears therefore that there is no shift from a Thl to a Th2 response because of a crippling of 
both Thl and Th2 cell responses, although such a shift may indeed exist among the memory cells. There 
may be an even more profound crippling of T helper type 2 cells. A more permissive environment to 
HIV replication is found in type 2 T cells, probably due to a higher cell expression of the chemokine 
receptor CXCR4, which is one o f the 2 co-receptor of entry of HIV-1 into the cells identified so far. 
This may be the basis for the observation that individuals with dominant Th2 responses, or merely a 
higher percentage of T cells involved in ongoing immune response at the time of HTV primary infection, 
are at risk of progressing more rapidly.
In vivo, it seems that this imbalance is more readily detectable in local mucosae than at the 
systemic levels, especially at sites of infections. Lastly, studies of recently infected HTV+ individuals 
show that an early, vigorous and specific type 1 CD4+ T cell response correlates at least with non­
progression to AIDS, and possibly with protection.
2.4 THE COMPLEX INTERACTION BETWEEN 
MYCOBACTERIOSES AND HIV/AIDS
2 .4 .1  D if f e r in g  In f l u e n c e  o f  H IV  o n  R e s p o n s e s  t o  D if f e r e n t  M y c o b a c t e r ia
Compared to normal, immuno-competent individuals, the epidemiology of various 
mycobacterioses is quite different in the HIV-positive population. Whereas several species of 
mycobacteria are usually harmless in the general population, eliciting at worst a localized infection, 
several species, such as Mycobacterium avium and a few other relatively fast growing species are 
particularly dangerous in immunodeficient, HIV+ individuals and in immuno-suppressed patients 
(Benson and Ellner 1993; Race, Adelson-Mitty et al. 1998).
Tuberculosis, erroneously regarded in recent years as a receding disease thanks to improved 
hygiene and efficient antibiotics, has re-emerged as a potential secondary major threat due to the 
development of multi-drug resistance and to an increase in the number of particularly vulnerable 
persons. One major group is HIV+ individuals (Havlir and Barnes 1999), but this also includes cancer 
patients undergoing immunosuppressive chemotherapy (Bloom 1994).
However, one mycobacterial disease does not seem to be associated with any increased 
incidence and/or worsening o f the clinical picture in HIV-infected immunodeficient patients: Leprosy 
(Pdnninghaus, Mwanjasi et al. 1991) (Munyao, Bwayo et al. 1994) (Frommel, Telde-Haimanot et al.
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1994) (Lienhardt, Kamate et al. 1996). Since the first case of a dually infected person was described 
(Lamfers, Bastiaans et al. 19S7), case reports from the literature so far have not mentioned any down­
grading along the Ridley & Jopling immuno-pathologic scale (Faye, Mahe et al. 1996). HIV 
seropositivity does not appear to favor any particular type of leprosy. Relatively small but carefully 
controlled epidemiological studies have also failed to demonstrate any significant influence of HIV on 
leprosy (Frommel, Telde-Haimanot et al. 1994). However, no one so far has carefully examined the 
influence of the type o f leprosy on the evolution of HIV disease. For example, according to the type 
1/type 2 theory discussed above, since lepromatous leprosy patients have a strong down regulation of 
CMI due to high expression o f type 2 cytokines at least in the skin, one might anticipate that these 
patients, once infected by HIV, would have an accelerated evolution towards AIDS (Bentwich, 
Kalinkovich et al. 1995). This has also been suggested and tested for tuberculosis (Goletti, Weissman et 
al. 1996) (reviewed by (Havlir and Bames 1999). However, in leprosy, it is believed that the immune 
activation in humans is minimal and mainly localized to sites o f infection: the skin. Therefore it is 
possible that leprosy does not influence the course of HIV infection, but this has not been tested with 
epidemiological surveys or in animal models.
2 .4 .2  CMI in  P e r s o n s  I n f e c t e d  w i t h  H IV  a n d  M ycobacteria spp.
2.4.2.1 Overview of CMI in Tuberculosis, and Comparison with CMI in Leprosy
Tuberculosis, which is a major pathogen of humans, has several features of CMI that are quite
similar to leprosy (reviewed by (Orme, Andersen et al. 1993). First, the majority (85-90%) of exposed
individuals successfully manages the infection, developing a strong DTH reaction characterized by a
type 1 cytokine milieu. Tuberculous pleuritis is an example of such a successful outcome (Ferrer 1997)
(Bames, Lu et al. 1993). Second, in the smaller fraction of infected persons developing progressive
tuberculous pneumonia, there is an insufficient of CMI, probably related to a down regulation of initial
strong CMI, characterized by a weakening of DTH, decreased LST against PPD antigens and a shift
from a type 1 to a type 0 cytokine profile (Sanchez, Rodriguez et al. 1994; Hemindez-Pando, Orozcoe
et al. 1996) (reviewed in (Cooper and Flynn 1995). It rarely culminates in an anergic response to the
purified protein derivative (PPD) test in a few persons in far advanced and disseminated disease. For
example, one epidemiological study found PPD anergy in 0.4 to 31% (median 6.1%) of tuberculosis
patients within 5 institutions (Johnston, Saltzman et al. 1960). Also, there is a fraction of infected
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persons that, after a weakening of the memory side o f CMI, have a late activation or re-activation of the 
disease (Havlir and Barnes 1999). This may occur in the elderly (Stead, Lofgren et al. 1985) and this is 
believed to be related to a weakening of the memory function, in human as well as in murine models 
(Orme 1988).
In contrast, leprosy is a spectral disease, characterized by a significant proportion of patients 
which develop a progressive infection related to a severely insufficient CMI, possibly corresponding to 
a shift from a type 1 to type 2 cytokine milieu (Modlin 1994), culminating in lepromatous leprosy. The 
alternate hypothesis is that a type 2 cytokine milieu develops initially in lepromatous patients, who may 
be genetically predisposed to this disease. This possibility would then be different from the known 
situation in tuberculosis, where the initial CMI response is considered to be set up in a strong type 1 
environment, as it is the case in tuberculous pleurisy (Bames, Lu et al. 1993). At the other end of the 
spectrum, tuberculoid patients exhibit strong CMI (Harboe 1994) (Kaufmann 1994), similar in 
magnitude to the CMI of PPD-positive healthy individuals exposed to M. tuberculosis.
The major diffemce in CMI between the two diseases could lie in the kinetics rather than the 
magnitude of the CMI due to pathogens drastically different in terms of growth and toxicity. Adequate, 
protective CMI may now be defined according to at least three factors: it must be rapid, strong enough 
(a high frequency of responder T cells, high cytokine and chemokine secretion) and appropriate to the 
features of the pathogen(type 1 for intracellular pathogen; type 2 CMI for extracellular parasites).
Another possibility is that CMI can be overwhelmed rather than initially inadequate/defective 
in both diseases. In lepromatous leprosy, LL patients may have to down-regulate an adequate (i.e. type 
1) response over time due to failure to control the growth of the organism, as in patients with 
progressive primary tuberculosis, rather than initially failing to adequately respond to the first exposure. 
Some reports suggest that healthy contact individuals with an absent Mitsuda reaction are at higher risk 
to develop LL disease (Harboe 1994). This does not necessarily disprove the hypothesis of down- 
regulation due to overwhelming M. leprae infection, since there is no measure o f exposure and early 
infection in leprosy, and therefore leprosy without gross lesions and nerve deficits could be more 
common than previously thought
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Alternatively, it may be that some patients, upon first exposure to either pathogen, have either 
an initial inadequate (i.e. Th2) CMI response, or an initial weak and delayed, but adequate (Thl) 
response culminating into disease development after widely different time intervals. These two 
hypotheses are not necessarily mutually exclusive, since an adequate but weaker and/or delayed CMI 
may be subsequently down-regulated.
In conclusion, both M. leprae and M. tuberculosis may elicit very similar patterns of immune 
response in the human host, but over very different setting of time intervals and possibly different initial 
strength. Microorganism virulence properties such as speed of multiplication, mode of entry in the host 
and host’s cells, and efficiency of intracellular multiplication may be determinants, but probably are not 
sufficient to explain all of the differences (Silver, Li et al. 1998).
2A.2.2 Tuberculosis in HIV Infected Patients
Tuberculosis is highly prevalent in HIV infected patients and often has a much poorer clinical
course (Bames, Bloch et al. 1991; Daley, Small et al. 1992; Moreno, Baraia-Etxaburu et al. 1993)
(reviewed in (Havlir and Bames 1999)). Anti-microbial chemotherapy is also less efficacious in HIV-
infected patients as compared with HIV- individuals (reviewed in (Shafer and Edlin 1996). Although
numerous species of mycobacteria are considered to be opportunistic infections in HIV+ patients, it is
not generally considered to be rigorously the case for tuberculosis for the following 3 reasons: 1) the
disease may occur quite early in the course of HIV infection, before obvious immunodeficiency is
apparent (Gallant and Ko 1996), 2) tuberculosis is prevalent in urban areas in certain groups of persons
such as the drug abusers, where HIV is also highly prevalent and 3) M. tuberculosis can induce disease
in immuno-competent individuals.
The rate of PPD anergy is higher in HTV+ individuals than in the general population and
correlates with low CD4+ T cell counts in the blood (Markowitz, Hansen et al. 1993; Havlir and Bames
1999). The PPD anergy often parallels anergy to other antigens such as those of Candida albicans and
tetanus toxoid (Markowitz, Hansen et al. 1993). In HIV+, PPD anergic patients, a loss o f lymphocyte
proliferation was observed in response to M. tuberculosis antigens, and this loss was associated with
deficient CD4 T cell helper activity, but was not correlated with the total number o f circulating CD4 T
cells (Zhang, Gong et al. 1994). More importantly, the HTV+ patients with tuberculosis had lower type 1
secretion and mRNA expression in PBMC cultures stimulated with M. tuberculosis antigens. Since
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there was no difference in type 1 cytokine secretion among cultured, sorted CD4+ T cells between 
HIV+ and HTV- individuals, the diminished type 1 cytokine secretion was believed to be due to lower 
numbers of CD4+ T cells after culture, not to a diminished secretion of these cytokine on a per-cell 
basis (Zhang, Gong et al. 1994).
Since the number of CD4+ T cells able to respond strongly to M. tuberculosis were reduced in 
HIV+ patients, the response of other T cell subsets such as CD8+ and y8 CD3 T cells have been 
investigated. Many of these cells, such as y8 CD4-CD8- (DN y5), are recruited early upon 
mycobacterial infection in man (Inoul, Yoshikai et al. 1991). Logically, defective HIV-infected or 
destroyed CD4+ T cells should not affect the responsiveness of CD4-negative y5 T cells. However, in 
HIV+ individuals, a subset of DN y8 cells, the Vy9V52 T cells, are reduced in number and reactivity to 
M. tuberculosis stimulation in vitro is very decreased or absent in the majority (~60%) of the HIV-1 
infected individuals with advancing HIV disease (CDC stages m  and IV). In contrast, there is 
polyclonal expansion of another yS T cells subset, V81+ cells (Boullier, Cochet et al. 1995). This sub­
population is known to contribute to immunity against mycobacteria through recognition of the 
phosphoandgen called TUBAg (Boullier, Poquet et al. 1999). This loss of reactivity was shown to be 
due to a deficiency of CD4+ T cells secreting a type 1 cytokine profile, since responsiveness could be 
restored in vitro with these latter cells (Wesch, Kabelitz et al. 1996). The yS Vy9V52 T cells also elicit 
strong type 1 cytokine secretion in HIV+ responders characterized by the selective production of IFNy 
and TNF-a. In contrast to CD4+ T cells specific for M. tuberculosis antigens from HIV+ patients 
(Zhang, Gong et al. 1994), HIV+ patient with the Vy9V52 T cells anergy did not have any significant 
secretion of type 1 or type 2 cytokines, even after stimulation with IL-12 and IL-15 (Boullier, Poquet et 
al. 1999). The mechanism of functional anergy of the Vy9V52 T cells from HIV+ patients is presently 
unknown. In summary, the results of these studies suggest a complex regulation of Mycobaterium 
tuberculosis-reactive yS T cells in HIV+ patients and a role o f CD4+ T cells in the adequate function of 
these cells.
2.4.2.3 Leprosy in HTV Infected Patients
Epidemiological studies so far have failed to show any increased incidence of leprosy, even in
areas of rapidly increasing incidence of HIV seropositivity and AIDS in Africa (Leonard, Sangare et al.
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1990; Tekle-Haimanot, Frommel et al. 1991) (Pdnninghaus, Mwanjasi et al. 1991) (Munyao, Bwayo et 
al. 1994) (Frommel, Tekle-Haimanot et al. 1994) (Lienhardt, Kamate et al. 1996), India (Sayal, Das et 
al. 1997) and South America (Machado, David et al. 1998). No similar study has been reported so far 
from southeastern Asia, where the epidemiology of leprosy is slightly different, with a higher proportion 
of lepromatous cases. One study from Tanzania has shown a slightly higher incidence rate of 
lepromatous leprosy in an urban cohort of HIV+ individuals (Borgdorff, van den Broek et al. 1993). 
These epidemiological studies on leprosy and HIV infection sharply contrast with the data concerning 
tuberculosis (TB), sometimes found in the same African survey (Pdnninghaus, Mwanjasi et al. 1991). 
Likewise, the only immuno-pathological study so far in humans did not reveal any difference between 
HIV+ and HIV- patients in the borderline tuberculoid or the borderline lepromatous area of the 
spectrum (Sampaio, Caneshi et al. 1995). Similar percentages of CD4+ and CD8+ T lymphocytes were 
present in lesions of HIV+ and HIV- borderline tuberculoid patients. Even though cytokine mRNA 
expression was not assessed in the lesions in this study, examination of gamma interferon mRNA 
expression from non stimulated and M. leprae sonicate (MLS) stimulated peripheral blood mononuclear 
cells were similar or higher in HIV+ individuals (Sampaio, Caneshi et al. 1995). Likewise, histo- 
pathological studies have failed to demonstrate any augmentation of the incidence of lepromatous 
leprosy or downgrading of leprosy from tuberculoid to lepromatous disease in humans (study and 
review in (Faye, Mahl et al. 1996). However, since no reliable test can be performed to assess the ratio 
of the individuals suffering from lepromatous/ multibacillary leprosy to the individuals exposed 
(infected) to the leprosy bacillus without disease (leprosy disease rate: leprosy infection rate) in an HIV- 
infected versus HIV-negative population, the question of whether HIV infection and/or disease favors 
the development of lepromatous leprosy after exposure to the pathogen remains largely unanswered and 
difficult to address. A few reports suggest an increased immunopathological (i.e. reversal) reactions in 
HIV+ individuals as compared with HIV- leprosy patients (Bwire and Kawuma 1994).
Experimentally controlled studies using rhesus monkeys inoculated with large doses of M. 
leprae and concurrently infected with SIV have shown higher proportion o f animals that develop 
persistent M. leprae infections compared with SIV- animals (Gormus 1989) (Gormus, Murphey-Corb et 
al. 1998). Rhesus macaques, which are considered as the best available model of HIV infection and
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disease (Simian AIDS) may react differently than humans. Alternatively, careful analysis of the timing 
of SIV inoculation and M. leprae inoculation suggests that the inoculation schedule may not be 
representative of what occurs in nature in humans co-infected with M. leprae and HIV. Numerous 
carefully controlled epidemiologic studies about M. leprae indicated that exposure to M. leprae in 
endemic areas occur early during childhood (Doull, Guinto et al. 1945; Fine 1982). In contrast, HTV 
infection is sexually transmitted and therefore individuals are exposed during early adulthood, aside 
from the vertically transmitted cases. Therefore it can be inferred that, in most cases, leprosy exposure 
precedes HIV infection. This inoculation schedule, that is leprosy being inoculated several months 
before SIV has not been reported in rhesus macaques. The higher proportion of rhesus macaques that 
developed persistent M. leprae infection was seen in animals that were inoculated with M. leprae at the 
same time, or 8 to 10 months after inoculation with SIV and were animals often with advanced SAIDS 
(Gormus 1989) (Gormus, Murphey-Corb et al. 1998). The very large doses of M. leprae used to 
inoculate these animals constitute another discrepancy between what is observed in experimental 
leprosy in SIV+ rhesus macaques and natural leprosy in HIV+ humans. Extrapolation of these findings 
to humans must therefore be made with caution.
2.4.3 T h e  I n f lu e n c e  o f  M y c o b a c te r i a  a n d  O t h e r  S e c o n d a r y  I n f e c t io n s  o n  
t h e  C o u r s e  o f  HIV I n f e c t io n
2.4.3.1 Antigen Challenge and Levels of Lendvirus Replication
Since the discovery of HTV, it has been known that the production of HIV-1 virions in vitro
requires activated lymphoblasts, as initially achieved by addition in the culture medium of recombinant
human IL-2 (Barre-Sinoussi, Chermann et al. 1983). HIV would replicate more efficiently in mitogen
stimulated peripheral lymphocytes (Folks, Kelly et al. 1986) and this feature was not merely a
consequence of dividing cells, since HTV, unlike many retroviruses, can infect and produce low levels
of virions in non-dividing cells (Heinzinger, Bukrinski et al. 1994).
In fact, this decade has witnessed a series of studies, both in vivo and in vitro, linking immune
activation during common, rather benign viral and bacterial infections to the progression of HIV-
infected individuals from the asymptomatic stage to AIDS related complex and AIDS (reviewed in
(Copeland and Heeney 1996) and (Bentwich, Kalinkovich et al. 1995)) (Weissman, Barker et al. 1996)
(Stanley, Ostrowski et al. 1996) (Staprans, Hamilton et al. 1995) (O'Brien, Grovit-Ferbas et al. 1995).
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Asymptomatic HIV-infected individuals receiving common vaccination protocols such as 
influenza vaccination and/or booster dose o f tetanus toxoid have transiently higher HIV titers in the 
blood and lymph nodes, corresponding to a boost in HIV replication (Stanley, Ostrowslci et al. 1996) 
(Staprans, Hamilton et al. 1995) (O'Brien, Grovit-Ferbas et al. 1995). In a cell culture system, similar 
results were found in APC pulsed with tetanus toxoid and CD4+ cells from HIV+ donors during the 
immune activation of an in vivo immunization. With this system, during Ag-speciflc immune activation, 
100 times fewer HIV virions are necessary to initiate a productive infection in vitro (Weissman, Barker 
et al. 1996). These immunologists have suggested that, in addition to or instead of a shift from Thl to 
Th0/Th2, a high state o f immune activation characterizes AIDS in developing countries and may readily 
explain the differences of clinicopathologic and epidemiologic features between the western 
industrialized world and Africa, for example (Marlink 1987) (Bentwich, Kalinkovich et al. 1995). 
Interestingly, several at-risk groups of the industrialized world have also a higher rate of chronic 
infections and diseases (Marlink 1987) (Quinn, Piot et al. 1987). Future work will be aimed at trying to 
decipher the mechanisms of the increased HIV replication associated with immune activation in order to 
attempt to counteract this component o f HIV pathogenesis without using drugs that induce 
immunosuppression (Greene 1996).
2.4.3.2 Do Active Tuberculosis and Other Mycobacterioses Precipitate the Evolution 
of HIV Disease?
As with other potentially persistent infections, such as cytomegalovirus and other herpes 
viruses, it is conceivable that a focus of M. tuberculosis infection may chronically and repeatedly 
stimulate the immune system and favor the progression of the HTV disease. In fact, tuberculosis is not 
always a disease of full-blown terminal AIDS as was observed with Af. avium and other opportunistic 
mycobacteria (Ellner 1990; Gallant and Ko 1996; Shafer and Edlin 1996; Havlir and Bames 1999), but 
has been shown to be associated with rapid deterioration of the clinical status of HIV-1 infected patients 
toward AIDS (Whalen, Horsburgh et al. 1995). The basis of this action is multiple and include increased 
replication of HIV in activated lymphocytes at the time of the acute phase of the disease (Goletti, 
Weissman et al. 1996) and macrophages when they phagocytize mycobacteria and/or secrete TNF-a 
(Shattock, Friedland et al. 1994)
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2.4.3.3 Leprosy and AIDS in Developing Countries
As pointed out m the introduction contrasting the epidemiology of different species of 
mycobacteria in HIV infected persons, there are essentially no data dealing with the influence of M. 
leprae infection and leprosy on the susceptibility and evolution of newly acquired HIV infection.
In addition to epidemiological studies in areas where both diseases are highly endemic, the use 
of different sequences of SIV and M. leprae dual infections in different species of monkeys, such as for 
example the sooty mangabey (Cercocebus atys), the cynomolgus macaque (Macaca fascicularis) and 
the rhesus macaque (Macaca mulatto) could be highly informative. Investigations in controlled 
experimental conditions have already been performed (Gormus, Murphey-Corb et al. 1998) after the 
fortuitous finding that rhesus monkeys accidentally infected with SIV of sooty mangabey origin at the 
time of M. leprae inoculation would develop disease in a higher proportion as compared with SIV- 
controls (60% of SIV+ versus 21% of SIV- developed leprosy) (Gormus 1989).
2.4.4 C o n c lu s io n
Reviewing the literature, it is puzzling to note the difference of susceptibility and prognosis 
between tuberculosis and leprosy in HIV+ individuals. Tuberculosis is more frequent and has a poorer 
prognosis in HIV+ individuals and AIDS patients. Tuberculosis also has been demonstrated to be a 
negative prognosis factor for development o f AIDS. In contrast, leprosy is not more frequent in HIV 
positive individuals or AIDS patients. A quite similar proportion o f clinico-pathologic presentations of 
leprosy exists in HIV+ and HIV- persons.
2.5 THE MEMORY STATUS OF THE IMMUNE RESPONSE
2.5.1 D e fin itio n  o f  a M e m o ry  T  L y m ph o cy te
The theoretical definition of a memory T lymphocyte seems quite easy. It is a T lymphocyte 
that was involved (or at least the lineage of which was involved) in an immune response. This T cell, or 
one of its predecessors, escaped down-regulating homeostasis, most often apoptosis, and possibly 
reverted to a non-activated state with an absence of mitoses and low metabolic activity. This cell should 
have a lower trigger of re-activation compared with a naive T cell and should express a set of adhesion 
molecules and chemokine receptors that favor the rapid recruitment of these cells in the tissue where the 
primary immune reaction took place. In practice, this cell should elicit vigorous and rapid response to 
recall antigen stimulation and survive treatment with drugs that destroy activated, multiplying T 
lymphocytes, such as die antimitotic drugs. The first practical definition o f a memory T cells is the
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cyclophosphamide-resistant T cell population that can confer DTH and protection within 2-3 days after 
adoptive transfer (Orme 1987; Orme 1988), developed in laboratories dealing with tuberculosis 
research.
“However, given the fact that the memory T cell is the primary target in the 
development o f new antituberculous vaccines, it is unfortunate that very little is really 
known about this population of cells and, because of the great expense incurred in 
maintaining infected animals over the long periods necessary, few laboratories have 
any interest in actively studying it.” Ian M. Orme et al, 1993.
This simple, very efficient definition of T cell memory is applicable only in well-controlled 
rodent experiments where adoptive transfers may be easily performed. For a long time now, simple 
surface markers of memory T cells have been sought (reviewed in (Cerottini and MacDonald 1989) 
with variable success.
Memory T cells are circulating lymphocytes that are said to perform immunosurveillance 
because they are present in the blood stream. Their frequency can be estimated using appropriate 
limiting dilution micro-culture systems and determining the frequency of effector cells precursors, such 
as cytotoxic T lymphocytes (CTLp) or of CD4+ helper T cells producing cytokines and capable of 
proliferation (Varga and Welsh 1998; London, Perez et al. 1999). Also, memory cells are characterized 
by a higher density of adhesion molecules and surface cofactors, and usually produce higher amounts of 
cytokines (Cerottini and MacDonald 1989). Lastly, memory T cells are suspected to differ qualitatively 
and quantitatively in the requirements for activation; they have a lower threshold for activation. 
Recently, important insights in the understanding of this last property have been made in the analysis of 
the common leukocyte antigen (CLA), also called CD4S, discussed below. Qualitative difference in 
activation requirements of memory T cells is also illustrated by the findings that memory T cells, but 
not naive T cells, are proliferating upon exposure to cytokines, such as EFNa, IFNp and IL-15 for CD8 
memory T cells, and IL-2 and IL-4 for CD4 T cells, during an infection (Ahmed 1996; Tough, Borrow 
et al. 1996; London, Perez et al. 1999).
2 .5 .2  P o t e n t ia l  M e m o r y  M a r k e r s  o f  T  L y m p h o c y t e s
2.5.2.1 The Short Isoform of the Common Leukocyte Atigen (CLA): CD45RO
In 1988 and 1989, Matthias Merkenschlager and collaborators showed that CD45RO was
preferentially expressed in both memory CD4+ and CD8+ T cells, that is cells responding to recall
antigens in stimulation tests in vitro (Merkenschlager, Terry et al. 1988) (Merkenschlager and Beverley
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1989). More recently, the intracytoplasmic domains of CD45 molecules have been shown to have 
tyrosine phosphatase activity (Trowbridge 1994). This phosphatase activity modulates the tyrosine 
kinase activity following TCR engagement and T cell activation (Chui, Ong et al. 1994; Ong, Chui et al.
1994) (reviewed by (Trowbridge 1994). By integrating this two findings, it may be proposed that 
CD45RO, which may require a lower activation threshold, contributes to the memory phenotype of T 
lymphocytes. However, the lower activation threshold of CD45RO isoforms have not been directly 
proven.
CD45 is a family of alternatively spliced proteins, ranging in size from 180 kDa to 220 kDa, 
expressed on all leukocytes, exclusively upon cells of the hematopoietic system. The alternative 
splicing of 3 exons, which encode sequences near the amino-terminus of the molecule, generates 8 
isoforms. For example, when the 3 exons 4, S, and 6 are spliced out, the isoform is termed CD4S6. 
When the 3 exons are present or only exon 6 is lacking, the isoforms are termed CD45a and CD45/3, 
respectively (reviewed by (Trowbridge 1994).
To identify these isoforms, a set of 4 monoclonal antibodies (MoAb) has been generated 
against human leukocytes expressing common leukocyte antigens, termed CD45R. The A, B and C 
MoAb recognize protein epitopes corresponding to protein isoforms, the genes of which contain exon 4, 
5 and 6, respectively. Hence, CD45a can be identified because a cocktail of CD45RA, CD45B and 
CD45RC will bind the isoform. The CD4SRO MoAb, corresponding to the clone UCHL-1 in humans, 
binds to an epitope of the protein isoform CD450. This epitope corresponds to an amino-acid sequence, 
the encoding gene of which includes exons 3 and 7 without the three intervening exons 4, 5 and 6 that 
had been spliced out during transcriptional maturation.
All leukocytes, including T cells, express variable exons at different maturation stages, but at 
least in T cells this expression is neither unidirectional nor irreversible in long term human T cell lines 
(Rothstein, Yamada et al. 1991). Moreover, transfer of CD45R+ or CD45R- allotype-marked CD4 T 
cells into athymic nude rats demonstrated that function followed phenotype, not parentage (Bell and 
Sparshott 1990). So, in contrast to other markers such as CD4 and CD8 in the thymus, CD45R are not 
maturation markers but rather functional markers. It can be stated that, in humans, CD45RO binds up- 
regulated CD450 isoforms that are abundant in activated cells in vitro. Recent experiments have shown
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that the memory phenotype was not exclusively found in cells expressing high densities of CD450 
isoforms (CD45ROhi cells), but could be found also in cells with higher molecular weight isoforms in 
rats (Hargreaves and Bell 1997) and humans (Richards, Chapman et al. 1997).
Therefore the studies linking the increase of CD45RO+ T cells associated with progression 
towards AIDS in HIV+ subjects (Bofill, Mocroft et al. 1996; Mahalingham, Pozniak et al. 1996; Benito, 
Zabay et al. 1997), which were apparently contradicted studies of memory cell functional loss 
(Miedema, Petit et al. 1988; Clerici, Stocks et al. 1989), were in fact indicative o f increased CD4 T cell 
activation. A previous study also exploring the activation markers HLA-DR and CD38 reached similar 
conclusions (Kestens, van Ham et al. 1994).
2.5.2.2 L-Selectin (CD62L)
High levels of L-selectins are present in naive T cells but not in memory T cells (reviewed in
(Dutton, Bradley et al. 1998). As with CD45R0 expression detected by CD4SRO MoAb, recent 
experiments suggest that the down regulation of L-selectin accompanies T cell activation rather than T 
cell memory (London, Perez et al. 1999). The implication that an adhesion molecule is differentially 
expressed between naive and memory function is interesting and should be expended by differential 
expression of other critical adhesion molecules. In fact, it has been shown that the |3 integrin LFA-1 
detected by the marker CD 1 lb  are also higher and associated with activated/memory T cells. However, 
again, costimulatory molecules are definitively more associated with activation than memory status.
2.5.2.3 The Surface Marker CD44
In a situation opposite to L-selectin, it was shown that CD44hi was present in memory T cells,
whereas CD441o is usually characteristic of naive T cells (reviewed in (Dutton, Bradley et al. 1998)).
2.5.3 C o n c lu s io n
Two theories of lymphocytes memory are currently put forth, that are not necessarily excluding 
each other: 1) “dormant” memory, recirculating long lived T lymphocytes and 2) periodic re-stimulation 
of memory lymphocytes, either through retained Ag in APC with frequent/recurrent presentations of 
persistent antigen fragments to T and B lymphocytes, or frequent re-stimulation o f memory cells with 
cytokines secreted during intermittent infections, since these latter ceils do not require co-stimulations 
(Dutton, Bradley et al. 1998). This latter mechanism (i.e. periodic re-stimulation) is particularly 
attractive to explain die selective loss of memory T cell pool in HIV infection, since the virus may
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replicate preferentially in activated T cells, and experimental data suggest that memory T cells have 
much less stringent requirements for activation than naive T cells during benign infections (Trowbridge
1994).
Non naive T and B-lymphocytes can be defined by markers but it is currently difficult to 
differentiate between activated naive and activated memory T lymphocytes. There are no established 
markers between species. Some markers are established markers of cell activation (such as CD45 RO) 
with uncertainties about their status/role as memory cells. However, the most convincing demonstration 
that CD45RO may be an adequate marker of T cell memory in addition to be an established marker of T 
cell activation lies in the fact that ex vivo CD4SRO+ cells are augmenting instead of diminishing in type 
1 cytokine secreting CD4 T cells during influenza vaccination (Kallas, Gibbons et al. 1999) 
(McElhaney, Pinkoslti et al. 1995).
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3 SORTING OF CD4 AND CD8 T CELLS FROM LYMPH 
NODE CELL SUSPENSIONS OF RHESUS 
MACAQUES USING ANTIBODY-COATED 
MAGNETIC MICROBEADS: A PRELIMINARY
STUDY
3.1 INTRODUCTION
Many immunological studies rely on the functional and phenotypic analysis of key cell subsets 
of lymphocytes, macrophages and natural killer cells. In addition to cell cultures in vitro, inflammatory 
and immune cells from an inflammatory site and draining regional lymph nodes (LN) can now be sorted 
and isolated to near purity ex vivo prior to be either cultured in vitro or analyzed for phenotypic 
properties or cytokine secretions (Orfao 1996). The most precise technique for isolating cell subsets that 
exhibit specific surface molecules is the fluorescent activated cell sorting (FACS) (Orfao 1996), which 
exhibits good performance even in rare cell subsets (McCoy 1991; Rosenblatt 1997). Ninety five 
percent to 99% purity of cells with a specific surface cell marker is common with this technology with 
high recovery, even using markers with dim fluorescent signal (Orfao 1996). However, this technique is 
relatively slow (McCoy 1991), requires to use reagents such as monoclonal antibodies (MoAb) that may 
alter the cells, may not allow the isolation of cells in sterile conditions (Orfao 1996). In addition, it must 
be performed on live cells and may generate aerosols, a potential source of hazards to laboratory 
workers when isolating cells that potentially harbor dangerous infectious agents.
Alternative technologies have been developed using columns and beads, taking advantage 
either of the magnetic field (Miltenyi, Muller et al. 1990) (Lea, Vartal et al. 1988) (reviewed in (Battye 
1991)) or of antigen-antibody affinity as the separation principle (Tanke 1993).
Our long-term goal is to isolate the memory/activated fraction of CD4+ T lymphocytes present 
in the regional LN draining skin inoculation sites in order to study the ex vivo cytokine mRNA 
expression of this important T cell subset after a second inoculation of fresh Mycobacterium leprae in 
rhesus macaques (Macaca mulatto). The cell surface marker chosen for the memory/activated fraction 
was CD4SRO, specifcally binding the short isoform CD4SRQ o f the common leukocyte antigen family 
of surface molecule. This marker has been shown to be more expressed on the cell surface of human 
activated/memory T lymphocytes (Akbar, Terry et al. 1988; Merkenschlager, Terry et al. 1988; Akbar,
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Timms et al. 1989). It has also been shown that the CD45R.O isoforms play a modulating role in the 
ease and magnitude of T cell responsiveness (Chui, Ong et al. 1994) (reviewed by (Trowbridge 1994).
In a preliminary effort to determine the feasibility to isolate the cell subsets present in healthy 
and SIV+ rhesus LN (rLN), we chose to use the magnetic cell sorting (MACS) technique to purify 
memory/activated T lymphocytes. Results indicate a performance of this method similar to human 
peripheral blood mononuclear cells (hPBMC) in purifying CD4 and CD8 T lymphocytes. However, 
only partial enrichment of memory/activated CD4 T lymphocytes could be achieved using the MACS 
technique in both hPBMC and rLN. The immplications of this are discussed.
3.2 MATERIALS AND METHODS
3 .2 .1  C e l l  Is o l a t io n  a n d  C e l l  Y ie l d s
Heparinized blood was collected from 2 healthy human volunteers. Lymph nodes were 
collected from one healthy and one SIV infected (SIV+) rhesus monkey (Macaca mulatto) housed at the 
Delta (Tulane) regional primate center under sedation or prior to euthanasia. Human PBMCs were 
isolated using density gradient centrifugation (Ficoll-paque®, Pharmacia,Upsalla, Sweden) at a ratio of 
3 ml o f Ficoll for 10 ml of blood. Lymph nodes (LN) were excised from the inguinal area, minced under 
sterile conditions, filtered through a 67 pm-wide metallic filter and suspended in RPMI medium with 
10% fetal calf serum. Cells were subsequently adhered to plastic petri dishes for 1 hour at 37°C to 
deplete B cells and macrophages from the starting LN cell suspensions (LNCS) and the starting hPBMC 
suspensions. A range of SO to 100 millions hPBMC and were isolated. Rhesus LNCS had a total yield 
varying from 2.4 107 (SIV+ animal) to 3.4 10s cells (SIV- animal).
3 .2 .2  Is o l a t io n  o f  CD4, CD8, CD45RO a n d  CD4+CD45RO+ T L y m p h o c y t e s  
U s in g  MACS
Columns of 1.5 ml capacity (Mini-columns™ type MS+/RS+ for Mini-MACS®), with a 
sheath of iron wool and were obtained from Miltenyi Biotec Inc, Auburn, CA. Magnetic beads coated 
with fluorescein isothiocyanate (FITC) and magnetic beads coated monoclonal antibodies (MoAb) were 
used. The reagents and sources were the following: anti-CD4-FITC isomer 1 (clone OKT4 -  Ortho, 
Raritan, NJ) used with anti-FITC isomer 1 microbeads (Miltenyi), anti-CD8-microbeads (clone SKI, 
Miltenyi) and anti-CD45RO-microbeads (clone UCHL-1, Miltenyi) monoclonal antibodies.
One parameter (single) and 2-parameter (double) magnetic cell sorting were performed 
according to manufacturer’s instructions (Miltenyi Biotec Inc, Auburn, CA). The linkage element of the
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iron microbeads to the anti-FITC MoAb is composed of a dextran polymer. The detachment necessary 
before the second sort is accomplished by incubation for 10 minutes with dextranase, an enzyme that 
catalyses the dextran bridge lysis.
Sorted fractions were kept at 4°C on ice until a sample was prepared for three-color flow 
cytometry using a FACScan™ (Becton Dickinson immunocytometry systems, San Jose, CA). Cells 
were incubated with the following MoAb: CD4-FITC and CD4-phycoerythrin (PE) (clone OK.T4 -  
Ortho), CD8(Leu2a )- peridinin chlorophyll protein (perCP) (clone SKI, Becton Dickinson), mouse 
anti-human CD3-PerCP (clone SK7, Becton Dickinson), mouse anti-monkey CD3-FITC (clone FN-18, 
Serotec, Oxford, UK), CD45RO-PE (clone UCHL-1, Dako, Carpinteria, CA). Incubation conditions, 
washing and fixation were performed under standard conditions: The MoAb were incubated at room 
temperature in the dark for 20 minutes, washed once with saline and fixed with 1% paraformaldehyde. 
The proportion of CD4+ macrophages in hPBMC and rhesus LNCS were assessed using CD14-FITC 
(clone TUK4, Dako).
3.2.3 P a n n in g  o f  B  C e l l s
Rhesus LNCS or rhesus PBMC were obtained from SIV- rhesus macaques and were depleted 
of B lymphocytes and macrophages using plastic surfaces coated with rabbit anti-human 
immunoglobulins (Accurate, inc., Westbury, NY -cat. # AXL230), according to standard protocol with 
slight modifications (Lewis and Kamin 1980). Two concentrations, 1.2 mg/ml (1:10 dilution) and 0.6 
mg/ml (1:20 dilution) were tried to pan B cells or Petri dishes and 25 cm2 cell culture flasks were 
compared for relative performance (figure 3.6). The system selected was plastic surfaces of 25 cm2 cell 
culture flasks coated overnight at 4 °C with immunoglobulins at a concentration of 0.6 mg/ml. Cells 
were added at a concentration of 1.5 107 cells/ml and incubated for 2 times for 45 min. at 37°C in 
humidified 5%C02 incubators was then used to deplete both macrophages and B cells.
Non adherent (non-adh) cells were collected by pipetting and stained with mouse anti-simian 
CD3 (FN18), mouse anti-human CD4 (OKT4) and analyzed by flow cytometry. The total CD3 
percentage is obtained from CD3 versus CD4 scatter plot quadrants of a 2 color flow cytometry 
analysis.
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3.3 RESULTS AND DISCUSSION
3.3.1 CD-4 P o s it iv e  S e l e c t io n  a n d  CD8 N e g a t iv e  S e l e c t io n
Performance was similar between hPBMC and rLN cells with regard to CD4 single sorting 
(positive selection), consistendy yielding fractions with >95% purity (Fig. 3.1). Similar results of 95% 
to 98% yields were obtained using CD8 single sorting of rLN (Fig. 3.2). Immunomagnetic sorting 
technology can be used in rhesus monkey lymphocytes to yield near-pure CD4 and CD8 cell fractions 
usable for further analysis with commercially available columns. This has also been performed in a few 
other transplantation studies using rhesus monkeys using CD8 and CD3 (clone FN18) negative selection 
(Thomas, Carver et al. 1991) and cynomolgus monkeys with CD8 (Voss, Nick et al. 1992). However, 
to our knowledge, there is no report describing the successful positive selection with high purity yields 
using immunomagnetic beads and CD4 marker (clone OKT4 -  Ortho). The advantages of MACS over 
FACS is the possibility o f performing near 100% purification of cell subsets with light equipment that 
can easily be placed in a common biohazard containment hood if cells are infected with hazardous 
agents.
3.3.2 Two P a r a m e t e r  CD4CD45RO D o u b l e  S o r t  F a il s  t o  E n r ic h  
CD4+CD45RO+ T L y m p h o c y t e s  in  B o t h  H u m a n s  a n d  R h e s u s  M o n k e y  
C e l l s  U s in g  M a g n e t ic  S o r t in g
The second sorting of CD45RO cells from CD4+ purified fraction was not successful. No 
enrichment was obtained either from human PBMC or rhesus LN cells using 2-parameter (double) sort 
with (Fig. 3.1). This failure may be due to an incomplete detachment of the magnetic beads attached to 
the anti-FlTC MoAb necessary for the first sort. The CD4 positive fraction was not passed through an 
additional column to remove any cell with persisting microbeads so the percent release could not be 
determined.
Recently, purification o f CD45RO and CD45RA cell subsets has been described from 
hPBMCS after CD4 and CD8 positive selection using detachable beads (O'Brien and Kemeny 1998). 
They used large quantities of blood (100ml), a large magnet and negative selection to enrich at > 90% 
purity CD45RO and CD45RA using mouse anti-human CD45RA (clone B-C15) and anti-human 
CD45RO (clone UCHL-1). Interestingly, purity o f CD45RO was not as good as purity with CD45RA 
(92 versus 98%). In another experiment assessing sorting and functional properties of cryo-preserved 
hPBMCs, positively selected CD4+ T cells with detachable magnetic microbeads were depleted of
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CD4SR0 and CD45RA using the same strategy as the study mentioned above and enrichment of at least 
90% were obtained (Sleasman, Leon et al. 1997).
3.1a 100
% CP4+RO+
20 I I  I  I  1  
I  I  I I  I
startsu sp  non-adher CD4+ CD4+/RO- CD4-*/RO+
SORTFRACTIONS
start susp non-adher CD4+ CD4VRO- CD4-WRO+ 
SORTFRACTIONS
Figure 3.1: Double sorting of (a) human PBMC and (b) SIV+ rhesus 
macaque’s lymph node cell suspension (LNC) for CD4 and CD45RO.
The bars represent the proportion (%) in a given cell fraction analyzed by 
flow cytometry. There was very good separation of CD4+ T cells using 
OKT4 MoAb but an absence of separation in the second sort for CD45RO 
in cells from both species.
The data depicted in (a) are the best results of 3 experiments to double sort 
human PBMCs. The data presented in (b) was from a single experiment. 
The total percentages of CD4+ cells (TOTCD4) and the total percentages of 
CD45RO+ cells (TOT RO) were obtained by adding the appropriate 2 
quadrants from CD4SRO versus CD4 scatter plots acquired from 3 color 
flow cytometry analysis. The percentages of double positive (DP) 
CD4+CD45RO+ cells among the total CD4 percentages (%CD4+RO+) are 
obtained by dividing the percentage of CD4+CD45RO+ DP cells (upper left 
quadrant) by TOT CD4 and multiplying the ratio by 100.
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Figure 3.2: Single sort of CD8+ cells T cells from one SIV- rhesus 
monkey’s lymph node cell suspension.
From the non-adherent cells (non-adher) collected after panning, there is a 
146.25% enrichment of CD4+ T cells in the negative fraction (CD8 neg) 
and 262.42% enrichment of CD8+ T cells in the positive fraction (CD8+ 
pos). The total percentages of CD4+ cells (TOTCD4) and the total 
percentages CD8+ cells (TOT CD8) are obtained by adding the appropriate 
2 quadrants from CD8 versus CD4 scatter plots acquired from 3 color flow 
cytometry analysis
In addition, in both rhesus and humans, only the cells having a high concentration of CD45RO 
epitopes (CD45ROhi) are retained by the magnetic field when percolating through the magnetic 
column. In fact, in both human and rhesus monkeys, CD45RO is characterized by a continuous band­
like cloud of points, varying from low to high expression, when viewed on a flow cytometry scaner plot 
(Fig. 3.3a) whereas CD4, CD3 and CD8 have discrete populations of frankly positive and frankly 
negative cells. This is due to the molecular biology of the CD45 isoforms that are often co-expressed on 
a particular cell (Trowbridge 1994). Interestingly, in hPBMCs, there were 2 populations of CD4+ 
lymphocytes, each representing approximately 45% of the gated cells, one with bright CD4+ cells and 
the other with dim CD4+ cells (Fig. 3.3b). Ninety % of these latter cells, whether of lymphoid or 
macrophagic lineage, were in also CD45RO positive. When these cells were positively selected by the 
CD4 first sort, they retained a high proportion of CD45RO. These cells, however, were not brighter with 
CD45RO marker than the bright CD4+ cells and would not have probably contributed to a better 
enrichment with CD45RO.
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Figure 3.3: a,b -  Flow cytometry scatter plot of the acquired events 
physically gated on lymphocytes using the CD4 positive fraction from (a) 
SIV+ rhesus macaque LNCS and (b) PBMCs from a healthy individual. 
These scatter plots show the continuous distribution of the CD45RO+ 
fluorescence. The X-axis (FL1) is CD4-FITC; the Y-axis (FL2) CD45RO- 
PE.
c-f - Flow cytometry scatter plots showing the two distinct sub­
population of double positive CD4+ CD45RO+ cells in human PBMC 
(starting cell suspension). Region R1 is composed of the bright CD4+ T 
cells (CD4hi) that are also 53% CD45RO positive. Region R2 is composed 
of the dim CD4+ T cells that represent 41% of the acquired events and are 
in great majority (90%) also CD45RO positive. These cells may be 
interpreted as monocyte/macrophages and/or lymphoblasts. CD3 
cytofluorometric analysis was not performed. SSC=side scatter; 
FSC=forward scatter.
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However, a higher concentration of CD45RO monoclonal antibodies used to label non 
adherent rLN cells permitted detection o f a higher proportion of positive CD45 RO cells, as assessed by 
a scatter plot with the same quadrant cut-off (Fig. 3.4a). In hPBMCs, there was a minimal 
augmentation (Fig. 3.4b). Together, results indicated a continuously varying concentration of CD45RO 
markers from low to high on the surface of CD4+ T lymphocytes that might have been detrimental to an 
efficient sorting using this marker. The microbead-coated CD4SRO monoclonal antibodies were used 
according the manufacturer’s recommendation, with no attempt to increase their concentration.
3.4a
100
80
60
u
S 40a.
20
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m  LN - start susp 
I  non-adher (45RO=4ul) 
I  non-adher (45ro=10ul)
TOT CD4 TOTRO 
FACS analysis
%CD4+RO+
3.4b
start susp (3 ul) I  start susp (10 ul)
TOTCD4 TOT45RO %CD4+RO+ 
FACS analysis
Figure 3.4: Effect of adhesion to plastic and augmenting the concentration 
of CD4SRO for labeling the starting suspensions (start susp) and the non­
adherent fractions (non-adher) of (a) rhesus LNSC and (b) hPBMCs. The 
proportions are on the y axis and the flow cytometry (FACS) analysis cell 
types (x axis) are identical to the definitions of figure 3.1.
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3.3.3 CD45RO S in g l e  S o r t  S l ig h t l y  E n r ic h e s  CD4+CD45RO+ T  L y m p h o c y t e s  
in  B o t h  H u m a n s  a n d  R h e s u s  M o n k e y  C e l l s
Increased percentages o f CD45RO+ cells, as assessed by flow cytometry, were obtained from 
the positive fraction after CD45RO single sort from non adherent rhesus LN (Fig. 3.5a). Similar results 
were obtained with negatively selected, enriched CD4+ cells after CD8 single sorting, also from rhesus 
LN from the same animal (Fig. 3.5b). The efficiency of the sorting was, however, much lower for 
CD4SRO single sort than CD4 and CD8 single sorts: 120% enrichment versus 483% (fig. 3.1b) and 
326% (fig. 3.2) enrichment, respectively, as defined by ratio of the percentage of yield over the 
percentage of starting cells suspension (% yield:%start ratio). The retention rate is defined by the 
following formula:
(% positive cells in original fraction) x (% negative cells in negative fraction) 
Retention rate: ________________________________________________________________
(% negative cells in original fraction) x (% positive cells in negative fraction)
The retention rate of CD4SRO single sorting, using the adherent cells as the original fraction, 
and of CD4SRO single sorting after CD8 negative selection, using the CD8 negative fraction as the 
original fraction, were 1.S3 and 3.74, respectively. A retention rate is considered adequate when the 
retention rate is between 6 and 8, according to the manufacturer’s instructions.
Lastly, whereas CD4+CD45RO+ were absent in SIV+ rhesus PBMCs and present in very low 
numbers in SIV+ rhesus LNSC (Figure 3.1b), they were present in more appreciable numbers in SIV- 
LNSC (Figure 3.5a and 3.5b), of the same order than hPBMC (figure 3.1a). There has been conflicting 
results as to whether the UCHL-1 clone is reactive in rhesus macaques (Polacino-Firpo, Axberg et al. 
1992; Jacobsen, Aasted et al. 1993; Reimann, Waite et al. 1994) and no immunoprecipitation studies 
have been done to clarify this. A recent study found weak staining (Sopper, Stahl-Hennig et al. 1997), 
like the preliminary study presented here. This suggests either a lower affinity o f the UCHL-1 
monoclonal antibody to the correct epitope, or alternatively, the existence of a cross-reacting irrelevant 
epitope in rhesus monkeys.
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Figure 3.5: CD45RO single sorting from (a) non-adherent cells and (b)
CD8 depleted, CD4 enriched cell fraction of lymph node cell suspensions of 
SIV- rhesus macaques.
A slight enrichment of CD45RO+ CD4+ T cells is obtained (120%) similar 
in the 2 different attempts. The flow cytometry analysis of cells is according 
those defined in figure 3.1 and 3.2. In panel b, the relatively high percentage 
of CD8+ cell in the CD8-/RO+ fraction can be explained by the relative 
numbers of cells sorted during the CD45RO sort: from 16.3 x 106 cells 
used, only 1.3 x 106 were sorted in the CD8-/CD45RO+ fraction. If it is 
assumed that -  all residual CD8+ cells of the CD8-negative fraction were 
preferentially retained in the CD8-CD45RO+ cell fractions and ~ none were 
retained in the CD8-CD45RO- fraction, then this result is readily explained.
3.3.4 E n r ic h m e n t  o f  CD3+ T L y m p h o c y te s  A f t e r  P a n n in g  o f  R h e s u s  PBM Cs 
w i th  R a b b i t  A n ti-H u m a n  Im m u n o g lo b u lin s
Since results of enrichment of CD4+ and CD4+CD45RO+ cells by depletion of CD8 cells 
were encouraging, additional enrichment of CD4+ cells was attempted by depleting the residual B cell 
population not adherent to plastic.). The enrichments for CD4+ and CD4+CD45RO+ were 155% and
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130%, repectively (Figure 3.5b). The principle is that B lymphocytes and some sub-populations of 
macrophages bind to the immunoglobulins bound to plastic, mainly through their Fc receptors (FcR). 
The non-adherent cells should then be mostly T lymphocytes.
Using Petri dishes and flasks with the modified protocol, reproducible enrichments in the range 
of 2 to 3 times the initial 033+  T cell proportions were achieved (Figure 3.6). This first step, combined 
with CD8 sort to obtain highly enriched 0 )4  populations, will permit to perform CD45RO enrichment 
if the proportion of CD4SROhi is sufficient among the rhesus LNCS to be studied.
100
start susp non-adh (1:101 non-adh (1:20) 
CELL FRACTIONS
Figure 3.6: Panning of rhesus PBMCs with rabbit anti-human Ig enriches in 
T lymphocytes.
There is 231.5% and 277.3% enrichment of the initial 0 )3 +  T cell pool, 
when analyzing the non-adherent (non-adh) cell fraction, using 1.2 mg/ml 
(1:10 dilution) and 0.6 mg/ml (1:20 dilution), respectively. The graph 
presents representative results from one out of 2 experiments.
3.4 CONCLUSION
We obtained very good sort results using anti-CD4 (OK.T-4) and anti-CD8 (SKI) monoclonal 
antibodies, reagents known to cross react between humans and rhesus macaques. The results obtained 
with CD45RO sorting are probably at least in part reflective of the lower affinity of the UCHL-1 clone 
monoclonal antibody for the homologous epitope of the CD45RO isoform expressed on simian 
leukocytes. The pattern of CD45RO reactivity that presents with a progression from CD45R01o and 
CD45ROhi expression could also account for the poor enrichment obtained after CD45RO single 
sorting of rhesus lymph node cell suspensions. The absence of enrichment obtained in the double sort of 
both h u m an  PBMCs and rhesus LNCS may be accounted for by an inadequate cell:CD45RO ratio or a
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non-coraplete cleavage o f the microbeads coating the MoAb present on the positively sorted fraction of 
the first sort.
These preliminary studies determined the following protocol to be optimal: I) panning on IgG- 
coated plastic to remove B cells, 2) CD8 magnetic sorting to remove CD8+ cells and 3) magnetic 
sorting of the CD45RO cells from the CD4 enriched, CD8 negative fraction to obtain an enriched 
CD4+CD45RO+ cell fraction.
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4 ANALYSIS OF RHESUS MACAQUE LEUKOCYTES 
ISOLATED FROM INCOMPLETE FREUND’S 
ADJUVANT INTRA-DERMAL INJECTION SITES: A 
PRELIMINARY STUDY
4.1 INTRODUCTION
Several methods have been developed to attempt to isolate and study mononuclear 
inflammatory cells at site of granulomatous response against an infectious agent, including blister 
formation (Kenney, Rangdaeng et al. 1987; Scollard, Suriyanon et al. 1990), use o f gelatin sponges 
(Buchanan and Murphy 1997) and use of type IV collagenase from site of lesions (Sacco, Jenson et al. 
1996). However, since at early time points after inoculation of M. leprae, it can be anticipated there 
will be an absence of well formed granulomas, the use of type IV collagenase may not be necessary. 
Moreover, since type I collagenase damages many cell surface molecules, jeopardizing phenotypic 
studies, it was decided to attempt to isolate lymphocytes from skin inoculation sites simply by fine 
mincing for the main study (see chapter 5).
In an effort to predict lymphocyte average yields a few days after M. leprae inoculations in the 
skin, we assessed the feasibility of collecting leukocytes present in skin lesional sites after injection of 
incomplete Freund’s adjuvant (IFA). Results indicated an adequate number of leukocytes collected, 
permitting flow cytometry analysis without density gradient purification, reverse transcriptase 
polymerase chain reaction (RT-PCR) from skin cell suspensions, and cytospin cytology. This sampling 
strategy is intended to be used for the study of M. leprae skin inoculation sites in naive animals and a 
second challenges in previously inoculated monkeys, as will be presented in subsequent chapters.
4.2 MATERIALS AND METHODS
The animals used in this pilot study were housed in Tulane’s Regional Primate Research 
Center, Covington, LA, in accordance with established standards of the United States Federal Animal 
Welfare Act, the American Association for Accreditation o f Laboratory Animal Care and the Guide for 
the Care and Use of Laboratory Animals. The procedures described below were performed on a group 
of 6 rhesus monkeys (Macaca mulatto) previously used in an unrelated study and scheduled for 
euthanasia.
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Two healthy rhesus monkeys each were sedated and inoculated with 0.1 ml o f Incomplete 
Freund’s Adjuvant (IFA) (Sigma immunochemicals, St Louis, MO) in the dermis o f the forearm at 2, 5 
and 7 days prior to sampling of inoculation sites. The inoculation sites, corresponding to a slightly 
thickened, red ~ 5-15 millimeter wide area, were collected as a 2.5 cm long wedge biopsy in all six 
monkeys the same day immediately after euthanasia, as well as heparinized peripheral blood. Margins 
of the biopsies were trimmed off to reduce the inoculation sites to approximately 6-10 millimeters in 
diameter. One half of each inoculation site was immediately immersed in buffered neutral 10% 
formalin. The other half of the each biopsy site was finely minced, and debris and clumps were filtered 
out using a 64-pm metallic screen (Fisher, Pittsburgh, PA).
4.2.1 C e l l  Y ie l d  D e t e r m in a t io n
Skin inoculation site cell suspensions (Skin CS) were diluted and maintained on ice in 10 ml of 
RPMI culture medium with 10% fetal calf serum until counted using an hemocytometer. Viability was 
assessed by Trypan blue dye exclusion. Aliquots of cells were sampled for flow cytometry, mRNA 
isolation and for cytospin in order to check for the relative qualitative composition of the Skin CS and a 
differential leukocyte count.
4.2.2 F lo w  C y t o m e t r y  A n a ly s is
Three parameter flow cytometry was performed using a FACScan™ (Becton Dickinson, 
Mountain View, CA) using the following monoclonal antibodies (MoAb): CD4-fluorescein 
isothiocyanate (FITC) (clone OKT4 -  Ortho, Raritan, NJ) and CD45RO-phycoerythrin (PE) (clone 
UCHL-1, Becton Dickinson), CD8 (Leu2a)-peridinin chlorophyll protein (PerCP) (clone SKI, Becton 
Dickinson). The proportion of CD4+ macrophages in blood and skin CS were assessed using CD 14- 
FITC (clone TUK4, Dako, Carpinteria, CA) and CD4-PE (clone OKT4 -  Ortho) by two-color flow 
cytometry. Mouse anti-human 62 -FITC (Endogen, Woburn, MA) and mouse anti-human CD 16 (Leu- 
1 lc)-PE (clone B73.1, Becton Dickinson) MoAb were also used to assess the numbers o f y6 T cells and 
NK cells, respectively. Incubation conditions, washing and fixation were performed under standard 
conditions. The MoAb were incubated at room temperature in the dark for 20 minutes, washed once 
with phosphate buffered saline and fixed with 1% paraformaldehyde.
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4 .2 .3  R N A  I s o l a t io n  a n d  R e v e r s e  T r a n s c r ip t io n  a n d  c D N A  A m p l if ic a t io n  B y  
PCR
For RNA isolation, I-S 106 cells were lyzed using RNA STAT-60 lysing solution (Tel-test”B", 
Friendswood, TX) and immediately frozen at -70°C. Subsequently, the lysates were thawed and total 
RNA was isolated using guanidinium thiocyanate according to the method of Chomczynski and Sacchi 
(Chomczynski and Sacchi 1987). Nucleic acid content determination and purity was assessed by 
measuring the 260 nm absorbency and the 260nm:280nm ratio, respectively, using a GenQuant™ 
(Pharmacia Biotech Biochrom Ltd, Cambridge, England, UK) spectrophotometer. The isolates were 
then reverse transcribed (RT) using Superscript II™ (Gibco Life Technology, Gaithersburg, MD) 
according to manufacturer’s specifications, with the addition of 1 U.I. of recombinant RQIRnase 
inhibitor proteins (Rnasin™, Promega, Madison, WI). Complementary DNA (cDNA) for rhesus p-actin 
was subsequently amplified by PCR for 30 cycles using primers designed to amplify human p-actin 
(Clonetech, Palo Alto, CA). The melting-annealing-extension temperatures were: 95°C-63 °C-72 °C, 
each for 1 minute, using a Perkin-Elmer 480 thermal cycler (Perkin Elmer- applied biosystems, 
Norwalk, CT). PCR conditions were as follows: IX PCR buffer II (PE applied biosystems), 20 
nanomoles of forward and reverse primers, ISO or 200 nanomoles of MgCl2, 80 nanomoles of 
deoxynucleotide tri-phosphate mixture (NTPs mix), and 1.25 units of Taq polymerase (PE Biosystems) 
in a 100 pi reaction volume. Since human P-actin primers may amplify genomic DNA, resulting in a 
product o f similar size, PCR from the RNA isolates without RT were also performed on experimental. 
Deoxy-ribonuclease I (DNase I) treatments were performed at room temperature for IS minutes at a 
ratio of 0.5:1 of Dnase I (units):RNA isolate (pg) (Gibco Life Technology) prior to RT. One sample 
with abundant P-actin as seen by PCR (K967 -  2nd replicate) was tested for genomic DNA (gDNA) 
contamination (Fig. 4.3b, see also Appendix 2).
4.2.4 C y t o l o g ic a l  E v a l u a t io n  o f  S k in  C e l l  S u s p e n s io n s  (CS)
At least 100,000 cells were used for the cytospins and prepared in a Shandon cytocentrifuge 
using standard procedures. Slides were stained with rapid modified Giemsa and according to the 
Papanicolaou procedure to evaluate the amount of contaminating epithelial cells. Amount of collagen 
fibers and other debris were qualitatively assessed as minimal (grade 0), slight (grade + ), moderate 
(grade ++) and abundant (grade +++).
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4 .2 .5  H is t o p a t h o l o g y
Formalin-fixed skin inoculation sites were embedded in paraffin, cut at 4 pm and stained with 
Harris’ hematoxylin and eosin (H&E) following standard procedures.
4.3 RESULTS
4 .3 .1  Y ie l d s  o f  C e l l s  W e r e  in  t h e  R a n g e  o f  1 t o  7 0  xlO6 V ia b l e  C e l l s
The total number of collected cells ranged from 2.6 x 106 to 68.6 x 106 , beyond what was 
initially expected. Data obtained from hemocytometer cell counts are presented in Table 4.1. There was 
no apparent difference of cell yields with regard to the number of days post inoculation (DPI). Trypan 
blue exclusion revealed <5% dead cells from Skin CS. A field representative of cell and debris present 
in cytospins is presented in Figure 4.1. Operator to operator variability in mincing and collection of cells 
may partially explain the important variability observed between each of the two skin CS at day 2 and 
day 7-post injection. Cells were counted by one investigator, without trying to exclude the granulocytes 
from the count.
Figure 4.1: Cytospin from the skin inoculation site cell suspension (skin 
CS) of rhesus monkey number L129 S days after intra-dermal injection of 
0.1 ml of Incomplete Freund’s Adjuvent (IFA). Notice the minimal 
contamination with collagen debris (arrow), numerous red blood cells and 
the presence of moderate numbers of granulocytes among the SISCS. Bar = 
75 fun, rapid modified Giemsa method.
See also Appendix 2 page 210.
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Table 4.1: Total cell yields and density of collagen fibers and other debris 
from skin cell suspensions from incomplete Freund’s adjuvent (IFA) 
injection sites.
Monkey # DPI total count collagen
K282 2 2.6 xlO6 +
K967 2 42.5 xlO6 +
K131 5 51.0 xlO6 +
L129 5 55.5 xlO6 0
K966 7 8.0 xlO6 ++
L132 7 68.6 xlO6 -I-
DPI: Days post inoculation of 0.1 ml of IFA.
Collagen amount grading is defined in material and method.
4 .3 .2  F l o w  C y t o m e t r y  A n a l y s is
The acquired events from the skin were gated on the physical properties of lymphocytes, a 
population either visible on the side versus forward scatter plots (fig. 4.2) or, when a discrete population 
of lymphocytes was not readily visible, extrapolated from the gate obtained when analyzing blood from 
the same animal. Isotype fluorescent MoAb controls showed that the non-specific staining due to debris 
and dead cells in the gated population in the skin varied from 5% to 15% (Fig. 4.2a,b). It was possible to 
obtain interpretable results of CD4, CD8 and CD45RO by 3 color flow cytometry (shown for CD4 and 
CD8 - Fig. 4.2c,d). Unfortunately, possibly due to high numbers of granulocytes, mainly eosinophils, 
that might have been activated to degranulate or degenerating and damage the mononuclear cells, most 
of the acquired samples had low total number of events and often insufficient numbers o f events gated 
on lymphocytes for optimal analysis (Table 4.2).
There were high proportions of y5 T cells amongst the gated lymphocytes (Average ± standard 
deviadon: 37.82 ± 21.78%). This proportion was 64% of the percentage of CD4 and CD8 cells CD8 
single positive cells (Average ± standard deviation: 59.23 ± 9.50%). These results could not be 
confirmed because mouse anti-monkey CD3 (clone FN18) was not used in this experiment to assess the 
proportion of CD4-CD8-CD3+ y5 T cells, and hence the potential proportion of non-specific staining. In 
blood, the proportion of yS T cells were less than 1% (Average ± standard deviation: 0.25 ± 0.11%). 
Importantly, the proportion of CD4+ T cells in the skin CS was significantly greater than the proportion 
of CD4+ T cells in the blood whether the double positive CD4+CD8+ T (DP) cells were included or not 
(p=0.01, one tail paired Student’s t test). The proportion o f CD8+ cells in the skin, including the DP 
cells, are also significantly different from the one in the skin (Table 4.2). However, the proportion of
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CD8+ T cells was not significantly different wbem excluding the double positive CD4+CD8+ cells 
(p=0.542, two tails paired Student’s t test). Taken together, proportions of lymphocytes in IFA injection 
sites were statistically significantly different (p<0.05, paired t test on combined CD4 and CD8 cells), 
which provides good evidence that the lymphocytes collected were not from the blood. Proportions of 
contaminating circulating lymphocytes cannot be rule out, however. Natural killer cells as assessed by 
CD 16 were not detected, suggesting that the marker was not binding any rhesus monkey cells.
Table 4.2: Gamma-delta, CD4 and CD8 percentages in the IFA skin injection sites and blood
total events cells gated cells % of y8 cells % of % of CD8*
__________________________ analyzed__________________ CD4*____________
gated on lymphocytes
Skin
AVG 3445.8 288.7 7.7% 37.82 54.70 39.29
STD 2840.8 305.3 3.7% 21.78 15.51 10.22
SEM 579.9 62.3 0.8% 8.89 6.33 4.17
Blood
AVG 10000.0 2219.1 22.2% 0.25 24.83 20.97
STD 0.0 931.5 9.3% 0.11 5.84 9.22
SEM 0.0 190.1 1.9% 0.05 2.38 3.77
T-TEST 0.020 0.007 0.007
* Percent of CD4+ and CD8+ cells including CD4+CD8+ double positive cells 
AVG = sample average (mean).
STD = sample standard deviation 
SEM = standard error of the mean 
T-TEST = two-tailed paired Student’s t test
4.3.3 RNA I s o l a t i o n  f ro m  S k in  CS Is F e a s ib le
A total of two aliquots of S xlO6 cells were removed from Skin CS from each animal, which 
had been lysed in 0.5 milliliter RNA-STAT60 and kept at -70°C, were studied, except for the 2 isolates 
from which insufficient numbers of cells were isolated (Monkeys # K282 and K966), where 0.5 million 
and 1 10* cells were lysed in 0.5 ml, respectively. Nucleic acid determination of the RNA isolate 
replicates by spectrophotometry revealed the isolates to be composed of a median of 23 pg (range 12-76 
pg) o f total nucleic acids with a median 260:280 ratio o f 1.452 (range 1.089 to 1.612). The low ratio of 
some isolates is attributed to possible hemoglobin and protein contamination secondary to a significant 
amount of red blood cells and dead cells, respectively. One pg o f each replicate o f the RNA isolates was
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reverse transcribed and amplified by PCR and bands at the expected size were found in 8 out of 12 
samples (Fig.4.3a).
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Figure 4.2: Scatter dot plots from the skin CS (incomplete Freund’s adjuvent 
injection site) of rhesus monkey K282. Events of each suspension of skin cells 
were physically gated on the lymphocytes (a,c). Percentages of each quadrant of 
fiiorescent scatter plots are represented in tables on the right side (b,d). 
a, b -  Isotype controls to assess non-specific staining. A total of S.6S % of the 
gated events exhibited non specific staining (Total events: S080; events gated: 
708 (13.94%). c, d -  CD8-PerCP (y-axis) versus CD4-FITC (x-axis) analysis. A 
significant proportion of events (*) from the upper right (UR) quadrant (double 
positive CD4+CD8+) and a minimal proportion o f the upper left quadrant 
(CD8+) are non-specific events. Total events: 9S20; events gated: 838 (8.80%).
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Performing direct PCR without RT showed that significant and often-abundant genomic (3- 
acdn DNA contaminations were present in rhesus monkey samples from these experiments (Fig. 4.3b -  
lane 4). Subsequent samples from rhesus monkeys, including rhesus, but not human, MLR cultures, 
using the same lysing solution under similar conditions of RNA isolation also occasionally contain 
genomic DNA contamination. Dnase I treatment succeeded in entirely digesting genomic DNA 
contaminants, as assessed by 31 cycles of amplification using the (3-actin human primers (Fig. 4.3b • 
lane 3).
4.3 .4  H isto pa th o lo g y
The IFA injection sites had consistently high content of inflammatory cells (Fig. 4.4). In
particular, small lymphocytes and lymphoblasts were numerous around capillaries and venules at day 2,
but waned thereafter. At day 2-post inoculation, the mononuclear cells: granulocytes ratio was close to
1, increasing to close to 3 at day 5 and falling to -2  at day 7 post injection (Table 4.3). At all time
points, in the panniculus, macrophages and eosinophils were numerous with fewer lymphocytes.
Lymphocytes were numerous in the deep dermis and subcutaneous panniculus at day S post inoculation.
Well formed eosinophilic granulomas with epithelioid macrophages and a few muldnucleate giant cells
were seen at day 7 post injection.
Figure 4 J :
a: P-actin RT-PCR from Skin CS. Two pg of total RNA isolate were 
reverse transcribed in a 40-pl volume. 5% (2 pi) of the RT product 
(equivalent to 0.1 pg of initial total RNA isolate) was used for 30 thermal 
cycles of PCR with (3-actin primers. Lanes: L: 100 bp ladder, A: K282, 2 
DPI; B: K967, 2 DPI; C: K 131, 5 DPI; D: L129, 5 DPI; E: K966, 7 DPI; F: 
L132, 7 DPI. panel 1: 1st replicates, panel 2:2nd replicates. Column G, lane 
2: negative control (distilled water). Lane H: panel l=positive control at 
1:100 dilution; panel 2=undiluted positive control, 
b: testing genomic cDNA contamination from Skin cell suspension: Total 
RNA isolated from CS of monkey # K967 -  2nd replicate. 2 pg of total RNA 
isolate were used for Dnase I treatment in a 20 pi volume. Half of the 
DNAse I treated product (1 pg) was reverse transcribed in a 40-pl volume. 
Template from lane 1 was 0.1 pg o f the RT-only product, lane 2 was 0.1 pg 
of the Dnasel+RT product, lane 3 was 10 % = 0.2 pg of Dnase I only 
product and lane 4 was 0.66 pg of the initial total RNA isolate, which were 
used to perform 31 thermal cycles with 20 nmoles of P-actin primers PCR. 
(fig. cont.)
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Table 4.3: Leukocyte percentages in sections of skin sites injected with 0.1 ml of IFA.
DPI* % granulocytes % monocytes mono/gran§
2 45.13 54.87 1.22
2 54.37 45.63 0.84
5 22.16 77.84 3.51
5 25.11 74.89 2.98
7 36.36 63.64 1.75
7 29.58 70.42 2.38
The counts were performed from H&E-stained, paraffin embedded sections. More 
than 200 cells were counted for each biopsy. 
♦DPI: Days post inoculation 
§ mono/gran = ratio of mononuclear cells: granulocytes.
Figure 4.4: Representative histology of an mtradermal injection site of IFA. 
Notice the prominence of the cellular infiltrate, significant edema and the 
mixture of lymphocytes, monocytes and granulocyte eosinophils around the 
vessels. 2 DPI. Hematoxylin and eosin stain. Bar = 120 pm.
4.4 DISCUSSION
The injection of incomplete Freund’s adjuvent (IFA) in the slan of rhesus macaques elicited a 
focal inflammatory response that enabled the collection of inflammatory cells for flow cytometry 
analysis o f  CD4 and CD8 and y5 lymphocytes, and cells for RNA isolation at 2, 5 and 7 days post-
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injection. The histopathological features of IFA injection sites, with abundant edema and eosinophils 
and dense lymphocytic infiltrates, correlated with the cell yield and quality as assessed by cytospins. 
This experiment was designed to determine the feasibility of a model for sampling the skin after M. 
leprae inoculation in the skin, and to optimize the methods.
However, early sampling after inoculation of M. leprae into the skin is anticipated to be more 
challenging because there may be less highly cellular lesions at the earliest time points. This will be 
especially true if there are no granulomas locally from which to extract large numbers of lymphocytes 
using collagenase to degrade reticulin fibers, such as type HI and Type IV collagenase, at early time 
points (see chapter 6). Investigations at early time point are limited to retrieving the recruited 
perivascular mononuclear cells after fine mincing only. In leprosy, this technique has been successfully 
performed to obtain a small number of cells for cloning from fully developed lesions, yielding cell 
suspensions from leprosy lesions of the range of 5 105 to 2 106 lymphocytes after purification by 
gradient sedimentation (Modlin, Mehra et al. 1986). In the preliminary study reported here, the total 
numbers of mononuclear cells ranged from 2.6 to 68.6 106 without density gradient purification after 
injection of 0.1 ml of incomplete Freund’s adjuvant.
One of the most encouraging findings with this approach was the strong evidence that the 
lymphocytes analyzed by flow cytometry are indeed recruited into the injection site, and were not 
merely circulating blood lymphocytes collected at the time of sampling, since CD4+ and yS T cells 
percentages from the blood and skin o f the same monkey are significantly different. The high to very 
high proportion of y8 T cells can be accounted for by the recent finding of an over-representation of T 
cells, the yS T cell receptor of which may recognize lipid and complex lipid (e.g. lipoglycans, 
lipopoteins) antigens in the context of CDlc (Porcelli, Brenner et al. 1989) (reviewed by (Sugita, 
Moody et al. 1998). To our knowledge, there is no study reporting high numbers of y§ T cells recruited 
at sites of IFA injection in rhesus macaques.
Abundant P-actin mRNA was obtained from 8 out of 12 RNA isolates, showing the feasibility 
and thedifiiculties o f this approach. Low or absent P-actin cDNA correlated with low 260 nm optical 
density (O.D.) and low purity as assessed by 260nm:280nm OD ratio, and was presumably due to 
inadequate isolation of nucleic acids. However, with the technology employed (Chomczynski and
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Sacchi 1987), we had consistent genomic DNA (gDNA) contamination. If variable am oun ts of gDNA 
are present in any of specimens, a competitive setting will be present during amplification between 
gDNA and complementary DNA (cDNA) that can further diminish the value of semi-quantification 
using relative RT-PCR, because the amount of cytokine mRNA would be under-estimated. Dnase I 
treatment before RT is necessary in such specimens to accurately standardize the samples for the 
housekeeping gene (3-actin to perform relative (“semi-quantitative”) RT-PCR.
Numerous granulocytes, a majority of which were eosinophils, were seen in the cutaneous IFA 
injection sites. Whether these cells may have been detrimental to optimal flow cytometry analysis by 
releasing their eosinophilic granules, for example, is unknown. It would be desirable to eliminate 
granulocytes by density gradient centrifugation, especially if high mononuclear cell yields can be 
obtained, as in this study. However, for the collection of inflammatory leukocytes from sites of injection 
of a less irritating inoculum, such as Mycobacterium leprae in buffered saline, lower numbers of 
leukocytes with minimal numbers of granulocytes may be retrieved, Skin CS analysis without density 
gradient centrifugation may be satisfactory for flow cytometry. The lower number of leukocytes with a 
minimal number of granulocytes can be anticipated, since M. leprae is minimally toxic by itself (Job 
1994)
Based on the results of this preliminary study, the following method will be used in the main 
study: 1) two 8 mm punch biopsies will be taken. 2) one will be swabbed with a sterile gauze to reduce 
blood contamination and be finely minced and filtered to obtain a Skin CS for FACS analysis only. 3) 
The other will be cut in two halves, one to be fixed in neutral buffered zinc-formalin and the other 
frozen for mRNA and immunohistochemistry.
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5 A VARIABLE CELL-MEDIATED IMMUNE 
RESPONSE IS PRESENT IN RHESUS MACAQUES 
(MACACA MULATTA) AFTER A SECOND 
INOCULATION OF MYCOBACTERIUM LEPRAE, 
WHICH CORRELATES WITH PERSISTENT 
INFECTION, BUT NOT THE SIV STATUS
5.1 INTRODUCTION
The main objective of this study was to assess any difference in the timing, the magnitude and 
the adequacy of the immune response to Mycobacterium leprae between SIV+ and SIV- rhesus 
macaques, in the context of documented demonstration of impaired immunity against most 
mycobacteria in SIV+ animals [Levy, 1996 #236]. Also evaluated was the correlation between 
phenotyping by flow cytometry and the levels of cytokine mRNA expression with the development of 
persistent M. leprae infection. The association between grossly visible inoculation sites and SIV status 
or persistent M. leprae infection was also examined. The necropsy findings at the closure of the study 
13 months after second M. leprae inoculation will be summarized. Performance of sorting of lymph 
node cell suspensions will be presented.
5.2 MATERIALS AND METHODS
5.2.1 A n im a ls
The animals studied have been described previously [Gormus, 1998, #126][Gormus, 1998 
#125]. They were housed in Tulane’s Regional Primate Research Center, Covington, LA, in accordance 
with established standards of the United States Federal Animal Welfare Act, the American Association 
for Accreditation of Laboratory Animal Care and the Guide for the Care and Use of Laboratory 
Animals. Eight female and one male rhesus macaques (Macaca mulatto), that did not develop any sign 
of leprosy after intravenous (IV) and intradennal (ID) inoculation 26 months earlier with M. leprae 
from nine-banded armadillo (Dasypus Novemcinctus, Linn.) were studied. This primary inoculation 
consisted of a total of 1.075 109 per animal, as previously described [Gormus, 1998 #126]. Two weeks 
before the initial M. leprae inoculation, 3 of them (N264, N356 and N976) were inoculated with the 
sooty mangabey-derived delta J943 strain of simian immunodeficiency virus (SIV).
One to 2 weeks before the M. leprae challenge, a biopsy of lymph node was taken from each 
animal as a reference control for baseline proportions of lymphocytes and baseline cytokine mRNA
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expressons. No skin from a non-inoculated area was taken at any time point, the normal skin being 
assumed to have negligible infiltrates with lymphocytes and resident histiocytes and an absence of 
detectable cytokine mRNA expression. Main signalment features and inoculation schedule of the 
animals used in this study are presented in table S.l.
Table 5.1: Signalment, inoculation schedule and euthanasia age of the rhesus 
macaques used for re-challenge with M. leprae. Also shown are the main clinical signs 
before euthanasia. On the first column from left is shown each monkey’s identification 
number.
SIV DOB Sex Age at inoculation Age at interval (year) Clinical Nasal
(years) euthanasia after 1st ML signs smear
SIV J 9 4 3 1st ML 2nd ML (years) inoculation AFB
N264 + 05/21/92 female 3.2 3.3 5.4 6.7 3.4 None -
N356 + 06/03/92 female 3.2 3.2 5.4 5.9 2.7 Diarrhea +
N976 + 04/05/93 female 2.4 2.4 4.5 5.2 2.8 Diarrhea -
M726 - 03/30/92 female 3.4 5.6 6.8 3.4 None -
M736 - 03/31/92 female 3.4 5.6 6.8 3.4 None -
M849 - 04/17/92 female 3.4 5.5 6.8 3.4 None -
M879 - 04/21/92 female 3.4 5.5 6.8 3.4 None -
N209 - 05/13/92 female 3.3 5.4 6.7 3.4 None -
P282 - 05/09/93 male 2.3 4.4 5.7 3.4 None -
AVG 07/17/92 2.9 3.1 S3 6.4 33
SIV: sooty mangabey-derived simian immunodeficiency virus chronic 
infection status (strain J943)
DOB: date of birth 
ML: Mycobacterium leprae 
AVG: average 
AFB: acid fast bacilli
5.2.2 C h a l le n g e
Fresh M. leprae from three nude (nu/nu) mouse footpad lepromas were collected aseptically 6 
months after inoculation, as previously described [Sibley, 1988 #149]. They yielded a total of 13.5 109 
bacilli with an typical bacterial viability for M. leprae as assessed by UC02 catabolic radiorespirometry 
measured at 1, 2 and 3 weeks post-culture medium inoculation, using Bactec460TB system® (Becton 
Dickinson, Sparks, MD) (Fig 5.1) as previously described [Franzblau, 1988 #151] [Franzblau, 1989 
#152].
The challenge consisted of 12 intra-dermal inoculations per animals in the thighs and arms (i.e. 
3 sites for each limb), each with 107 M. leprae bacilli suspended in lOOpL of phosphate buffer saline. 
The total dose per animal was 12 10s bacteria. Typical inoculation sites are shown in Figure 5.2. The 
inoculation sites were not tattooed to avoid o f non-specific inflammatory responses to that procedure.
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Instead, they were topographically mapped relative to anatomical landmarks such as bony processes of 
the elbow and knees.
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Figure 5.1: Evaluation o f M. leprae inoculum viability using >4C 
radiorespirometry. A total of 8 aliquots were evaluated at time of leproma 
collection, 1, 2 and 3 weeks later. The evaluation system is the following: 
The scale is from 0 to 999.0 < Growth index (GI) t. 300: low activity; 300 
< GI < 600: medium activity; 600 < GI < 999: high activity.
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Figure 5.2: Photograph of the intra-dermal inoculation sites in the arms of a 
rhesus monkey.
5 .2 .3  S a m p l in g  a n d  S a m p l e  U s e s
The schedule of sampling is summarized in figure 5.3. Sampling of the inoculation sites were 
not at random, but matched the sampling of lymph node biopsy for a particular time point (fig. 5.4). The 
schedule for skin sampling was as follows: two 8-millimeter diameter punch biopsies were taken at days 
2, 5, 8, 12, 26 and 62. One o f these biopsy specimens sampled at each time point was immediately 
swabbed of excess blood, finely minced in RPMI culture medium with 30% fetal calf serum (RPMI-30), 
filtered through a nylon gauze and collected in a 15 ml centrifugation tube, and kept on ice until counted 
with an hemocytometer and processed for flow cytometry 2-4 hours later. The optimization of this 
sampling technique on inoculation sites has been tested on a model o f intra-dermal injection of 
incomplete Freund’s adjuvant, the results of which are presented in the chapter four.
The other skin biopsy was bisected and one half was immediately embedded in OCT 
compound (Sakura, Torrance, CA) and snap-frozen in liquid nitrogen for CD4 and CD8 
immunophenotyping by immunohistochemistry and ex vivo cytokine mRNA expression by relative 
reverse transcriptase-polymerase chain reaction (RT-PCR). The other half was immersed in 4% neutral 
buffered zinc-formalin for standard histopathological assessment of inoculation sites.
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Figure 5 J : Sequential sampling of the inoculation sites, regional lymph 
nodes and peripheral blood.
The axillary or inguinal lymph node (LN) biopsies were taken at day -14/-7 (baseline), day 5, 
day 26 and day 62 after inoculation, with care to have them match the timing and location of the skin 
inoculation site biopsies (Fig.5.4). Approximately 15-20% of the LN biopsy was immersed in 4% 
neutral zinc-buffered formalin for standard histopathological assessment of possible disease and/or 
mycobacteria spreading. Another -  15-20% was snap-frozen in liquid nitrogen. The remaining tissue 
was finely minced, passed through a 67-|im mesh and collected in RPMI-10, to obtain a lymph node 
cell suspension (LNCS). A sample of the LNCS was utilized for flow cytometry cell surface marker 
studies, another sample (5 x 106 cells) was processed for mRNA cytokine expression studies and the 
rest panned to remove B cells and sorted immuno-magnetically into CD8 and non-CD8 cell fractions 
(described in chapter 6).
Four ml of heparinized blood was collected intravenously at days -7/-14 (baseline), day 5, day 
26 and day 62 for immunophenotyping by flow cytometry. At day 5 and 96, an additional 15 ml of 
blood was drawn to collect PBMC by density gradient centrifugation in order to perform in vitro 
lymphocyte functional studies (lymphocyte proliferation assay).
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1,2: day 2 
3,4: day 5 
5,6: day 8 
7,8: day 12
9,10: day 26 
11,12: day 62
o Skin inoculation sites
0  Loco-regional lymph 
nodes studied
Figure 5.4: Schematic drawing of the skin inoculation sites with regional 
lymph nodes. The numbers refer to the sequential succession of skin and 
lymph node biopsies. Skin and LN sampling match anatomically. All the 
inoculations, surgery procedures and sampling were performed by a trained 
veterinary surgeon. B = Baseline sampling 1 to 2 weeks before inoculation 
(-7 o r-14 DPI).
5.2.4 D a t a  A c q u ire d  b y  C o l l a b o r a t o r s
5.2.4.1 Evaluation of Grossly Visible Inoculation Sites
At the time of biopsy performed by a veterinary surgeon (Dr Marion Ratterree), the animals
were evaluated for the presence or the absence of grossly visible inoculation sites, information which 
was recorded on each animal’s medical history record. When a grossly visible site was noted, it was 
distinguished between 1) frankly visible, defined as an easily visible redness or an induration easily 
palpable and 2) barely visible, corresponding to slight, minimal gross changes noted at the inoculation 
site. Association with SFV status and outcome with regard of persistent M. leprae infection (see next 
section) were tested using a x-square test.
5.2.4.2 Post-Mortem Evaluation of Disease and Infection Status
When SIV+ animals developed SAIDS-associated untreatable disease necessitating humane
euthanasia (see Table 3.1), or 15 months after the second inoculation o f M. leprae, the animals were 
sacrified by overdose of pentobarbirtal and a complete necropsy with sampling for microscopic 
evaluation was performed by Dr Gary Baskin, from the Tulane’s delta primate research center. Nerves, 
including the peroneal and sciatic nerves, several areas of the skin, including the inoculation sites, and 
nasal mucosa were systemically sampled and examined for persistent M. leprae infection and 
disseminated lesions. Persistent M. leprae infection was defined as the presence of one or more lesions
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characteristic of leprosy in the peripheral nerves, skin areas remote from inoculation sites or nasal 
mucosa.
5.3 RESULTS
5.3.1 G ross F in d in g s  in  t h e  S io n  o f  Rh esu s  M a c a q u es
Grossly visible lesions were discrete, small and often barely visible. At early time points, they 
were characterized by redness and slight elevation. At later time points (day 26 and 62), they were O.S 
to 1-cm slightly indurated areas (Fig S.S).
Figure 5.5: Grossly visible inoculation sites on the right arm of a SIV- 
rhesus monkey (N209) at day 26 post inoculation. This animal did not 
develop persistent AS. leprae infection. The sites were red, slightly raised 
and indurated (arrows). Also shown is a healing biopsy site from day 12 
(arrowheads).
The proportion of animals grouped by SIV status and persistent AS. leprae infection outcome 
(leprosy status), as assessed at post-mortem examination, exhibiting grossly visible inoculation sites, are 
presented in figure 5.6.
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Grossly visible inoculation sites were first seen at day 2 in SIV- animals and at day 5 in SIV+ 
animals. SIV+ animals had more frankly visible lesions at day 62, suggesting more persistent 
inflammation at site of inoculation. Frankly visible inoculation sites at early time points, most evident 
at day 5, were significantly associated with resistance to persistent M. leprae infection (p<0.0S).
Interestingly, the animals that did not show any lesions were not randomly distributed. For 
example, the SIV+ animal that did not show any gross lesion from day S to day 62 was consistently the 
monkey number N3S6. It corresponded to an animal with minimal to no recruitment of lymphocytes as 
assessed by histology and immunohistochemistry (see below chapter 6). Moreover, the Fite stain 
showed histiocytes filled with acid fast bacilli (AFB) at day 5, indicating that the inoculation site was 
indeed biopsied. This particular animal (N356) developed disseminated leprosy (LL-like disease) 6 
months after the last sampling (62 DPI), as indicated by a positive nasal smear for AFB before 
euthanasia (Table 5.1) and microscopically by the presence of granuloma composed of histiocytes and 
numerous AFB in the lesions in the nerves, skin and nasal mucosa (Table 5.2).
5 .3 .2  S t u d y  E n d - p o in t : P o s t  M o r t e m  F in d in g s
Two SIV + animals developed incurable diarrhea by 2 and 4 months. Due to the rapid 
deterioration of their clinical conditions, euthanasia was performed at 6 months (N356) and at 8 months 
(N976) after the second challenge with M. leprae. All the other animals remained apparently healthy 
and were scheduled to be sacrificed 15 months after the second inoculation, at an average of 6.63 years 
of age, and 3.4 years after the first M. leprae inoculation (Table 5.1). Except for the two SIV+ animals 
that had clinical signs associated with gastro-intestinal (GI) disease, all the monkeys were clinically 
healthy and did not have any gross skin lesions similar to what is seen in humans with leprosy. At the 
time of euthanasia, no skin change suggestive of early leprosy was observed, except the SIV+ monkey 
N356 that had multifocal areas o f hyperkeratosis in the skin, corresponding microscopically to 
widespread lesions in the skin and the nose, hi this animal, the right superficial peroneal nerve and 
many cutaneous nerves were heavily infiltrated with histiocytes, which contained globi and numerous
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Table S.2: Gross and histo-pathological lesions found at post-mortem examination
Rhesus # SIV Gross
lesions1
Leprosy
status^
localization AFB in 
nerve
other diagnosis (dx.) 1 other dx. 2 other dx 3
nerve skin nose
N264 + - none mild pneumonia (P. carinii)
N356 + +*1 LL + + + 3+ pneumonia (P. carinii) MAI infection? cytomegalovirus
N976 + - none Enteritis (cryptosporidiosis)
M726 - - BL + + + 2+
M736 - - BL + + 1+
M849 - - BL + + 3+
M879 - - BL + + + 3+
N209 - - none
P282 - - none
"in the skin only, ''multifocal areas of hyperkeratosis, corresponding to leprosy skin lesions microscopically.
D as detected microscopically: LL: lepromatous leprosy BL: borderline lepromatous as defined in [Ridley, 1966] modified for the rhesus monkey model by 
[Baskin, 1993][Gormus, 1998b],
a b
SIV- (n=6) ■  SIV+ (n=3)
1.00
e
r
8.e
0.67
0.33
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Figure 5.6: Proportions of rhesus monkeys exhibiting grossly visible skin 
inoculation sites. Graphs (a) and (c) show the frankly visible skin 
inoculation sites. Graphs (b) and (d) include the barely visible ones. 
Proportions are grouped by SIV status (a, b) and persistent M. leprae 
infection (c, d). Grossly visible inoculation sites were first seen at day 2 in 
SIV- and at day 5 in SIV+ animals. SIV+ animals had more frankly visible 
lesions at day 62, suggesting more persistent inflammation at site of 
inoculation. Frankly visible inoculation sites at early time points, most 
evident at day 5, were significantly associated with resistance to persistent 
M. leprae infection (p<0.05). Statistically significant results are marked by
C).
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AFB. The skin of the nose, ears, arms and hands were also infiltrated and contained abundant AFB, as 
did the nasal septum. This monkey was therefore classified in the lepromatous leprosy (LL) part of the 
Ridley and Jopling spectrum (Ridley, 1966) based on these microscopic criteria because o f widespread 
dissemination of the infection and the nature of the granulomatous infiltrate, even though no gross 
lesions such as lepromas were seen. This is most probably related to the short time range between the 
second M. leprae inoculum and euthanasia due to SAIDS opportunistic diseases (Table S. 1 and table
5.2).
5.3.3 Q u a l i t y  C o n t r o l  o f  t h e  S k in  S a m p lin g  b y  E x a m in a tio n  o f  t h e  
F o r m a l in  F ix e d  a n d  F r o z e n  S k in  B iopsies
It was discovered retrospectively that some sites at day 5, 8 and 12 had been partially or 
completely missed when grossly visible lesions were observed adjacent to sampling scars at later time 
points, and confirmed microscopically on fixed and frozen biopsies. Those data were deleted from the 
flow cytometry (FC) database and not further processed for cytokine mRNA expression by RT-PCR. 
All data from day 8 was dropped from flow cytometry analysis for this reason (4 documented missed 
biopsies for flow cytometry) and cytokine analysis from frozen biopsies (3 missed sites confirmed on 
immunohistochemistry). Documented non-missed sites from day 8 were stained by 
immunohistochemistry (IHC) for CD4 marker only (see chapter 6). Day 5 and 12 had 2 confirmed 
missed sites on frozen biopsies that were not further processed and 2 suspected missed sites for flow 
cytometry that were deleted from the database.
5.3.4 P e r f o r m a n c e  o f  t h e  Im m u n o -M a g n e tic  S o r t i n g  o f  Lym ph N o d e  C e l l  
S u sp en sio n
The performance of the CD8 positive selection by Immuno-Magnetic Sorting (MACS) could 
not be evaluated due to the inability of CD8+ lymphocytes coated with anti-CD8 beads to be adequately 
labeled with anti-CD8-PerCP. We did not have any monoclonal antibodies tagged with PerCP or other 
fluorescent dye directed against magnetic beads, preventing performance analysis of the CD8 during the 
main study. The results in chapter 3 on magnetic sorting optimization indicate a very high performance 
of this sorting (consistently >95% purity). Results of descriptive statistics of the performance of this 
negative selection o f CD4+ cells in the CD8 single sort are shown in Table 5.3. The standard deviation 
is higher than for a positively selected fraction. These results are better than those obtained during the 
preliminary attempts from rhesus LNCS reported in chapter 3 (see figure3.2 page).
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Table 53: Performance of the CD4 enriched fraction from lymph node cell 
suspensions.
% total CD4* %CD8 “/oDP4 % total CD8
average 74.22 9.53 6.63 16.16
std deviation* 17.69 15.97 8.32 22.48
median 74.65 2.20 1.75 3.56
minimum 43.70 0.19 0.06 0.25
maximum 94.14 60.95 29.19 80.05
* average of measures from 2 tubes, one tube having replicates measures (n=108)
4 DP=double positive CD4-CD8 lymphocytes
* std = standard
5.3.5 T h e  M o n k e y s  S h o w  E v id e n c e  o f  C e l l  M e d ia te d  IIm m u n ity  A g a in s t  M. 
le p r a e  A n t ig e n s
In the initial study design, lymphocyte stimulation tests would have been performed on day 5, 
day 26 and 62. However, day 5 cultures were contaminated. Day 26 and 62 were not done for logistic 
reasons. Rather, blood was collected at 96 DPI. Lower counts than expected were obtained with PHA 
stimulation, for unknown reasons. A statistically significant response was obtained in both ML-S 
stimulated cultures as compared with the non-stimulated cultures (p<0.0S). An increased response was 
obtained with the higher concentrations of ML-S [ML-S] tested, that was statistically different from the 
lower [ML-S] when the natural logarithm of the counts per minute (lncpm) instead of cpm was used as 
the dependant variable in the ANOVA analysis (p<0.05) (Table 5.4).
Table 5.4: Stimulation indices of M.leprae-sonicate stimulated with rhesus 
PBMC at 96 days following the second challenge with M. leprae.
Stimulation None5 ML-S* PHA§
dose NA* 5 |ig/ml 10 |ig/ml 4 ]4g/ml
Lncpm1 4.63 5.21 5.43 6.32
SI** 1.00 1.78 2.23 5.39
\  Medium only 
¥  Af./eprae-sonicate 
§ Phytohemagglutinin 
* NA = non applicable.
K Lncpm = natural logarithm (Neperian) of the average counts per minutes 
** SI = stimulation index
5.4 DISCUSSION
The primary goal o f this immuno-pathological study was to compare the local and regional 
response to skin inoculations of M. leprae between SIV [+] and SIV [-] rhesus macaques, the best 
known model of HIV infection and AIDS in man. Our goal was not, therefore, to determine whether the
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rhesus macaques represent the best animal model of human leprosy. The strength o f this model is that, 
with large quantities of sooty-mangabey-derived, nude mouse-derived and/or armadillo-derived M. 
leprae inoculations, different forms of leprosy can be produced within a few years in a small proportion 
of rhesus macaques, with occasional nasal excretion of leprosy bacilli, thereby mimicking the situation 
in humans (Gormus, Xu et al. 1998). Human-derived immunological reagents are also widely available. 
The weakness is that there are usually no gross cutaneous lesions in the animals developing the 
persisitent infection, except in some severely immunodeficient, SIV-infected animals (Baskin 1990). 
The long incubation time before evidence of persistent infection is also a disadvantage, and the classic 
tuberculoid forms are not produced as in humans (Gormus, Xu et al. 1998). Upon gross examination of 
the skin inoculation sites at the time of sampling, no significant difference was observed between SIV+ 
and SIV- animals, in terms of both the intensity of the reaction and the proportions of animals showing 
visible lesions after inoculation. However, when comparing animals that later developed persistent M. 
leprae infection with those that did not, grossly visible inoculation sites were observed soon after 
inoculation, within 5 days, in the the latter group.
Upon re-inoculation. 5 out of 9 monkeys developed persistent M. leprae infection, which is 
substantially higher than the proportion reported in previous studies (Gormus, Xu et al. 1998). The 
results in this study need to be taken with caution due to the low number of animals. They suggest, 
however, that among animals that apparently handled the infection without clinical consequences, some 
will develop persistent infection. An unsettled issue in this study that might be worth testing in further 
experiments would be to know whether those animals were already harboring M. leprae prior to re­
inoculation or were without persistent foci of M. leprae until the second inoculation. This is an 
important point to consider in interpreting the cytokine data, notably from lymph node cell suspensions 
(see chapter 7).
These results also raise the question concerning repeated exposure to M. leprae. The classical 
view regarding immunity to bacteria and mycobacteria is that once an animal has been challenged with 
a dose of virulent organism and developed immunity against it, disease should not develop upon the 
second challenge. In light of these results, however, the matter of repeated M. leprae inoculations to 
experimental animal models is worth exploring. Lastly, the same number of animals that did not
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develop persistent M. leprae infection was observed in both SIV- and SIV+ animals, suggesting that 
the rhesus macaques from the group of slow progressors towards SAIDS can handle a second challenge 
with M. leprae. It might be that there is a dichotomy of reaction in SIV+ animals with regard to primary 
and secondary responses to M. leprae. Upon primary infection, slightly more animals developed 
persistent infection (Gormus 1989; Gormus, Murphey-Corb et al. 1998). However, it is possible that the 
SIV+ animals that successfully limit the primary infection will better handle a second challenge. This 
would in any case be an hypothesis to explore with larger numbers of rhesus macaques and no firm 
conclusions should be drawn from this limited number of animals.
The “typical” exposure dose of M. leprae from a multibacillary human patient to contacts is 
unknown. Also the exact route and mode of exposure remains unknown in humans (Fine 1982). The 
transmission from the environment to abraded skin has recently been the subject of a renewed 
epidemiological interest (Abraham, Mozhi et al. 1998) in leprosy. These authors showed that the cooler 
and unprotected areas of the body were more likely to be site of the first detected leprosy lesion in 
children in Southern India. These results are compatible with findings from other investigators 
(reviewed in (Abraham, Mozhi et al. 1998), supporting the hypothesis that this route is likely in human 
leprosy, in addition to the alternative, but also unproven, nasal route (Rees, McDougall et al. 1974). 
Studies from nasal secretions from lepromatous patients have revealed an excretion rate of the order of 
10 millions (107) per day (Davey and Rees 1974). Infective doses of other pathogens were extensively 
studied in the past and were found important in terms of development of cellular versus humoral 
immunity (reviewed by (Constant and Bottomly 1997). Recently, it has been shown that dose can 
influence the cytokine response to a mycobacterial infection in susceptible mice (Power, Wei et al. 
1998).
The dose used in this study was appropriate based on the above considerations. Whether this 
particular dose of M. leprae might have favored a TH2/type 2 over a TH 1/type 1 response in non-naive, 
M. /eprae-infected monkeys in a manner similar to high dosed BCG-infected mice is unknown (Power, 
Wei et al. 1998). This possibility deserves to be investigated in future experiments.
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6 CD4+ CELL RECRUITMENT AFTER A SECOND 
CHALLENGE WITH M. LEPRAE IS DELAYED IN 
SKIN INOCULATION SITES IN RHESUS MONKEYS 
WITH SUBSEQUENT PERSISTENT M. LEPRAE
INFECTION
6.1 INTRODUCTION
The epidemiology of various mycobacteriosis is quite different in human immunodeficiency 
virus (HIV)-infected individuals than in immunocompetent individuals. Whereas Mycobacteria such as 
M. avium and other mycobacteria such as M. kansasii and M. marinum elicit only benign self-limiting 
infections at site of inoculation in most individuals, they have a devastating impact on acquired 
immuno-deficiency syndrome (AIDS) patients. Also tuberculosis is a more serious condition among 
HIV-infected persons, usually having a harsher evolution and worse prognosis. However, there are no 
reports suggesting an increase in incidence or a worsening of the evolution o f leprosy in HIV-infected 
individuals and AIDS patients (Frommel, Tekle-Haimanot et al. 1994; Sampaio, Caneshi et al. 199S; 
Faye, Mahe et al. 1996; Machado, David et al. 1998). Studies are therefore needed to investigate the 
basis of this differential susceptibility in the immuno-compromised host to mycobacteria.
The rapid recruitment of primed, antigen-specific helper and cytotoxic CD4+ T lymphocytes at 
sites of invasion of Mycobacteria is believed to be critical for the outcome of mycobacterial infection 
(Reviewed in (Orme, Andersen et al. 1993). Whereas in tuberculosis the invasion site is usually the 
lung, it is believed that the portal of entry of the leprosy bacillus, Mycobacterium leprae, is through 
abraded skin and/or nasal mucosa (reviewed by (Fine 1982). The early pathogenic mechanisms involved 
in leprosy after natural exposure to the organism remain poorly understood because of a lack of well 
established models of the human infection that would enable studies of the early and probably critical 
events following the exposure to the organism. In humans, it is believed that single lesions of the 
indeterminate type (Harboe 1994; Job 1994; Job 1997) may represent the earliest manifestations of the 
disease, but the time interval after infection is not known. The only way to examine the early events in 
response to M. leprae exposure is to perform longitudinal studies in animal models such as the non­
human primates (reviewed by (Meyers, Goimus et al. 1994). It is possible that the primary lesion and
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initial immune response is polymorphic and predictive of the outcome, either healing or development of 
disseminated disease. In addition, it may be that the primary lesion and immune response at the site of 
M. leprae inoculation might be different in HIV+ patients compared with HIV- individuals.
To examine these early events, we re-inoculated M. leprae into the skin of 9 rhesus monkeys 
previously inoculated by M. leprae, which remained free of leprosy disease for 26 months: three 
animals that were simian immunodeficiency virus (SIV) positive and six were SIV negative monkeys. 
The doses of M. leprae inoculated corresponded to the average number of bacilli excreted by nasal 
secretions of lepromatous humans (107 viable bacilli per day) (Davey and Rees 1974).
The main hypothesis of this in vivo study was that the SIV positive rhesus macaques mount an 
inadequate cell mediated immunity against recall inoculations of M. leprae in the skin, as compared 
with SIV negative animals. In particular, we tested the hypothesis that SIV+ rhesus monkeys recruit 
inadequate proportions of recruited CD4+ T lymphocytes and insufficient numbers of activated/memory 
CD4+CD45RO+ T cells at site of skin inoculation.
6.2 MATERIALS AND METHODS
6 .2 .1  A n im a l s
The animals studied have been described previously (Gormus, Murphey-Corb et al. 1998; 
Gormus, Xu et al. 1998). They were housed in Tulane’s Regional Primate Research Center, Covington, 
LA, in accordance with established standards of the United States Federal Animal Welfare Act, the 
American Association for Accreditation of Laboratory Animal Care and the Guide for the Care and Use 
of Laboratory Animals. Eight female and one male rhesus macaques (Macaca mulatto), that did not 
develop any sign of leprosy after intravenous (IV) and intradermal (ID) inoculation 26 months earlier 
with M. leprae from nine-banded armadillo (Dasypus Novemcinctus, Linn.) were studied. This primary 
inoculation consisted of a total o f 1.07S 109 per animal, as previously described (Gormus, Xu et al. 
1998). Two weeks before the initial M. leprae inoculation, 3 of them (N264, N3S6 and N976) were 
inoculated with the sooty mangabey-derived delta J943 strain of simian immunodeficiency virus (SIV).
One to 2 weeks before the M. leprae challenge, a biopsy of lymph node was taken from each 
animal as a reference control for baseline proportions of lymphocytes and baseline cytokine mRNA 
expressons. No sldn from a non-inoculated area was taken at any time point, the normal skin being
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assumed to have negligible infiltrates with lymphocytes and resident histiocytes and an absence of 
detectable cytokine mRNA expression.
6.2.2 C h a l l e n g e
Fresh M. leprae from three nude (nu/nu) mouse footpad lepromas were collected aseptically 6 
months after inoculation, as previously described (Sibley and Krahenbuhl 1988). They yielded a total of
13.5 109 bacilli with an typical bacterial viability for M. leprae as assessed by >4C 02 catabolic 
radiorespirometry measured at I, 2 and 3 weeks post-culture medium inoculation, using Bactec460TB 
system® (Becton Dickinson, Sparks, MD) as previously described (Franzblau 1988) (Franzblau 1989).
The challenge consisted of 12 intra-dermal inoculations per animals in the thighs and arms (i.e. 
3 sites for each limb), each with 107 M. leprae bacilli suspended in lOOpL of phosphate buffer saline. 
The total dose per animal was 1.2 10* bacteria. Typical inoculation sites are shown in Figure 5.2. The 
inoculation sites were not tattooed to avoid of non-specific inflammatory responses to that procedure. 
Instead, they were topographically mapped relative to anatomical landmarks such as bony processes of 
the elbow and knees.
6.2.3 S am p lin g  a n d  S a m p le  U ses
The schedule for skin sampling was as follows: two 8-millimeter diameter punch biopsies were 
taken at days 2, 5, 8, 12, 26 and 62 from arms and thighs. One of these biopsy specimens sampled at 
each time point was immediately swabbed of excess blood, finely minced in RPMI culture medium with 
30% fetal calf serum (RPMI-30), filtered through a nylon gauze and collected in a 15 ml centrifugation 
tube, and kept on ice until counted with an hemocytometer and processed for flow cytometry 2-4 hours 
later. The optimization of this sampling technique on inoculation sites has been tested on a model of 
intra-dermal injection of incomplete Freund’s adjuvant, the results of which are presented in the chapter 
four.
The other skin biopsy was bisected and one half was immediately embedded in OCT 
compound (Sakura, Torrance, CA) and snap-frozen in liquid nitrogen for CD4 and CD8 
immunophenotyping by immunohistochemistry and ex vivo cytokine mRNA expression by relative 
reverse transcriptase-polymerase chain reaction (RT-PCR). The other half was immersed in 4% neutral 
buffered zinc-formalin for standard histopathological assessment o f inoculation sites.
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The axillary or inguinal lymph node (LN) biopsies were taken at day -14/-7 (baseline), day 5, 
day 26 and day 62 after inoculation, with care to have them match the timing and location of the skin 
inoculation site biopsies. Approximately 15-20% of the LN biopsy was immersed in 4% neutral zinc- 
buffered formalin for standard histopathological assessment of possible disease and/or mycobacteria 
spreading. Another ~ 15-20% was snap-frozen in liquid nitrogen. The remaining tissue was finely 
minced, passed through a 67-pm mesh and collected in RPMI-10, to obtain a lymph node cell 
suspension (LNCS). A sample of the LNCS was utilized for flow cytometry cell surface marker studies, 
another sample (5 x 106 cells) was processed for mRNA cytokine expression studies and the rest panned 
to remove B cells and sorted immuno-magnetically into CD8 and non-CD8 cell fractions.
6.2.4 M ic ro s c o p ic  E v a l u a t io n
6.2.4.1 Histopathology
Half of one of the two biopsies was fixed in 4% buffered zinc formalin overnight. They were 
then dehydrated and embedded using standard procedures. Standard Hematoxylin and Eosin and 
standard Fite Faraco stains were performed on all biopsy specimens. The inflammation was graded as 
follows: Perivascular mononuclear infiltrates were graded as mild (+), moderate (++) or severe (+++) 
when one row, 1-5 and >5 rows, respectively, of mononuclear cells were present around the vessels. 
The magnitude (size) and nature (aggregates of monocytes/histiocytes versus epithelioid macrophages) 
of the granulomas, first apparent at day 5, were also evaluated. These reading was performed before the 
outcome data was available.
6.2.4.2 Immunohistochemistry
Halves of eight-millimeter punch skin biopsies were covered with OTC compuound (Tissue-
Tek®, Sakura Finetek, Torrance, CA), snap frozen in liquid nitrogen immediately after excision. Frozen 
sections (4 pm) were cut using a Jung 4800 freezing microtome (Leica, Nuflloch, Germany) and 
immediately fixed for 10 seconds in cold acetone (-20 0 C) and then allowed to dry. They were either 
stored at - 70° C until processed (usually the next day) or directly forwarded to immunohistochemistry 
using the following protocol:
The sections were dehydrated for 5 min in cold acetone and washed twice in phosphate 
buffered saline (PBS). The majority of processed slides were pre-incubated for 20 minutes at 42 0 C in 
avidin solution, then for 20 minutes at 42 ° C in 2 % biotin solution (Dako, Carpinteria, CA) to reduce
122
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the non-specific binding of antibodies to collagen bundles of the skin. They were then incubated with 
primary antibodies for I hour at 42 0 C at the following working concentrations: mouse anti-macaque 
CD3 (clone FN-18, Serotec, Raleigh, NC) monoclonal antibodies: 1/50; mouse anti-human CD8 (clone 
DK25, DAKO, Carpinteria, CA): 1/50 and anti-CD4 (clone OKT4/Fischer, Houston, TX): 1/25. Due to 
the often weak CD4 immunostaining, an amplification technique, based on the local deposition of 
biotinyl tyramide at site of specific primary binding (Raikow 1998), was optimized and used according to 
manufacturer’s instructions (TSA™-indirect, NEN™ life science products, Boston, MA). Performance 
were similar or better using a CD4 MoAb at a dilution of 1:100 with tyramide signal amplification as 
compared with the previous protocol, using OKT4 antibodies diluted at 1:25.
For generating the IHC data, no minimum number of cells counted was adopted, due to the 
minimal inflammation in some animals, especially, but not only, at early time points (up to day 8 PI). 
The criterion for inclusion as a positive cell was a complete peripheral staining of the cytoplasm. 
Granular cytoplasmic staining was rare and was considered as non-specific (fig. 7.8 c and d). Areas 
such as perivascular infiltrates and granuloma were individually counted as units and then the average 
between the areas was done to generate the definitive average percentage of CD4, CD8 and CD3 
positive cells. Comparison of CD4 IHC slides with and without biotinyl tyramide (BT) showed similar 
results, BT amplified slides having slightly higher proportions of CD4+ cells, as expected.
6.2.5 F l o w  C y to m etry
Cell suspensions from the first skin biopsy and an aliquot of the LNCS were used for a 3-color 
flow cytometry. The cell suspensions obtained from the skin and lymph nodes were counted using an 
hemocytometer. The suspension of cells from each skin biopsy were equally divided between 4 
polyethylene tubes. Approximately 0.05 x 107cells from the starting LNCS and the sorted fractions were 
used for flow cytometry. Skin and LNSC aliquots were incubated for 20 minutes in the dark with the 
following monoclonal antibodies linked to fluorescent dyes, shown in Table 6.1. The cells were 
subsequently washed in PBS, fixed in 4% paraformaldehyde and stored at 4° C prior to FACS analysis.
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Table 6.1: List of flow cytometry monoclonal antibody reagents
M arkerf Clone IgGt Isotype Source
Tube 1: Isotype CTRLf-FITC X40 IgGl BD*
Isotype CTRL-PE X39 IgG2a BD
Isotype CTRL-PerCP IgGl BD
Tube 2: CD4-FITC OKT-4 IgG2a Fischer Scientific^
CD45R0-PE UCHL-1 Dako¥
CD8-PerCP SK-1 IgGl BD
Tube 3: y8 T cells-FTTC TC 81 Endogen*
CD4-PE OKT-4 IgG2a Fischer Scientific
CD8-PerCP SK-1 IgGl BD
Tube 4: CD14-FITC TUK-4 Dako
CD16-PE Leu11c IgGl BD
fFITC: fluorescein isothiocyanate, PE: phycoerythrin and PerCP: peritidin 
chlorophyll protein. 
tCTRL = control
tlgG = imtnunoglobin G 
Becton Dickinson Immunocytometry systems, San Jose, CA.
£ Houston, TX, ¥Carpinteria, CA, *Wobura, MA
Data were acquired using a FACScan (Becton Dickinson, San Jose, CA) and analyzed using a 
Lysis-II software version 1.1 (Becton Dickinson). The acquired events were gated on the lymphocyte 
population, that was still identifiable in the skin, by forward and side scatter (FSC and SSC, 
respectively). Then two dimensional dot displays evaluated fluorescent subsets of the gated population. 
The percentage (%) of CD4+ and CD8+ cells present in the skin, lymph node and blood, called 
‘totCD4’ and ‘totCD8’ respectively, were obtained by adding the %of double positive cells CD4+CD8+ 
to the % of CD4+CD8- and CD8+CD4-, respectively. The CD4: CD8 ratio was similarly obtained by 
dividing ‘totCD4’ by ‘totCD8’. The percentage of CD45RO+ cells among CD4+ and CD8+ T cells was 
obtained by dividing the % of double positive quadrant CD4+CD45RO+ and CD8+CD45RO+ 
respectively, with *totCD4’ and ‘totCD8\ respectively. In the skin, corrected values for the double­
positive quadrants (CD4+CD8+, CD4+CD45RO+ and CD8+CD45RO+) were obtained by subtracting 
any percentage obtained with the isotype controls in the matching upper right quadrant for each tube 
analyzed in the same animal (see figure 6.3 page 137).
6 .2 .6  S o r t in g  o f  L N  C e l l  S u s p e n s io n s
The optimal protocol was developed after preliminary experiments with peripheral blood 
mononuclear cells (PBMCs) and lymph node cell suspensions from humans and rhesus monkeys and
124
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the different approaches and results are presented in chapter 3 of this volume. The protocol used in the 
main study of this work is the following:
6.2.6.1 Panning of B Cells
Starting, freshly minced rhesus LNCS were depleted of B lymphocytes using 25 cm2 cell
culture flasks with the bottom plastic surface coated with rabbit anti-human immunoglobulins overnight 
at 4°C (Accurate, inc., Westbury, NY -cat. # AXL230), according to standard protocol (Lewis and 
Goodman 1978; Lewis and Kamin 1980), at a concentration of 0.6 mg/ml (1:20). They were incubated 
for 2X 45 min. at 37°C in humid 5%CC>2 incubators to deplete both macrophages and B cells. The 
obtained post-panning cell fraction was counted and a part of it (5 x 10® cells) used for mRNA cytokine 
expression by RT-PCR.
6.2.6.2 Isolation of CD4, CD8, CD45RO and CD4+CD45RO+ T Lymphocytes 
Using MACS
Columns of 1.5 ml capacity (Mini-columns™ type MS+/RS+ for Mini-MACS®), with a 
sheath of iron wool, were obtained from Miltenyi Biotec Inc, Auburn, CA. The reagents and sources of 
magnetic beads coated with monoclonal antibodies (MoAb) were the following: anti-CD8-microbeads 
(clone SKI, Miltenyi) and anti-CD45RO-microbeads (clone UCHL-1, Miltenyi) MoAb were used 
according to manufacturer’s specifications (Miltenyi Biotec Inc, Auburn, CA). Because they were not 
already coated with the appropriate fluorescent dye, purity evaluation by flow cytometry was performed 
by staining with the standard 3-color staining, using a cocktail of CD4 (OKT4)-FITC, CD45RO-PE and 
CD8 (SK-1) PerCP.
Prior to sorting, the percentage of CD4+ and CD45RO+ cells was determined by flow 
cytometry. Two successive, one-parameter, magnetic cell sorts (2 “single” sorts) were performed 
according to manufacturer’s instructions. The first sort used CD8-coated micro-beads and was 
performed on all LNCS. The negatively selected, CD4-enriched fraction bearing no beads was then 
sampled for RNA isolation (Fraction 1) and, if sufficient cells were present with at least 5% CD45RO+ 
cells in the starting LNCS, were further processed. The second sort used CD45RO-coated micro-beads. 
The CD4-enriched (CD4+) CD45RO- were then first collected (Fraction 3) and then the CD4+ 
CD45RO+ fraction (Fraction 4). Sorted fractions were kept on ice until they were processed for RNA 
isolation and until three-color (1“ sort) or two-color flow cytometry (2"d sort) was used to evaluate for
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purity and to determine the proportion o f CD45RO+ cells among the first sort. Five (S) million cells and 
of CD8 sorted fractions (Fraction I and 2) and 1 x 106 cells from CD45RO sorted fractions (Fractions 3 
and 4) were further processed for RNA isolation. The fraction 4 (CD4+CD45RO+ usually had a low 
yield, with often < 1 x 106 cells sampled for RNA isolation.
6.3 RESULTS
6 .3 .1  L y m p h o c y t e s  C o l l e c t e d  D i r e c t l y  f r o m  M in c e d  S k in  B io p s ie s  a t  
M.le p r a e  I n o c u l a t i o n  S i t e s  C a n  B e  A n a l y z e d  b y  F l o w  C y t o m e t r y
Based on the preliminary study on skin inoculation with incomplete Freund’s adjuvant (see chapter 4 
page 97), infiltrating inflammatory cells were isolated directly from biopsy samples of M. leprae 
inoculation sites without gradient purification and collagenase treatment and the entire collection of skin 
inoculation site cell suspensions was used (SkinCS). As few as 2.7% of the first 2 tubes analyzed per 
monkey (n=108) could not be analyzed, nor could 14.4% of the entire set of samples acquired (n=234). 
Large numbers of total events were acquired, in most cases: 80% and 70% were above 5,000 and 10,000 
total acquired events, respectively (Fig. 6.1c). However, a frequent concern was the relative low number 
of events gated on lymphocytes: 11% of the tubes analyzed had less than 500 events gated (Fig. 6.1a) 
and 28% had less than 1000 events gated on lymphocytes on forward scatter and side scatter plot 
displays (Fig. 6.1b). The cell acquisition of less than 100 events gated on lymphocytes (4 tubes -  2%) 
were not considered for further analysis.
Figure 6.1: a - Distribution frequencies of the acquired events gated on 
lymphocytes (gated events) from 183 skin cell suspensions. The average of 
gated events (M) ± standard deviation (SD) was 2579 ±1731 events. The 
sum (percent) of the aliquots of skin cell suspensions of less than 400 events 
analyzed, corresponding of values beyond M -  1.25 SD is 20 (11%). 
b - Plot of the acquired events gated for lymphocytes from skin cell 
suspensions: On the x-axis are the events acquired for each tube. The y-axis 
expresses the number of events gated on the small lymphocyte window. The 
tubes were sorted according to increasing number of events. Four (2%), 11 
(6%) and 51 (28%) tubes have less than 100, 200 and 1000 events gated on 
lymphocytes, respectively. They were further analyzed when the events 
were > 100.
c - Plot o f the total acquired events from skin cell suspensions. The tube 
order matches the sorted tubes in Fig. 5.1b. Total event acquisitions of 
>5,000 and 10,000 events represent 146 tubes (80%) and 128 (70%), 
respectively.
(fig. cont.)
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The skin cell suspensions were composed of a majority of mononuclear cells, with rare 
keradnocytes and granulocytes, and relatively abundant collagen bundles and debris (Fig. 6.2). The 
cytospins from M. leprae skin inoculation site cell suspensions contrasted in terms o f amounts of 
granulocytes and collagen debris with the cytospins of the incomplete Freund’s adjuvant skin injection 
site cell suspensions (Fig 4.1). Total yields for skin were between 0.02 and 3.24 million cells [average 
(AVG) ± standard deviation (SD) is 0.61± 0.78 x 106]. Significantly higher cell yields (p<0.0l- 
Student’s t test) were obtained at day S compared with day 2 and day 8. There was no difference of total 
cell numbers between the SIV+ and the SIV- animals. In the lymph nodes, there were between 11.8 and 
438 million cells (average ± standard deviation is 11.61 ± 10.07 x 107).
Figure 6.2: Photograph of a cytospin of skin cell suspension from M. 
leprae inoculation site. Note the abundance o f collagen fibers (arrow). This 
concentration is over-estimated due to the deposition of the collagen fibers 
at the bottom of the centrifuge tubes, the culot of which has been sampled 
for cytospin smear. Bar= 75 pm. Giemsa stain.
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In the analysis of CD4/CD8/CD45RO, 52 tubes from all an im a ls  could be analyzed; 2 tubes 
could not be analyzed and 3 tubes had fewer than 400 events gated. Data corrected with the isotype 
controls were considered for further analysis (Fig. 6.3) and resulted in %CD4+CD45RO+ data with 
lower standard deviation and hence lower standard error, enabling the validation of the model with 
regard to parametric statistics (p<0.05).
6.3a
• 111/ 3/061020050
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i l l 1/3/081020080
  Quad stats ------
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Parameter*: FLl-HtL0G),FL3-HCL0G 
Total* 10000 Gated* 3383 
Quad Event* X Gatad X Total
1 UL 288 8.80 2.88
2 UR 39 1.16 0.39
3 LL 3029 90.34 30.29
4 LR 0 0.00 0.00
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Evants X Gatad X Total
1 UL 1744 33.14 11.63
2 UR 181 2.67 1.01
3 LL 1,930 36.67 12.87
4 LR 1438 27.32 9.89
Figure 6.3: Representative flow cytometry scatter plots from the skin o f a 
SlV-negative rhesus monkey (N209). a -  Scatter dot-plot of events 
physically gated on lymphocytes, stained with fluorescent isotype controls 
(tube 1) on a semi-logarythmic scale, shows a diagonal trail of non-specific 
staining, b -  Matching scatter plot stained with CD4 (FITC) and CD8 
(PerCP) (tube 2).
This case is representative o f average data quality obtained from skin cell 
suspensions from finely minced inoculation sites, gated on lymphocytes. 
There was a diagonal-shaped area of non-specific staining after gating on 
lymphocytes. This artifact was consistent and did not or minimally impede 
data analysis. These artifacts are interpreted as non-specific staining from 
dead cells and/or small collagen debris.
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6.3.2 F lo w  C y to m etr y  C D 4+  C e ll  P er c en ta g es  C o rr ela te  w ith  
Im m u n o h isto c h em istry  in  t h e  S kin
The percentages of CD4 and CD8 cells present in sldn cell suspensions analyzed by flow 
cytometry and recruited in the skin by immunohistochemistry (IHC) were compared (Fig. 6.4). The 
findings in flow cytometry (FC) in the skin were confirmed by the observations made after 
determination of the proportions of recruited CD4+ T cells in skin inoculation sites by IHC. The 
proportions of CD4+ T lymphocytes at day 2, 5 and 62 were similar from one animal to the next , 
although consistently higher by IHC as compared with FC. At day 12 and 26 post inoculation, there 
were a higher % CD4+ T cells in IHC than by flow cytometry (Fig. 6.4).
Correlation between the 2 technologies was adequate to good for several time points (Table
6.2). For example, good correlations of %CD4 cells are noted at day 2 and day S. Overall, however, we 
cannot confirm that the two approaches can replace one other. Despite the time consumed and the 
imprecision of manual counting, immunohistochemistry enables the evaluation of the relative 
composition of lymphocyte subsets in different structures such as the granulomas and the lymphocyte- 
rich perivascular infiltrates. Flow cytometry is however promising for ex vivo lymphocyte analysis from 
an inoculation site because it is characterized by a lower variance, is more automated and standardized 
and enables the evaluation of at least 3 surface markers.
Table 6.2: Spearman’s correlation coefficients on ranked data with 
associated probability that the parameter observed with both technologies 
are not correlated:
CD4%
Day 2 day 5 day 8 day 12 day 26 day 62 day 2+5 Overall
Number (N) 8 7 6 5 9 7 15 42
Corr. Coeff. 0.9762 0.9285 -0.0285 -0.5000 0.6000 0.2857 0.8299 0.3383
Probability 0.0001 0.0025 0.9572 0.3916 0.0876 0.5345 <0.05 0.0284
CD8%
Day 2 Day 5 day 8 day 12 day 26 day 62 day 2+5 Overall
Number (N) 5 6 0 5 7 8 11 31
Corr. Coeff. 0 .0000 0.2571 NA -0.8018 0.7143 -0.3333 0.5960 0.1302
Probability 1.0000 0.6228 0.1041 0.0713 0.4198 >0.05 0.4850
NA = not done
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Figure 6.4: Comparison of data obtained by flow cytometry (FC) and 
immunohistochemistry (IHC). The percentage of CD4 positive cells 
(Percent CD4+ cells) was plotted in function of time. There is a good 
agreement between the median values obtained by both methods.
Differences are mainly present at day 12 and 26 and may be accounted for 
by the a significant number of CD4+ cells o f larger size at these time points 
that may have not been selected on the lymphocyte physical gate by FC.At 
these time points, epithelioid macrophages were easily visible and CD4 
negative.
6.3.3 The P r o p o r t io n  o f  CD4+ T L y m p h o c y te s  in  t h e  S k in , Lym ph N o d e s  a n d  
B lo o d  is C o n s i s t e n t ly  L o w e r  in  SIV+ A n im a ls  b y  FACS D u r in g  t h e  
F i r s t  M o n th  P o s t - I n o c u la t io n
By flow cytometry analysis, the proportion of infiltrating CD4+ T lymphocytes in the skin was 
consistently and significantly lower in SIV positive animals as compared with SIV- rhesus monkeys at 
all time points (day 2, 5, 12, and 26) (p<0.05) except at day 62 (p>0.78) (figure 6.5a). The difference 
between the two groups was most profound at day 5-post inoculation (p<0.001) because of an early
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peak of the %CD4+ T lymphocytes in the SIV- population. This peak is apparent on median CD4+ 
percentages of the SIV- group (Fig. 6.5a). Similarly, the CD4: CD8 ratios were consistently different 
between the 2 groups at all time points (p<0.005) except at day 62 (p>0.09) and the ratios were most 
different at day 5 (p<0.0002) for the same reason. The increased mean CD4 percentage observed at day 
5 post challenge was not statistically significant, whether the entire group (n=9) or the SIV- group (n=6) 
was considered.
The proportions of CD4+ T cells were significantly lower in the blood (p<0.002) and lymph 
nodes (p<0.001) of SIV+ animals, at all sampling time points, compared with SIV- monkeys (Fig. 6.5b 
and 6.5c). The same finding was noted with CD4: CD8 ratio. Patterns of CD4+ percentages over time 
in the blood and LN were similar in both groups, with a slight trend of slightly increased %CD4+ cells 
at day 5 in the LN and a slight tendency towards reduced %CD4+ cells in the blood (both phenomena 
statistically non-significant).
In the skin, analysis of IHC data indicates that the recruitment o f CD4+ T cells in the SIV+ and 
SIV- animals was very similar until day 12 (Fig. 6.6b). IHC results consolidated the trend, without 
confirming it, that the first maximum median value of %CD4 suggestive of a recruitment peak may be 
around day 5 in SIV- animals (Fig. 6.6a) and around day 12 in SIV+ animals (Fig 6.6b). With both 
techniques, at day 26, SIV+ animals have significantly lower percentages of CD4+ cells than SIV- 
monkeys (p<0.01), with no overlapping %CD4 values between the two groups in IHC (Fig 6.6a and 
6.6b) and FC (Fig. 6.5a). However, independent of the SIV status, IHC demonstrated high (>50%) 
%CD4+ cells (Fig. 6.6b) at day 2 in 3 animals, which also showed vigorous perivascular accumulation 
of almost exclusively CD4+ T cells at day 2 (Fig 6.8). Interestingly, the flow cytometry data showed the 
3 highest percentages of CD4+ (>30%) in the same 3 animals. These 3 animals are the ones that 
remained free of persistent M. leprae infection 12 months after the last sampling day. The fourth animal 
that remained free persistent M. leprae infection (N976) had a vigorous CD8 accumulation as assessed 
by flow cytometry and IHC.
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Figure 6.5: The proportion of CD4 + lymphocytes (a) at sites of M.leprae 
cutaneous inoculation, (b) in regional lymph nodes and (c) blood.
Graph a: percent CD4+ lymphocytes in SIV+ monkeys do not augment at 
day 5 like the SIV- animals. There is significantly higher percentage of 
CD4+ lymphocytes in M. leprae-ooly infected monkeys compared to co­
infected animals, except at day 62 (p<0.05).
Graphs b and c: patterns of CD4+ percentages are similar in the blood and 
lymph nodes in both groups, with a slight increase in the regional LN and a 
slight drop in the blood at day 5 (not statistically significant).
(Fig. Cont’d)
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Figure 6.6: Comparison of percentages of CD4+ in the skin of SIV+ and 
SIV- animals as determined by (a) flow cytometry and (b) immuno­
histochemistry. Comparison of both graphs at early time points (up to day 
12) indicate that a higher proportion of CD4+ T cells is present (a) at day 5 
by flow cytometry in SIV- and (b) at day 12 in SIV+ animals by 
immunohistochemistry (non statistically significant). Results are concordant 
by both technologies in day 26 and 62.
135
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6.3.4 In  t h e  S k in , t h e  P r o p o r t i o n o f  CD45RO+ C e l l s  W a s  C o n s i s t e n t ly  
H ig h e r  A m ong  T h e  CD4+ T C e l l s  in  SIV + A n im a ls
In SIV infected animals (n=3), there is a higher percentage of CD45RO+ among the CD4+ 
cells in the skin and lymph nodes than in SIV- animals (Figure 6.7a and 6.7b). This finding was 
statistically significant in the skin only at day S and day 62 (p<0.0S), where the general linear model 
using the corrected percentage of CD45RO+ cells among CD4+ T cells was validated (p=0.048). The 
%CD45RO corrected on isotype control background was normally distributed. In the lymph node, a 
trend towards higher percentages of CD45RO+ cells among CD4+ T cells was observed at day 5 and 
day 26. However the differences in median values were not statistically significant. At baseline and at 
day 62 PI, median values were almost identical. Although no firm conclusion can be drawn from the LN 
data, these results in the skin and LN suggest that CD4+CD45RO+ T cells are recruited in the regional 
lymph node at day S (Fig. 6.7b) in response to M. leprae challenge.
6.3.5 T h e  E a r l y  R e c r u i tm e n t  o f  N u m e ro u s  CD4+ T  C e l l s  C o r r e l a t e  w ith  
P r o te c t io n ,  R e g a r d le s s  o f  t h e  SIV S t a t u s
The three animals having the highest numbers of perivascular lymphocytes, with a proportion 
of >50% of CD4% T cells at day 2, did not develop persistent M.leprae infection 12 months after re­
challenge whereas the animals that developed persistent M.leprae infection had mininal recruitment 
(Fig. 6.8 - See also Appendix 4 page 212 and Table 6.3). The exact same pattern was observed with 
CD3 staining (data not shown). This early dichotomy of response was no longer evident at day S, where 
higher percentages of CD4% cells were observed in animals that developed persistent M.leprae 
infection. Similar results, albeit less clear cut, were seen by FC, supporting these in situ observations.
The fourth SIV+ animal, that did not develop persistent M.leprae infection 12 months after re­
challenge, is unique and showed an in situ marked recruitment of CD8+ lymphocytes at day 2 and day 
5, both by FC and IHC. Examples of strong reactions and weak reactions are shown in Figure 7.8. The 
other monkeys developed substantial infiltrates only after day 8 or later by IHC.
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Figure 6.7: The proportion of CD4+CD45RO+ lymphocytes (a) at sites of 
M.leprae cutaneous inoculation and (b) in regional lymph nodes.
There was no significant difference between percentages o f CD4+ 
CD45RO+ lymphocytes obtained from any site of the SIV-positive and 
SIV-negative groups of M. leprae inoculated monkeys, except in the skin at 
day 62 (7.6a). In lymph nodes at day 5 and 26 (7.6b), there was a trend 
towards a higher percentage of CD4+ CD45RO+ in SIV+ monkeys as 
compared with SIV- animals.
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Clearance of acid fast bacilli (AFB) was similar for all animals. However, there was a trend 
towards fewer AFB as early as day 8 in animals which had had vigorous lymphocyte recruitment at day 
2 and S. At later time points, histopathological analysis and immuno-histochemistry revealed 
persistence of high lymphocyte cellularity with numerous CD3+ T cells and C04+ cells in the group of 
monkeys that had high proportions of CD4+ and CD3+ T cells at early time points (Figures 6.9a and 
6.10a). Specifically, more small lymphocytes were present at 62 DPI in animals that were devoid of 
evidence of M. leprae infection at the termination of the study (Fig. 6.9a and 6.9b) compared with the 
animals that presented with persistent infection (Fig 6.9b and 6.10b) and this was observed in both the 
SIV+ (Fig. 6.10) and the SIV- group (Fig. 6.9). Granuloma morphology was also an indicator of 
protection, with more organized granuloma in resistant animals, especially at early time points.
Rhesus SIV §Outcome day2 day 5 day 8
Number Persistent
infections
Periv.
infiltrJh
%CD4 Periv.
infiltrh
% CD4 4* Periv.
infiltrb
% CD4 4» clearance 
AFB (fite)
N264 pos 0 1+++ 68.68 + + 42.82 -H* 36.54 +
N356 pos LL 0 12.66 0 ND* ND ND ND
N976 pos 0 + 26.43 + + + 36.14 + 32.20 +
M726 neg BL + + 27.42 + + 49.28 -H- 20.83 + +
M736 neg BL + 35.44 ND ND + + 33.33 +
M849 neg BL + 30.43 + 57.89 + + 37.50 +++
M879 neg BL + ND* + 47.63 + ND* ++
N209 neg 0 +++ 50.89 + + 40.62 + 46.15 +
P282 neg 0 + + + 51.76 + + 32.63 ND ND ND
AVG 32.66 38.01 25.82
l> Periv. Infiltr. = perivascular infiltrates;^! +++=marked, ++=moderate, +=mild, 0=minimal/absent 
perivascular infiltrates. Evaluation on hematoxylin &eosin (HE) stained, formalin fixed sections.
4*: Evaluation from frozen biopsies immunostained for CD4 (OKT4, Fischer).
ND*= insufficient numbers of cell to count CD4+ T cells on IHC sections.
ND= missed sites. AVG = average of the % CD4 cells.
§ Outcome (leprosy in nerves ± nasal mucosa and skin): LL= disseminated lepromatous leprosy; BT= 
borderline tuberculoid; BL= borderline lepromatous; 0= no evidence of disease 14 months after re­
challenge at necropsy.
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2 - ii  2 -i+
Figure 6.8: CD4 immunohistochemistry from SIV+ and SIV- animals at 2 
day post inoculation (DPI). A -  Monkey N264 (SIV+) showing dense CD4 
recruitment. Arrow: cutaneous nerve, devoid of infiltrate. B -  Monkey 
N209 (SIV-) showing dense CD4 recruitment. Arrow: cutaneous nerve, 
devoid of infiltrate. ML: persistent M. leprae infection status.
C -  Monkey N3S6 (SIV+) showing sparse CD4+ cell recruitment. Discrete 
non-specific staining is present (arrowhead). D -  Monkey M726 (SIV-) 
showing weak, minimal CD4+ cell recruitment (center). Non specific 
staining is present at die edge o f the section (upper left and lower right 
comers). Bar* 20 pm. Harris’ hematoxylin counterstain.
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ab
Figure 6.9: Histopathology of skin inoculation sites at day 62 post­
inoculation in SIV-negative animals (a) without evidence of persistent M. 
leprae infection (N209) and (b) with evidence of persistent M. leprae 
infection (M726). Bar -  300 pm.
See also Appendix S page 208.
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Figure 6.10: Histopathology of skin inoculation sites at 62 DPI in SIV 
positive animals, (a) without evidence of persistent M. leprae infection -  
monkey N264 (a) evidence of persistent M. leprae infection -  Monkey 
N356 (SIV+). Bar = 300 pm.
See also Appendix 6 page 210.
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6.3.6 F lo w  C y to m e t r y  E v a l u a t e d  o f  C e l l s  S ta in in g  w i th  y8, CD14 a n d  CD16 
M a r k e r s
The proportion of total y8 T cells in the blood in this study were similar to the ones described 
in rhesus monkeys (Average ± SD is 4.8% ± 4.4% versus 5.7% reported) (Wallace, Gan et al. 1994). 
The gamma-delta (y5) T cells were not prominent in any of the sample analyzed or in any group of 
monkey studied. They were higher in the skin and LN as compared with blood (one tail heteroscedastic 
Student’s t test p<0.001) (Table 6.4). More importantly, there was no difference in the proportion of y8 
T lymphocytes over time, even in the skin, or between SIV+ and SIV- groups. Likewise, no suggestion 
of higher or lower proportions of y8 T cells in animals with or without persistent M.leprae infection was 
noted (data not shown).
Table 6.4: Percentages of double positive, CD8+yS+ and CD4+y8+ T lymphocytes in 
the skin, lymph nodes (LN) and blood.______________________________________
SKIN LN BLOOD
CD8+75+ CD4-Fy5+ CD8+78+ CD4-ty8+ CD8+78+ CD4+y8+
Number (%) 
analyzed
44(81.5) 45(83.3) 20 (62.5) 10(31.2) 45(100) 45(100)
Mean 3.08 6.14 3.52 3.49 1.03 0.33
SD 2.92 12.01 3.23 3.08 0.98 0.49
SD= sample standard deviation. #= total number of tubes. Double positive fractions
are presented. Not shown are the CD4- and CD8- y8 and double negative y8 T cells.
The proportions of CD 14 cells in the lymphocyte gate remained low, even in the skin at day 26 
and 62, in the range of 5 to 10%. In ungated samples, more CD 14+ cells were observed, up to 25 %. At 
day 62, the proportion of CD4+ CD14+ cells was very low, both gated and ungated. CD16+ cells were 
not observed at any time point in any system, possibly due to difficulties with the antibody conjugate 
used.
6.4 DISCUSSION
Results showed that, at 2 months (62 days post inoculation) after inoculation, SIV + animals 
had similar proportion of CD4+ T cells in the skin with higher percentage o f CD4+CD45RO+ positive 
cells compared to SIV-negative monkeys, suggestive of compensatory mechanism and a more sustained
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reaction in SIV+ rhesus monkeys. In addition and very importantly, disease development did not 
correlate with SIV positivity but rather with an early, vigorous CD4+ and CD3+ recruitment in skin 
inoculation sites.
Skin cell suspensions, without prior collagenase treatment, were analyzed by flow cytometry 
(FC) because histologic examination reveals that, at early time points, there is no significant granuloma 
formation and an absence of significant reticulin fiber formation. Gradient centrifugation was not 
feasible (Ficoll-Hypaque) due to low cell yields. As a result, small collagen debris, that non specifically 
adsorbed the monoclonal antibodies, consistently gave a diagonal pattern within the lymphocyte gate 
after staining with isotype controls. The CD4+ or CD8+ T lymphocytes identified by flow cytometry 
were most likely recruited cells instead of contamination with peripheral lymphocytes for two reasons. 
First, there was a strong correlation between the percentage of CD4 T cells obtained with FACS and 
IHC technology at early time points (2 and 5 DPI), times where it was most suspected that the analyzed 
cells by flow cytometry would be contaminated by peripheral blood lymphocytes. Second, analysis of 
variance (ANOVA) analysis of concatenated FACS data in the blood and skin revealed the %CD4+ 
from the skin to be statistically different from %CD4+ from peripheral blood at day 26 (p<0.02).
By flow cytometry, the median proportion of CD4+ T lymphocytes present at sites of M.leprae 
inoculation was significantly lower in SIV+ rhesus monkeys as compared with SIV negative animals, at 
all time points except at day 62 post inoculation. By immunohistochemistry and FC, a trend towards 
higher proportions of CD4+ cells were observed at day 12 in SIV+ animals. This trend is interestingly 
very similar to a previous study investigating the primary response to M. leprae in a naive population of 
rhesus monkeys (Lathrop, Scollard et al. 1996). These combined results suggest delayed recruitment of 
CD4+ T lymphocytes at sites of skin inoculation after recall challenge of M. leprae. This suggests that, 
even though the SIV positive animals seem to have a decreased capacity to recmit CD4+ lymphocytes 
soon after bacterial inoculation, presumably due to their ongoing chronic retroviral infection, they still 
have the capacity to respond through the recruitment of these cells, resulting in a median maximum at 
day 12 post inoculation.
The proportion of activated/memory CD4+ T lymphocytes, as assessed by monoclonal 
antibody specifically bindng to the short CD4S6 isoform of the common leukocyte antigen (CLA)
143
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
family of transmembrane protein, otherwise called CD4SRO marker, is consistently higher in SIV+ 
animals in the skin and lymph nodes, in a significative manner day 62 in the skin. The same trend (not 
statistically significant) was observed in the LN at all time points. This result suggests that SIV infected 
animals can recruit a higher proportion of CD4 T cells with up-regulated CD45Q isoforms. Since these 
latter cells are believed to belong to the group of activated/memory lymphocyte subset 
(Merkenschlager, Terry et al. 1988), this may be due to a compensatory mechanism. Alternatively, this 
phenomenon may be non-specific, with higher activation levels of CD4 T cells related to persistent SIV 
infection, similar to what is observed in HIV infection (Copeland and Heeney 1996). The replication of 
HIV occurs preferentially in activated CD4+ lymphocytes (Copeland and Heeney 1996). In children 
infected in utero with HIV, higher numbers of CD4+CD45RO+ are infected with HTV provirus than 
naive CD4+CD45RA+ cells (Sleasman, Aleixo et ai. 1996). In this latter study in infants and children, 
however, the normal age-related predominance of CD4+CD45RA+ T cells in the blood was maintained.
At day 62, no morphological difference in the nature and distribution of lymphocytes and 
granuloma was observed between the SIV + and the SIV -  animals, and the proportions of recruited 
CD4+ T cells or CD4:CD8 ratio was very similar. This is consistent with the published data concerning 
humans infected by both leprosy and HIV, where no difference in the nature of the established skin 
lesions was observed between the HIV+ and HIV- patients (studied and reviewed by (Faye, Mahe et al. 
1996))(Machado, David et al. 1998). In these human studies, although no time fhune data can be 
obtained, it is very likely that the lesions studied are older than 2 months, and in any case, events within 
the first month could not be assessed in human studies.
Examination of IHC and HE slides revealed the cellular response to be quite heterogenous in 
these animals, regardless of the SIV infection status of rhesus monkeys. Forty four percent (4/9) were 
early strong responders, including 2 SIV+ monkeys. This exactly correlated with absence of persistent 
infection with M. leprae in these latter animals.
Delayed type hypersensitivity (DTH) is characterized by strong cell mediated immunity (CMI) 
after injection of antigens. There is early (48-36 hours) dense perivascular accumulation o f CD3+CD4+ 
T lymphocytes, fibrin and edema histo-pathologically. Grossly, the injection site is red and thickened. 
Since this study deals with inoculation with live Mycobacterium leprae instead o f antigens, a
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morphological picture at day 2 similar to a DTH reaction will be called a DTH-like reaction. Notably in 
this study of rhesus monkeys, the development of persistent M. leprae infection was inversely 
associated with a DTH-like reaction in the skin, independently o f whether the subjects were chronically 
infected with SIV. In humans, a strong DTH to tuberculin associated with an absence of pulmonary 
lesions suggestive of tuberculosis is an indicator of resistance to disease among highly exposed contacts 
of tuberculosis patients (i.e nurses) (Stead, Lofgren et al. 198S). Loss of the DTH response to tuberculin 
and other antigens in HIV-i- patients has a high predictive value for subsequent development of AIDS, 
correlating with tuberculosis (Markowitz, Hansen et al. 1993) (reviewed by (Smith and Moss 1994)) 
and Mycobacteria-induced secondary opportunistic infection and disease (Birx, Brundage et al. 1993; 
Blatt, Hendrix et al. 1993). Moreover, and very importantly, there is a decrease of DTH and peripheral 
lymphocyte stimulation to tuberculin antigens in patients progressing to clinical Mycobacterium 
tuberculosis infection, such as pneumonia (Sanchez, Rodriguez et al. 1994; Surcel, Troye-Blomberg et 
al. 1994), reviewed in (Cooper and Flynn 1995).
In tuberculosis, most researchers believe that, whereas genetic factors of “innate immunity” are 
most important to determine whether an individual will develop tuberculosis after primary exposure to 
M. tuberculosis, acquired cell mediated immunity is thought to be crucial for the outcome upon re­
exposure to tubercle bacilli and/or reactivation of tuberculosis disease (Bloom 1994). Our data suggest 
that the response to M.leprae infection and disease (i.e localization to nerves), it might be similar. The 
study of the cytokines expressed locally and regionally at sites of inoculations by these monkeys 
indicates that an early, vigorous Thl/type 1 response correlates with an absence of persistence and/or 
dissemination of the leprosy bacillus in rhesus monkeys.
Lastly, there was no preferential recruitment of y8 T cells in the skin or augmentation of y5 T 
cells in the LN, as evaluated by flow cytometry. The proportion of total y8 T cells in the blood were 
similar to the ones described in rhesus monkeys (Wallace, Gan et al. 1994). More importantly, there was 
no difference in the proportion of y8 T lymphocytes at early time points or over time in the lymph node 
or in the skin, where significant numbers of yS T cells have been previously described early after 
inoculation with mycobacteria in rodents (Inoue, Yoshikai et al. 1991). In another study in mice, the yS 
T cell recruitment parallelled but did not outnumber the accumulation o f a|3T cells in response to live
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M. bovis strain BCG or M. tuberculosis-inoculated mice (Griffin, Harshan et al. 1991). In addition, the 
latter study did not find any prominent accumulation of yS T cells in memory immune mice upon re­
challenge as in this study.
Therefore, the recruitment however paralleled but did not outnumber the accumulation of a(3T 
cells in mycobacteria-inoculated mice, and no accumulation of y5 T cells in memory immune mice upon 
re-challenge was observed(Griffin, Harshan et al. 1991). This is similar to what was noticed in this 
study dealing with rhesus macaque re-challenged with M. leprae.
CD 16+ cells, indicative o f the natural killer cell subset, were not observed at any time point in 
this study, questioning the validity of this marker in rhesus monkeys, despite reports showing that it 
stained cells in this species (Reimann, Waite et al. 1994). This is consistent with previous studies 
revealing that, although the clone Leul la, unlabeled or linked with FITC, stains lymphocytes in rhesus 
monkeys (Polacino-Firpo, Axberg et al. 1992; Sopper, Stahl-Hennig et al. 1997), the clone Leullc 
linked with PE does not label rhesus macaque cells although both clones have been designed to label the 
same human marker, CD 16 (Polacino-Firpo, Axberg et al. 1992).
In conclusion, this analysis showed that SIV+ animals are able to recruit CD4+ T cells in a 
manner similar to SIV- animal at early time points after a recall inoculation of M. leprae in the skin, 
with a delay of approximately one week. Protection against persistent AS. leprae infection correlated 
with an early and vigorous recruitment of T lymphocytes primarily, but not exclusively, CD4 T cells, 
thereby mimicking the cell recruitment observed in a DTH reaction (Buchanan and Murphy 1997). In 
short, protection correlated with a DTH-like phenomenon, but not with the SIV status.
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7 THE STRENGTH AND TIMING OF THE CYTOKINE 
RESPONSES TO RECALL M. LEPRAE 
INOCULATIONS IN THE SKIN OF RHESUS 
MONKEYS CORRELATES WITH OUTCOMES OF M
LEPRAE INFECTION
7.1 INTRODUCTION
T lymphocyte mediated immunity is now understood to develop along two pathways defined 
by the pattern of cytokines secreted in the local environments by at least CD4- and CD8-positive T 
cells, after exposure and stimulation with foreign antigens and pathogens. The T helper 1 (Thl) and the 
T helper 2 (Th2), each of which identifies a major immune response, are defined by precise arrays of 
cytokines with antagonistic consequences (Romagnani 1996). Both represent adaptive cellular 
immunity to distinct class o f pathogens and both may have beneficial and detrimental effects. These 
arrays of cytokines are thought to reciprocally cross-regulate each other, in a complex manner (Muraille 
and Leo 1998). In leprosy, where a spectrum of immuno-pathologic manifestations characterizes the 
disease, both types of T cell help are present in fully developed disease (Modlin 1994). Among the 
exposed individuals that have developed active Hansen’s disease, type 2 T cell help (Th2) is present in 
lepromatous skin lesions and type 1 T cell help (Thl) is present in tuberculoid skin lesions (Yamamura, 
Uyemura et al. 1991). In T cell clones derived from these lesions and blood, two studies essentially 
confirmed the ex vivo findings (Salgame, Abrams et al. 1991; Misra, Murtaza et al. 199S), whereas 
another study using skin and blood derived T cell clones showed functional heterogeneity, that did not 
strongly correlate with disease classification, and phenotype evolution over time of cultured skin T cell 
clones (Howe, Wondimu et al. 199S). In this context, nothing is presently known about the evolution 
over time and critical aspects of the cytokine profile upon first exposure and re-exposure to 
Mycobacterium leprae in humans. Similarly, the manner in which these responses to M. leprae may be 
modified by HIV infection are unclear (Pdnninghaus, Mwanjasi et al. 1991).
Most epidemiological (Pdnninghaus, Mwanjasi et al. 1991; Frommei, Tekle-Haimanot et al. 
1994; Munyao, Bwayo et al. 1994; Lienhardt, Kamate et al. 1996; Machado, David et al. 1998), 
immuno-pathological (Sampaio, Caneshi et al. 1995) and histo-pathological (reviewed in (Faye, Mahe
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et al. 1996) studies have failed to demonstrate any increase of the incidence of leprosy or downgrading 
of leprosy from tuberculoid to lepromatous disease in humans infected with HIV. However, since no 
reliable test can be performed to assess the ratio o f the number of individuals suffering from leprosy to 
the number of individuals exposed to the leprosy bacillus without disease (leprosy disease rate: leprosy 
infection rate) in HIV-infected versus HIV-negative populations, the question of whether HIV infection 
and/or disease favors the development of leprosy after exposure to the pathogen remains unanswered 
and difficult to address. Likewise, there is an absence of data concerning the effect of leprosy and its 
different clinico-pathologic forms on the evolution of HIV infection/disease, in contrast with 
tuberculosis (Goletti, Weissman et al. 1996).
Experimentally, using large intra-venous and intra-dermal doses, inoculations of rhesus 
macaques (Macaca mulatto) have resulted in the development of persistent and, more rarely, 
disseminated M.leprae infection, resembling the development of human leprosy, in 26.5 to 45.7 % of 
them (Gormus, Xu et al. 1998). This has suggested that rhesus macaques, like humans and unlike nine- 
banded armadillo and sooty mangabey monkeys, have a heterogeneous response to the leprosy bacillus. 
Comparison of SIV+ and SIV- rhesus macaques has revealed higher percentages of SIV+ animals that 
eventually developed a leprosy-like disease, when inoculated with M. leprae at the time of SIVinfection 
(Gormus, Murphey-Corb et al. 1989; Baskin 1990; Gormus, Murphey-Corb et al. 1998) or 8-10 months 
later, when these rhesus usually express advanced SAIDS (Gormus, Murphey-Corb et al. 1998). Non 
human primates may have an unexpected value and important applications in leprosy research and to 
study the interactions between leprosy and immunosuppressive lentiviruses (Meyers 1992; Meyers, 
Gormus et al. 1994). A previous pilot study, dealing with the cellular and the cytokine secretion pattern 
following a primary exposure to M. leprae in rhesus monkeys, had indicated a delayed recruitment and 
a delayed cytokine response in SIV positive animals as compared with SIV negative ones (Scollard, 
Gillis et al. 1997).
This study examined the consequences o f a re-exposure with M. leprae and utilized 9 rhesus 
monkeys, 3 of which were chronically infected with simian immunodeficiency virus (SIV), addressing 
the question of the type of cytokine response in the skin and regional draining lymph node (LN) of 
rhesus macaques shortly after re-exposure to a live inoculum of M. leprae, taking advantage of the
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recent optimization of primers for cytokine cDNA am pliation in this species by RT-PCR (Villinger, 
Hunt et al. 1993; Villinger, Brar et al. 1995). The hypothesis of this study was that the SIV+ slow 
progressors would not mount an adequate Thl but instead a Th0/Th2 response upon re-challenge with 
M. leprae. A related hypothesis was that differences in cytokine responses exist between the groups that 
do or do not develop persistent M. leprae infection.
7.2 MATERIALS AND METHODS
7 .2 .1  R N A  Is o l a t io n
Ribonucleic acid (RNA) isolation was based on the property that RNA stays in solution when 8 
M of guanidinium isothiocyanate is used to disrupt the nucleo-protein complexes. This property allows 
a rapid one step isolation procedure, which can be successfully applied to series of samples 
(Chomczynski and Sacchi 1987). This method was applied for all specimens of this study. However, for 
skin biopsies, where often low numbers of cells infiltrate the inoculation site, a longer procedure, 
including 2 lysing steps and 2 rounds of isopropanol precipitation overnight at -20°C, was used in an 
attempt to improve the yield and purity of nucleic acid isolates. The comparison of performance 
between the two methods was carried out using a skin sample and confirmed the better performance 
with better yields and slightly higher OD260:OD280 ratio using 2 lysing steps.
7 .2 .1 .1  RNA Isolation from Lymph Node Cell Suspensions
Five millions (5 106) cells from lymph node cell suspensions (LNCS) were lysed for 2 minutes
using RNA-STAT60™ (Tel-test”B’\  inc., solution (TeI-test”B’\  Friendswood, TX) and immediately 
frozen at -70°C the day of sampling, during and after cell sorting.The isolation was later carried out in 
less than 90 minutes using 100 pi of lysing solution /106 cells in 1.5-ml microfuge tubes with tipped 
ends (Sarstedt, Newton, NC), according to the manufacturer’s instructions, with slight modifications: 
the second ultra-centrifugation, after isopropanol precipitation, was carried out for 25 minutes instead of 
15 minutes, due to the high content of nucleic acid noted by OD26o reading in the supernatant. When 
pipetting out the aqueous phase, care was taken to leave 2-3 mm above the meniscus to prevent 
contamination by the lysing solution and unwanted DNA and proteins. After drying 20-30 minutes in a 
vacuum chamber, the isolates usually stayed in an aqueous phase and were dissolved in di-ethyl-phenyl- 
carbazine (DEPC)-treated distilled water up to a total volume of 100 pi. Four pi of the isolate was
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diluted 1:20 in 76 pL of DEPC water to determine the amount of nucleic acid by spectrophotometry 
(GenQuant™, Pharmacia Biotech Ltd, Cambridge, England, UK).
7.2.1.2 RNA Isolation from Frozen Skin Biopsies
Depending upon the abundance of the inflammatory infiltrate present, thirty to fifty 10 pm-
thick sections from each sldn biopsy were cut using a freezing microtome (Jung frigocut 2800E, Leica, 
Nuflloch, Germany). These frozen sections were collected in 1.5 ml microfuge tubes (Sarstedt, Newton, 
NC) and kept at -27 °C until guanidinium isothiocyanate lysing solution was added while thawing. 
Isolation of the total RNA was performed using the RNA isolation kit (RNAgent™, Promega, Madison, 
WI), according to the manufacturer’s instructions for low to very low amounts of nucleic acid. The 
RNA isolate did not dry completely after 20 minutes in a vacuum chamber and was diluted to -  40 pL 
by adding 30 pL of DEPC water. When necessary due to high nucleic acid yield, the samples were put 
in a water bath for 3 min at 700 C to melt the isolate. An aliquot of 4 pi diluted 1:10 and/or 1:20 was 
used to determine the quantity of nucleic acid by spectrophotometry, using the same instrument as for 
the lymph nodes.
Optical densities (OD) read at 260 and 280 nm were recorded to determine approximately the 
quantities and purity of nucleic acid isolates. Repeatability testing from blanks and specimen samples 
showed typically a precision of approximately +/- 0.010, which is about the reproducibility indicated by 
the manufacturer. In several samples where the reading had a high variability, serial dilutions at 1:40 
and 1:80 were undertaken with more repeatable readings. This approach was also an opportunity to 
check for linearity of the corresponding OD values. Since we did not use any other method to determine 
nucleic acid concentration, the precision (accuracy) of the used spectrophotometer for these studies 
could not be determined. Comparison with other spectrophotometers indicated higher OD260:OD280 
ratios, but very similar OD260 values.
7.2.2 T o t a l  N u c le ic  A c id  Y ie ld s  a n d  P u r i t y
7.2.2.1 Skin
Absorbency o f emitted UV light at 260nm from the ‘total RNA’ isolates from skin revealed 
typically heterogeneous and low total nucleic acid concentrations, especially at early time points. The 
average (AVG) ± standard deviation (SD) o f calculated RNA concentrations was 10.1 pg ± 17.6 pg 
(n=42 isolates, including 6 repeats). After removing two extremes o f >50 pg, the AVG ± SD was 6.5 ±
153
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6.0 pg. The lowest yield was from day 2, with an AVG ± SD of 1.3 ± 1.3 |ig. The average purity ± SD 
of the isolates, as assessed by the OD260:OD280 ratio, was 1.31 ± 0.13. The RNA isolates consistently 
had genomic DNA contamination, similar to the ones seen in chapter 4 (Fig. 4.3b page 99).
7.2.2.2 Lymph Node
There was no notable difference between the total RNA values from LN cell suspensions 
obtained at day 0, 5, 26 and 62. For example, at day 5, the AVG ± SD was 57.9 ± 28.5 pm (n=35). The 
average purity ± SD of the isolates, as assessed by the OD260:OD280 ratio at day 5, was 1.340 ±0.15. 
This purity measure was low, but was still higher than on the other days. To ascertain that this was not 
merely an instrument-related phenomenon, 12 samples from day 5 were assayed with another 
instrument (Beckman DU 600, Beckman Coulter inc., Fullerton, CA). The OD260 values were similar. 
Table 7.1 summarizes the OD ratio findings. For purity assessment, relative performances have been 
taken into account, not absolute values.
Table 7.1: Instrument comparison in OD determination and ratio in LN nucleic acid isolates at day 5.
all samples day 5____________side by side comparison________
OD ratio Tot. Nucl. Acid OD ratio Total Nucl.Acid
Pharmacia Beckman Pharmacia Beckman
number tested 30 30 12 12 12 12
AVG 1.340 57.9 1.350 1.831 70.6 68.9
STD 0.151 27.6 0.130 0.222 34.4 24.2
7.2.3 D e o x y r ib o n u c le a s e  I (D n a se  I) T r e a t m e n t  o f  T o t a l  N u c le ic  A c id  
I s o l a t e s
Amplification by polymerae chain reaction (PCR) without reverse transcription (RT) revealed 
that both lymph node cell suspension isolates and skin isolates had genomic DNA contamination, 
similar to what was noticed when RNA was isolated from Imcomplete Freund’s Adjuvent skin injection 
sites (Figure 4.3b page 99). Therefore, DNase I (GIBCO BRL -  Life technologies, Gaithersburg, MD) 
treatments were performed prior to the reverse transcription, according to manufacturer’s 
recommendations, on a total of 1 pg of nucleic acid isolate from both skin and LN. To minimize loss of 
messenger RNA during the treatment, the reaction was carried out at room temperature (~ 20-22 °C) for 
precisely 15 minutes.
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7.2.4 R e v e r s e  T r a n s c r ip t io n  a n d  P o ly m e r a s e  C h a in  R e a c t io n  o f  t h e  E x  Vivo  
T o t a l  RNA I s o l a t e s
7.2.4.1 Reverse Transcription
Half (0.5 |ig of nucleic acid) of the Dnase I treated samples were reverse transcribed for 50
minutes at 42 °C using superscript n® (GEBCO BRL -  Life technologies, Gaithersburg, MD) with 
slight modification of the manufacturer’s recommendations. The total reaction volume was 40 pi 
instead of 20 pi and 0.5 unit of Rnase inhibitor (Rnasin® - Promega, Madison, WI) was added. The 
ratio of RNA isolate in pg to reverse transcriptase in units of specific activity was 1:1.
7.2.4.2 Polymerase Chain Reaction
Polymerase chain reaction (PCR) was carried out using a thermal cycler 480 (Perkin-Eimer
Cetus Applied Biosystems, Norwalk, CT) using the following basic amplification program: melting 2 
min. at 95 °C for 1 cycle, I min. at 95 °C, 1 min. at the optimal annealing temperature, then extension 
for lmin. at 72 °C for n cycles and finally extension for 7 min. at 72 °C. Annealing temperature, cycle 
number and other parameters specific for each amplified cDNA are presented in Table 7.2. The primers 
and oligoprobe sequences for each rhesus macaque cytokine were published earlier (Villinger, Hunt et 
al. 1993; Villinger, Brar et al. 1995), except for IFNy, for which primers designed for human IFNy 
cDNA were used (Yamamura, Uyemura et al. 1991). All sequences are presented in Table 7.3.
Table 7.2: RT-PCR standardized conditions for the ex vivo cytokine study.
3-actin IFNy IL-4 IL-2 IL-10
[primer| (pM) 0.2 0.2 0.1 0.2 0.1
Annealing T (°C) 63 55 62 62 62
[MgCI2| (mM) 2 2 2.5 2.5 2
dNTP mixture (mM) 0.8 0.8 0.8 0.8 0.8
Cycles number 30 37 37 37 37
Taq (Units) 1.25 1.25 1.25 1.25 1.25
T= temperature
[MgCI2|=  concentration in magnesium chloride
dNTP= deoxynucleotide tri-phosphate
Taq= Thermus aquaticus thermostable DNA polymerase
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Table 7 J :  Sequences of forward and reverse primers and biotin-labeled oligoprobes (PB) used 
to amplify rhesus macaques cytokines
Cytokine Name Sequence
IFN-g hIFNg-5'
MFNg-3’
HIFNg-PB
AGT TAT ATC TTG GCT TIT CA 
ACC GAA TAA TTA GTC AGC TT 
ATT TGG CTC TGC ATT ATT TTT CTG T
IL-2 Rh IL-2 - 5’ 
Rh IL-2 - 3' 
Rh IL-2 PB
ATG TAC AGG ATG CAA CTC CTG 
CAC ATG AAT GTT GTT TCA GAT CCCT 
ACC CAG GGA CTT AAT CAG CAA TAT CAA
IL-10 Rh IL-10 - 7x 
Rh IL-10 - 6 
Rh IL-10 PB
TGC TCT AGA AGG CAT GCA CAG CTC AGC 
TCT CAA GGG GCT GGG TCA GCT ATC CCA 
GGC CGT GGA GCA GGT GAA GAA TGC CTT TAA
IL-4 Rh IL-4 - 5' 
Rh IL-4 - 3' 
Rh IL-4 - PB
ATG GGT CTC ACC TCC CAA CTG
TCA GCT CGA ACA CTT TGA ATA TTT CTC TCT
CAG CAG TTC CAC AGG CAC AAG CAG C
The strategy for relative RT-PCR was as follows: from the RT product, 2 pi (5%) was sampled 
for cDNA standardization using the housekeeping gene, (i-actin, amplified for 30 cycles, based on the 
saturation curve from half of a pg of DNAse I treated nucleic acid (‘total RNA’) isolate (Fig. 7.1). Even 
though 40 cycles may have been at first analysis more appropriate to obtain signals visible after gel 
elctrophoresis of PCR products, 37 cycles instead of 40 cycles were chosen after IFNy amplification 
optimization from DNAse I-treated samples from day 2 and 26 in the skin to avoid risks of product 
saturation. The number o f cycles was the same for all the cytokines, for isolates from skin and LN 
(Table 7.2). Negative controls of PCR were water to check for contaminations before amplification. In a 
few PCR procedures, reverse transcribed RNA from normal rhesus skin were useed as negative 
controls. Positive control cDNA mixtures for PCR cytokine detection were RNAs isolated from 
alloreactive mixed lymphoid cultures from rhesus monkey blood with S pg/ml o f concanavalin A or 2 
pg/ml of phyto-hemagglutinin-A. In addition, IL-4, which was only marginally detected or detected 
only after hybridization with biotin-labeled oligoprobes in alloreactive mixed lymphocyte cultures, and 
IFNy benefitted o f serial dilution of cloned pGEM plasmids containing IL-4 and IFNy cDNA inserts as 
positive controls.
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Figure 7.1: PCR saturation curves of (a) human P-actin cDNA and (b) 
rhesus lymph node cell suspensions (LNCS) cDNA. (a) SO attomoles of a 
commercially available human P-actin cDNA positive control (Clontech, 
Palo Alto, CA) and (b) 0.S pm of total RNA isolate from 3 representative 
rhesus macaque LNCS were used. Linear amplification was observed (a) 
between 17 and 25 cycles in the former and (b) between 25 and 35 cycle in 
the latter. The IOD values are based on the density of bands on agarose 
gels.
Twenty-five (25) percent of the PCR product was separated by electrophoresis, using a 2 % 
agarose gel stained with 55 ppm ethidium bromide at 80 volts for 2 hours. The bands were 
photographed with constant standard exposure time and aperture (1 second, aperture 8) and scanned at 
300 dpi per cm using an XRS™ 3cx scanner (X-Ray Scanner Corp., Torrance, CA) and PerfectScan™ 
software (Perfect Byte, Inc., Omaha, NE). An integrated optical density (IOD) value was obtained using 
Sunview™ software (Millipore Corp., Bedford, MA) with standardized parameters. This software
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calculated the OD and surface of each scanned band and gave the integrated optical density (IOD) as a 
measure of the relative quantities of P-actin PCR products. Relative quantities of p-actin were 
standardized using the weakest signal of a given batch as an undiluted or minimally diluted reference. 
For each of the four cytokines, 23.75% (0.95/4) o f the diluted standardized RT product was used: the 
remaining 5% was used for amplifying the adjusted sample for P-actin. After PCR amplification, ~ 25% 
of the product of each cytokine and the standardized housekeeping gene was separated by 
electrophoresis using the exact same protocol, and the bands obtained were scanned and an IOD value 
was obtained. Relative expression of each cytokine mRNA for each animal was obtained by calculating 
the lODcyuiune: IODp.actii, ratio (IOD RATIO). Since the primary goal was to compare SIV+ versus SIV- 
groups, PCR runs and gels were usually grouped by sampling day and by sorted fractions. The 
consequence is that, unless of sufficient magnitude, day to day variation should be interpreted with 
more caution than intra-day variations observed between groups of animals.
7.2.5 S o u t h e r n  B l o t t i n g  a n d  C h e m ilu m in e s c e n t  D e t e c t io n  o f  PCR P r o d u c t s  
N o n  V is ib le  o n  t h e  G e ls
When all the bands could not be directly detected after PCR amplification on ethidium bromide 
stained gels, the DNA from the gels were transferred overnight to a positively charged nylon membrane 
(Tropilon-plus™, Tropix, Bedford, MA) using an upward capillary transfer, i.e. a strong ionic gradient 
from a high salt, 10 x salt-sodium citrate (SSC) buffer to a low salt, 2X SSC buffer (Southern blot 
procedure) (Southern 1975) and subsequently fixed with 0.4M NaOH for 3 minutes (Brown 1993). 
Hybridization for each cytokine was performed using commercially available reagents (Southern- 
light™, Tropix) and oligoprobes specific for monkey IL-2, IL-4 and 11-10 cDNA (Villinger, Hunt et al. 
1993) and human IFNy specific oligoprobe that specifically bound the rhesus IFNy cDNA sequence 
amplified from rhesus monkey RNA (sequence kindly provided by Sonia Montenegro-James, Tulane 
University, New Orleans, LA). Relative sensitivity o f IL4 and IFNy detection was assessed by serial 10- 
fold dilutions of pGEM plasmids containing IL-4 and IFNy cDNA sequences from rhesus macaques 
(kind gift from Dr. Villinger, Emory University, Atlanta, GA). Results indicated similar detection 
performances, within 2 logio units, between the two probes. Oligoprobe affinity performance for IL-2
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and IL-10 cDNA was not done, since we did not use cDNA inserted in plasmids of known quantity for 
these latter 2 cytokines.
Oligoprobe concentration in the hybridization buffer, hybridization temperature and film 
exposure times were standardized for all 4 cytokines, skin and LN and all time points at 2.S pmoles/ml, 
S0°C and 1 hour, respectively. The chemiluminescent detection was done according to the 
manufacturer’s instructions. The films were exposed to the nylon membrane for 1 hour immediately and 
one hour after the beginning of the luminescent chemical reaction (the reaction intensity peaks 
approximately 2-5 hours after its start).
To integrate results from strongly expressed cytokine(s) readily visible by ethidium bromide- 
stained gels, such as IFNy, and data obtained from weakly expressed cytokine detected only by 
Southern blotting and chemi-luminescent detection, such as IL-4, the ranking system presented in Table
7.3 was used. This ranking system utilizes and combines qualitative criteria from the Southern blotting 
and ranks from intervals of the integrated optical density (IOD) ratio. It avoids the overestimation of 
weak signals when taking IOD ratio data alone. It does not, however, discriminate between levels of 
high expression. IOD ratio values are used to compare relative high expression of cytokine mRNA 
between groups. Because baseline expression in the lymph nodes was not homogenous between samples 
for a given cytokine, up-regulation or down-regulation of expression was assessed using IOD ratio 
adjusted on baseline, defined as follows:
Corr IOD ratio = IOD ratio a»y n -  IOD ratio bueiine- n ={5,26,62}.
The adjusted rank o f IL-2, IL-10 and IFNy was then determined according to the corrected IOD ratio 
adjusted on baseline defined as follows [rank (corr IOD ratio)]. 11-4 had no detectable baseline mRNA 
expression in the lymph nodes.
Table 7 J :  Ranking system to compare weak and strong cytokine expression.
Grade 0: no detectable band by southern blot hybridization (exposure time > 1 hour).
Grade 1: band visible only by southern blot hybridization
Grade 2: detection limit by gel - IOD ratio < 0.5 -  usually strong hybridization signal.
Grade 3: detected by gel - 0.5 <IOD ratio < 1; cases of gel detection limit when P-actin bands are weak. 
Grade 4: detected by gel - IOD ratio > 1
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The acquired ranked data were used to generate Figure 7.3 through 7.6, where the data grouped 
by SIV status and disease outcome is presented as median ranks. Figure 7.2 is an illustration showing 
the flow of data acquisition to obtain IOD ratios of mRNA expression in the skin and lymph nodes. The 
example given is IL-2 from day 2 in the skin (Figure 7.2). A summary of the methods used are also 
mentioned in the legend.
7 .2 .6  L y m p h o c y t e  S t im u l a t io n  T e s t s  w it h  M . L e p ra e  So n ic a t e
Three months (96 DPI) after re-challenge with M. leprae, 10-14 ml of heparinized peripheral 
blood was drawn from each monkey. Mononuclear cells were isolated by density gradient centrifugation 
(Ficoll-Paque™, Pharmacia, Uppsala, Sweden) washed and re-suspended in RPMI-10 at a concentration 
of 2 106 cells per ml. Approximately 200,000 (1.94± 0.31 105 ) mononuclear cells were plated in 
triplicate in round bottomed 96 well plates (Millipore, Bedford, MA ) in the presence of 
phytohemagglutinin (PHA) at a concentration o f 4 10** G/mL, or M.leprae sonicate (ML-S) at 10 lO-6 
G/mL (1:10 dilution) and S 10-6 G/mL (1:20 dilution). Negative control cultures received medium alone. 
Cells were cultured with PHA for 3 days, and with M. leprae and medium alone for 6 days. The cultures 
were pulsed for the last 18 hours with tritiated thymidine. Incorporated }H was collected on filter paper, 
immersed in a scintillation fluid measured using a scintillation counter (Beckman LS 6000IC, Beckman 
coulter corp., Fullerton, CA). Results were expressed in counts per minutes (CPM) (Fig. 7.9). Statistical 
analysis of the results was performed on count per minutes (cpm) and the natural logarithm of the cpm 
(lncpm).
7 .2 .7  St a t is t ic a l  A n a l y s e s
Tukey’s studentized range test was performed on IOD ratio and ranked data, when comparing 
the four cytokines. When normally distributed as tested with an univariate procedure using SAS 
software version 6.12 (Cary, NC), further statistical analyses were performed using an analysis of 
variance (ANOVA) on ranked data (Krusval-Wallis) through the general linear model (GLM) procedure 
of the SAS software version 6.12 (Cary, NC). When the model was not valid, as for IOD ratio by SIV 
status in skin and LN due to a high variances, Wilkoxon’s ranked sum tests were used.
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Figure 7.2: Illustration of data acquisition and ranking of cytokine 
mRNA expression. This was performed by integrating gel electrophoresis 
band quantification (a, c) and semi-chemiluminescent detection of weak 
signals after Southern blotting (b).
Frozen skin biopsies, from which the RNA isolates were obtained, are 
arranged in the same ascending order in a, b, c, and d. The same method 
was applied to the lymph node cell suspensions.
a: relative RT-PCR: 0.5 pg of Dnasel treated RNA isolate was reverse 
transcribed using Superscript II® (Gibco BRL) and standardized samples 
were amplified using PCR. Upper panel of the gel: (3-actin cDNA band at 
947 base pairs (bp). Lower panel: IL-2 cDNA at 346bp. L: 100 bp ladder; 
+C = positive control; C = negative control
b: Southern blot: The gel was blotted overnight on a positively charged 
nylon membrane (Tropilon-plus®, Tropix), fixed with 0.4M NaOH for 3 
minutes and hybridized with rhesus macaque cytokine cDNA-specific 
biotinylated oligonucleotides at S0°C overnight. Hybridization was detected 
using CSPD® based chemiluminescent kit (Southern Light®, Tropix). 
Exposure time was 1 hour.
c: IOD ratio: IOD data were acquired by scanning the photo shown in a 
and using Sunview® software (Millipore, corp.). Histograms of the 
integrated optical density ratio IODn .-kIPD^ ; . ,  (IOD ratio); lines at 0.5 
and 1 delimit ranks 2, 3 and 4 (see table 7.3) in bands visible with gel 
electrophoresis.
d: Data integration: IOD data, IOD ratio, chemiluminescant hybridization 
signals and ranks obtained by combining the IOD ratio data from the 
histogram in c and the Hybr. Signals in blot in b. Ranks were obtained using 
the criteria used in the table 7.3 shown above. Southern blots primed above 
IOD ratio data, i.e. no band detected is ranked 0, whatever the IOD ratio 
value.
Also shown are the SIV status of the animals and whether they developed 
persistent AS. leprae infection (DZ outcome +) or not (DZ outcome -) [see 
also chapter 5 pages 112-113].
The acquired ranked data were used to generate Figure 7.3, 7.4 and 7.7 
through 7.10, where the data grouped by SIV status and disease outcome is 
presented as median ranks.
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7.3 RESULTS
7.3.1 G a m m a  In t e r f e r o n  m R N A  E x p r e s s io n  Is  E l e v a t e d  in  A l l  A n im a l s  
St u d ie d
Gamma interferon was the dominant cytokine mRNA expressed in the skin (Fig. 7.3d) and post 
panned unfractionated cells from lymph node cell suspensions (LNCS) (fig. 7.4d), including the CD4- 
enriched and CD8 fractions of the LNCS (7.Sc, 7.5d, 7.6c, 7.6d), in all the 9 animals studied.
7.3.1.1 Skin:
At the inoculation sites in the skin, when all the monkeys were considered (n=9), the maximum 
expression was at day 26, with a mean rank of 3.55 and a mean IOD ratio of 1.88 ± 1.15 (mean ± SD, 
n=9) and was significantly higher than day 2,5 and 12, but not day 62 (p<0.05) (Fig. 7.3d).
Similar levels of IFNy mRNA expression were observed up to day 26 in SIV- and SIV+ 
monkeys (Fig. 7.5a and fig. 7.7d). At day 62, SIV+ monkeys had significantly higher IFNy mRNA 
expression than did SIV- animals (p<0.05), (fig. 7.5a). Significantly higher IFN-y levels were present at 
day 5 and at day 26 in animals that did not have any evidence of persistent/disseminated M. leprae 
infection at the termination of the study compared with those which did develop persistent lesions (Fig. 
7.6a and 7.8d; p<0.05).
An unexpected result was the low expression of IFNy observed at day 12 in the skin, where 
only 2 bands were visible on the gel and where hybridization was required to detect most products, 
despite (J-actin levels similar to the other days, such as day 5 and day 26 (Fig. 7.3d). Even though the 
possibility of day-to-day variation must be mentioned and considered, this may suggest a real down 
regulation of inflammation and pro-inflammatory cytokines such as IFN-y at day 12, that also correlates 
partially with observations at gross inoculation sites where fewer inoculation sites were visible (Fig. 5.6 
page 116).
7.3.1.2 Lymph Nodes
In the unfractionated LNCS, IFNy expression overall was only moderately and not
significantly increased at day 5 and 26 compared to baseline expression, as assessed by both the mean 
rank (Fig. 7.4d) and the median IOD ratios.
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Figure 73: Average local (skin) cytokine response observed in the 
entire group of 9 monkeys analyzed over time. Results are expressed as 
mean rank (bars) ± standard deviation (error bars). Ranked are defined in 
Table 73. Integrated optical density GOD) ratios, from which the ranks 
were partly determined, were normally distributed, when tested with a 
univariate procedure using SAS software version 6.12 (Cary, NC). (a) IL-4 
mRNA expression in the skin (b) IL-2 mRNA expression in the skin (c) IL- 
10 mRNA expression in the skin (d) IFNy mRNA expression in the skin.
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Figure 7.4: Average regional (lymph node) cytokine response observed 
in the entire group of 9 monkeys analyzed over time. Results are 
expressed as mean rank (bars) ± standard deviation (error bars). Ranked are 
defined in Table 7.3. Integrated optical density (IOD) ratios, from which the 
ranks were partly determined, were normally distributed, when tested with a 
univariate procedure using SAS software version 6.12 (Cary, NC). (a) IL-4 
mRNA expression in the skin (b) IL-2 mRNA expression in the skin (c) IL- 
10 mRNA expression in the skin (d) IFNy mRNA expression in the skin.
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Figure 7.5: Gamma-interferon mRNA expression found in the skin and 
the unsorted and sorted lymph node cell suspensions, by SIV status.
Comparison of median integrated optical density (IOD) ratio of IFNy 
mRNA expression, standardized on p-actin mRNA, by SIV ratio in (a) the 
skin, (b) unfractionated LN cell suspensions, (c) CD4 T lymphocyte 
enriched fraction and (d) CD8 fraction sorted immuno-magnetically. In the 
skin, day 12 is not shown.
Significant differences are indicated by (*) (p<0.05).
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Figure 7.6: Gamma-interferon mRNA expression found in the skin and 
the unsorted and sorted lymph node cell suspensions, analyzed by 
persistence of M. leprae infection. Comparison of the median IOD ratio of 
IFNy mRNA expression, standardized on P-actin mRNA, between animals 
that did not show any evidence of persistent AS. leprae infection (ML-; 
animal number n=4) and animals that show pathologic evidence of 
persistent AS. leprae infection (ML+; n=5). In the slrin, day 12 is not shown.
Significant differences are indicated by (*) (p<0.05).
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In the CD4 and CD8 fractions, however, a sharp increase of IFNy mRNA expression was noted at day 
S-post inoculation (Fig. 7.5c, d and fig. 7.6c, d). In the unftactionated LNCS, the expression of gamma- 
interferon returned to or below baseline levels after the slight increase at day 5 and day 26 (p<0.05). 
Due to possible day-to-day variations, it is difficult to know whether there was, on average, a true down 
regulation of IFNy mRNA expression at day 62 in unfractionated LNCS. Interestingly, this sharp 
decline in IFNy expression was also observed on sorted fractions of LNSC, but earlier compared with 
unfractionated LNCS, at day 26, both in the CD4-enriched fraction and the CD8 fraction, suggesting a 
peak of IFN-y at day 5 with no sustained expression at day 26 in lymphocytes (Fig. 8.2c, fig. 8.2g, fig. 
8.2d and fig. 8.2h). A statistically significant higher expression compared to baseline is noted at day 5 
both in CD4 enriched (IOD ratio ± SD was 3.64 ± 1.91) and CD8 fractions (IOD ratio ± SD was 6.61 ± 
3.39) of lymph nodes (p<0.001).
In the lymph nodes, and in contrast to the skin, higher expression of IFNy mRNA was 
consistently observed in SIV+ animals at day 5 and 26 as compared with SIV- animals in unfractionated 
LNCS (p<0.05 - Fig. 7.5b), whereas in sorted CD8 fractions, SIV+ animals had a trend of lower IFNy 
expression levels at day 5 (Fig. 7.5d). Notably, no difference of IFNy expression was observed at any 
time point between SIV+ and SIV- animals in the CD4-enriched fraction (Fig. 7.5c)
7.3.2 IL4 mR N A  Ex pressio n  Is  N o t  a  F ea tu re  o f  the  S eco n d a r y  R e spo n se  to  
M .le p ra e  in  th e  S k in  b u t  in  L y m ph  N o d es  Is P r ed ic tiv e  o f  P ersisten t  
In fectio n
Overall and in contrast to IFN-y, IL-4 mRNA expression was weak and detected mainly after 
southern blotting, hybridization and chemiluminescent detection, and hence assumed rank values of 0 or 
1, giving mean rank values between 0 and 1 (Fig. 7.3a and fig. 7.4a).
7.3.2.1 Skin
In the skin, IL-4 mRNA expression was observed in a minority o f animals, only after Southern 
blotting, hybridization and chemiluminescent detection (Fig. 7.3a). Since this highly sensitive technique 
was necessary to detect IL-4 mRNA message, it can be stated that upon re-inoculation of M. leprae in 
the skin, only low/minimal expression of IL-4 is noted in rhesus macaques. At day 26 post-inoculation, 
the highest frequency o f animals (4/9) with a detectable IL-4 mRNA was observed (Table 7.4). This 
detection corresponded to the same animals which had early high mRNA expression of IL-2 and IFNy
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at day 2 and 5. Interestingly, these same 4 monkeys with detectable IL-4 mRNA at day 26 also had 
time-wise the highest expression of IL-2 locally at day 2 and IFNy locally. In the skin at day 26, there 
was no statistically significant difference of IL-4 mRNA expression between the SIV+ and SIV- (table 
7.4, x-square test p> 0.40). However, the presence of a weak IL-4 signal in the skin at day 26, but not at 
day 12 or day 2, was associated with animals which had the highest IFN-y and IL-2 mRNA expression 
and presented no development of persistent M. leprae infection and lesions (Table 7.4 x-square test p< 
0.05 and fig. 7.8a,7.8b and fig 7.8d).
Table 7.4: IL-4 mRNA expression in the skin -  frequency counts and 
statistical analysis
IL-4 day 2 day 12 day 26 day 62 expected
RANK results observed observed observed observed (if no effect)
SIV+ (n= 3) 1 0 2 0 1.5
SIV- (n= 6) 0 I 2 1 3
chi-square 0.075 0.092 0.479 0.092
ML+ (n= 5) 0 0 0 I 2.5
ML- (n=4) 1 I 4 0 2
chi-square 0.083 0.083 0.034 0.089
Notes: No IL-4 was detected at day 5 post inoculation and was not shown. 
SIV+: Rhesus monkeys with M. leprae inoculation and persistent, chronic 
J976 simian immuno-deficiency infection.
SIV-: Rhesus monkeys inoculated with M. leprae.
ML+: Rhesus monkeys with persistent M. leprae infection at the 
completion of the study, regardless of the SIV status.
ML-: Rhesus monkeys without signs of any persistent M. leprae infection 
at the completion of the study, regardless of the SIV status.
7.3.2.2 Lymph Nodes
Baseline IL-4 was absent in all animals in all LN cell fractions. Messanger RNA for IL-4 was
mainly detected in the unfractionated cells of lymph nodes (Fig. 7.4a). Rare positive bands were also
detected in the sorted CD4-enriched fractions at day 26 and 62 (Table 7.5). Hybridization was required
to detect the PCR product in all but one animal (M736), which had a visible cDNA band in agarose gel
at day 5 (Table 7.5). No expression of IL-4 was observed in sorted CD8 cell fraction.
At day 5 post-inoculation, the highest frequency of animals (4/9) with a detectable IL-4 mRNA
was observed (Table 7.5). SIV status was not predictive of the IL-4 mRNA expression in lymph nodes
(X1 test -  p=0.48). However, IL-4 mRNA expression was predictive of disease outcome: persistent M.
leprae infection and lesions developed in 4/5 (80%) animals with a detected IL-4 mRNA signal in the
169
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LN at day 5 (x1 test - p<0.05), and corresponded to lower levels of IFNy in the unfractionated LN cells
among this latter group (fig. 7.6b).
Table 7.5: a IL-4 mRNA expressions in the post-panning, unfractionated 
and the sorted CD4-enriched lymph node cell fractions, with b the sum of 
ranks and statistical analysis on unfractionated LNCS.
a Rhesus SIV ML* baseline Day 5 day 26 day 62
Post -panning N264 1 0 0 0 0 0
cell fraction N976 1 0 0 0 0 0
Unfractionated N209 0 0 0 0 1 IP282 0 0 0 0 0 0
N356 I 1 0 1 0 0
M726 0 1 0 1 0 1
M736 0 1 0 2 1 0
M849 0 1 0 0 0 0
M879 0 1 0 1 0 0
Fraction 1 N264 1 0 ND 0 0 0
(CD4) N976 1 0 0 0 0 1
N209 0 0 0 0 0 0
P282 0 0 ND 0 0 0
N356 1 1 0 0 0 0
M726 0 1 ND 0 0 0
M736 0 1 0 0 0 1
M849 0 1 ND 0 0 0
M879 0 1 0 0 0 0
Fraction 2 N264 1 0 ND 0 0 0
(CD8) N976 1 0 0 0 0 0
N209 0 0 0 0 0 0
P282 0 0 ND 0 0 0
N356 1 1 0 0 0 0
M726 0 1 ND 0 0 0
M736 0 1 0 0 0 0
M849 0 1 ND 0 0 0
M879 0 1 ND 0 0 0
* ML: 0 = no pathological evidence of persistent M. leprae infection. 1=
persistent M. leprae infection. Animal sorted according to this criteria.
SIV: 0 = SIV-negative; 1 = SIV-positive.
ND: not done.
b IL-4, unfractionated Sum of ranks
baseline day 5 day 26 day 62 expected
observed observed Observed observed (if no effect)
SIV+ (n= 3) 0 1 1 1 1.5
SIV- (n= 6) 0 3 1 1 3
chi-square 0.09 0.22 0.22
ML+ (n= 5) 0 5 1 1 2.5
ML- (n= 4) 0 0 1 1 2
chi-square 0.03 0.24 0.24
Notes: see figure 7.9 and 7.10 pages 170 and 171.
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Figure 7.7: Median ranked relative mRNA expression in the skin 
inoculation sites grouped by SIV status of (a) IL-4, (b) IL-2, (c) IL-10 and 
(d) IFNy. The ranks are defined in Table 7.3.
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Figure 7.8: Median ranked relative mRNA expression in the skin 
inoculation sites grouped by disease outcome of (a) IL-4, (b) IL-2, (c) IL-10 
and (d) IFNy. Disease outcome is defined as the positive persistence (ML+) 
or negative persistence (ML-) of M. leprae infection at the termination of 
the study. The ranks are defined in Table 7.3. Statistically significant 
differences (p<0.05) are marked by (*).
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Figure 7.9: Median ranked relative mRNA expression in unfractionated 
lymph node cell suspensions grouped by SIV status of (a) IL-4, (b) IL-2, (c) 
IL-10 and (d) IFNy. The ranks are defined in Table 7.3.
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Figure 7.10: Median ranked relative mRNA expression in the post-panning 
unfractionated lymph node cell suspensions grouped by disease outcome of 
(a) IL-4, (b) IL-2, (c) IL-10 and (d) IFNy. Disease outcome is defined as the 
positive (ML+) or negative persistence (ML-) o f M. leprae infection at the 
termination of the study. The ranks are defined in Table 7.3. Statistically 
significant differences (p<O.OS) are marked by (*).
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7 .3 .3  E a r l y  V ig o r o u s  IL 2  mRNA E x p r e s s io n  C o r r e l a t e s  w it h  F a il u r e  t o  
D e v e l o p  P e r s is t e n t  M . L e p ra e  In f e c t io n
Overall, IL-2 mRNA expression in the skin and lymph node was intermediate between that of 
IFN-y and IL-4 (Fig. 7.3b and fig 7.4b).
7.3.3.1 Skin
The highest levels o f expression of interleukin 2 were observed at day 2 and then progressively 
went down to lower levels over time, the lowest mRNA expression levels being seen at day 62 (Fig. 
7.3b). IL-2 mRNA expression in the skin was detectable in agarose gels in most animals until day 12 
post-inoculation, afier which it came back to levels detectable most often only with Southern blot 
hybridization. The average IL-2 IOD ratios at day 2 for the 9 monkeys studied was not statistically 
higher than those at day 5 or 12 (pX).07). No significant difference o f expression of IL-2 mRNA in the 
skin was observed between SIV+ and SIV- animals (Fig. 7.7b).
However, when disease outcome was used to group IL-2 IOD values (data not shown) and the 
corresponding ranks in the skin (Fig 7.8b), the difference is striking: the animals that did not develop 
persistent M. leprae infection had a much higher level of IL-2 at day 2 in the skin than the animals that 
did develop the persistent/disseminated M. leprae infection and lesions, which had no and barely 
detectable levels (p<0.001). A higher IL-2 mRNA expression was noted at day 12 in animals that did 
develop persistent infection than the (Fig. 7.8b), but this result was not statistically significant when 
compared to the animals that resisted persistent AS. leprae infection, comparing both the IOD ratio 
(p=0.07) or median ranks (p>0.05). Subsequent days did not have any significant difference between 
animals that did and did not develop the persistent infection.
7.3.3.2 Lymph Nodes
Significantly lower mean rank of IL-2 mRNA expression was observed at day 5 in the
unfractionated LN cells when all monkeys were considered, compared to IL-2 mRNA mean ranks 
obtained at baseline and day 26 (Fig. 7.4b). Baseline levels o f IL-2 mRNA expression were similar 
between SIV+ and SIV- rhesus monkeys, as those at the other sampling time points (Fig. 7.9b). 
Significantly higher median ranked IL-2 mRNA expression was observed in animals that resisted 
persistent M. leprae infection at baseline, a few days before re-inoculation. Other time points did not 
have any significant difference between animals with and without persistent M. leprae infection (Fig.
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7.10b). Higher levels of IL-2 mRNA expression at day 5, as compared with baseline levels, were 
observed in only 2 SIV- an im a ls that developed persistent M. leprae infection.
7.3.4 IL10 mRNA Expression
The level of expression of IL-10 mRNA was very similar to IL-2 in magnitude. However, IL-2
mRNA was mainly expressed at early time points, generally before IFN-y, whereas IL-10 was expressed 
later than DFN-y (Fig. 7.3c and 7.4c).
7.3.4.1 Skin
In the skin, IL-10 expression was not detectable in ethidium bromide stained gels at day 2, S 
and 12 in the majority of animals. When all animals were considered, the highest mean rank was 
observed at day 26 post-inoculation and then waned at day 62 (Fig. 7.3c). At no time was any 
significant difference observed IL-10 mRNA expression in the skin between SIV+ and SIV- animals 
(Fig. 7.7c) or between animals that did not or did that developed persistent M. leprae infection (Fig. 
7.8c).
7.3.4.2 Lym ph Nodes
In the lymph nodes, there was no significant difference of IL-10 mRNA expression between
SIV+ and SIV- animals or between monkeys that did and did not that develop persistent M. leprae 
infection (fig. 7.9c and 7.10c). Slight, not significant up-regulation of IL-10 expression was observed at 
day S in rhesus monkeys that developed persistent M. leprae infection, when each animal was analyzed 
according to ranked data from IOD ratio adjusted on baseline IOD ratio (data not shown). However, 
ranking of data without baseline adjustment did not reveal a higher median level of IL-10 mRNA in this 
group (Fig. 7.10c). Moreover, baseline and day 62 levels of IL-10 were consistently but not 
significantly higher in animals that did not develop the disease (Fig 7.10c).
7.3.5 PBMC S t im u la t io n  T e s t  C o n f irm s  L o w e r  P r o l i f e r a t i o n  C a p a b i l i t i e s  t o  
M  le p r a e  in  SIV+ A n im a ls
Lymphocyte stimulation assays run 96 days post re-inoculation in the 9 animals revealed a 
significantly higher proliferative response to M.leprae sonicate (ML-S) at both concentrations tested, as 
compared to unstimulated cells (p<0.0S). Cell proliferations horn SIV+ rhesus monkeys consistently 
had lower cpm than those recorded from SIV- animals. These results were significant when stimulated 
with PHA and the higher concentration of ML-S (10) (p< 0.05), but not the lower concentration of ML- 
S (5 pg/ml) (p=0.755) (Fig. 7.11). The proliferation of PBMC stimulated by both concentrations of ML-
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S, as assessed by cpm, from SIV+ animals was not significantly higher than untimulated cells from the 
SIV+ group (p>0.20), whereas it was significantly higher in the SIV-negative group at both 
concentrations of ML-S than untimulated cells from the SIV-negative group (p<0.0l).
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Figure 7.11: Lymphocyte stimulation tests from PBMC 96 days post­
inoculation. Mis = M. leprae sonicate. Mls-1 = 1:10 dilution corresponding 
to lOpg/ml of Mis; Mls-2 = 1:20 dilution corresponding to 5 pg/ml. PHA = 
phytohemagglutinin. None= culture medium only. Bars and error bars 
represent the group mean ± standard deviation (M±SD).
Lower counts per minutes (cpm) were consistently found in SIV+ animals 
as compared with SIV- animals, except for baseline (the ‘none’treatment 
group). Comparisons between SIV+ and SIV- monkeys by treatment group 
that are statistically significant are marked by (*) (p<0.05)
All comparisons achieve significance at p<0.001 except for baseline when 
the natural logarithm (lncpm) of the count per minutes is used as responder 
variable.
When the natural logarithm transformation of the cpm variable (lncpm) was analyzed 
statistically, it upgraded the significance levels from less than 5% to less than l%o in most comparisons. 
Of note is the significantly lower lncpm at the S pg/ml concentration o f ML-S in SIV-)- animals than
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lncpm from SIV- monkeys (p<0.001). However, the cells from SIV+ monkeys stimulated by 10 pg/ml 
of ML-S, but not 5 pg/ml of ML-S, did have significantly higher lncpm than lncpm from unstimulated 
cells from the same group (SIV+) of animals (p<0.02 and p=0.261, respectively). Combined with the 
cpm data, this statistical analysis suggests that SIV+ monkeys are still capable to respond, albeit to a 
lesser magnitude, to M. leprae sonicate at both concentrations, like the non-SIV-infected animals.
We obtained unexpectedly low counts per minutes, even though the triplicates were all 
consistent both per animal and with regard to treatments, in this experiment: the mean±standard 
deviation (M±SD) of the maximum triplicate cpm was 964.8±73.2 (phytohemagglutinin treatment) and 
the M±SD of the minimum triplicate cpm was 82.6±4.3 (no treatment). This was interpreted 
retrospectively as a technical error since an inappropriate scintillation fluid for LST was used.
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Figure 7.12: CD4:CD8 ratios of sim ian  immunodeficiency (SIV)-positive 
and SIV-negative an im a ls . The ratios of SIV-positive monkeys are 
consistently and significantly lower than the SIV-negative animals 
(pO.Ol).liiis graph was generated from flow cytometry data amd analysis 
(see chapter 6).
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Besides the consistently and significantly lower proliferation potential of SIV+ animals to PHA 
and M. leprae sonicates, these animals has consistently and significantly lower CD4:CD8 ratio 
throughout the experiment than the SIV-negative animals (Figure 7.12).
7.4 DISCUSSION
7.4.1 T he Study  H ypothesis
This study indicates that, in the skin, upon re-challenge with M. leprae 26 months after the 
initial M. leprae infection, the SIV+ survivors that had been challenged with SIV J943 2 weeks prior to 
the first M. leprae infection, have very similar levels of expression to that of the SIV-negative for all the 
cytokines studied, especially at early time points.
Results indicate that all the animals mounted an initial type 1 cytokine profile in the skin, 
suggesting that the imunologically crippled SIV+ monkeys are still capable of eliciting locally an 
adequate cytokine response that is similar to the SIV- counterparts, despite systemic signs of diminished 
cell mediated immunity. However, the animals that eventually developed persistent/disseminated 
disease had a delayed and weaker up-regulation of type 1 cytokines in the skin and an inadequate 
Th0/Th2 cytokine up-regulation in the lymph nodes draining the skin inoculation sites.
The level of expression of IL-2 at day 2 in the skin is not statistically different between the 
SIV+ and the SIV-negative groups. At later time points, the SIV+ monkeys tend to have a more 
sustained mRNA expression, such as, for example, in the case of IFNy at 62 DPI, where significantly 
higher levels are observed in SIV+ monkeys, suggestive of compensatory mechanisms in the skin 
and/or a more persistent local inflammatory response in SIV+ animals. Likewise, in the LN, there were 
similar levels of secreted cytokines between the SIV+ and the SIV- animals overall.
This result is quite surprising and is different from the cytokine mRNA expressed in broncho- 
alveolar lavage (BAL) of HTV+ and HIV- patient with pulmonary tuberculosis: in BAL of tuberculous 
patients, steady state (ex vivo) IFN-y mRNA was decreased in 4 HIV+ patient compared with 4 HIV- 
patients (Law, Jagirdar et al. 1996). Surprisingly, very few studies focused on cytokine expression at 
sites of inflammation in other mycobacterial infections in HTV+ patients, such as for example in M. 
avium infection where, to our knowledge, only macrophage cytokine expression are published (Denis 
and Ghadirian 1994).
179
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
However, these results are consistent with evidence concerning the interactions of leprosy and 
HIV infection at other levels of investigation, such as epidemiology (Meeran 1989; Leonard, Sangare et 
al. 1990; FrommeL, Tekle-Haimanot et al. 1994), (Faye, Mahe et al. 1996). At the level of cytokine 
production in leprosy lesions in HIV+ patients, there is so far no report concerning cytokine expression 
between HTV+ and HIV- leprosy patients. One study did examine cytokine mRNA expression 
evaluation from PBMCs and noted no differences (Sampaio, Caneshi et al. 199S). The major studies of 
ex vivo cytokine expression in the skin lesion of leprosy patients did not investigate whether HIV+ 
patients would have altered cytokine expression (Yamamura, Uyemura et al. 1991). This is therefore the 
fust study 1) documenting cytokine expression at inoculation sites of M. leprae and 2) addressing the 
question of a difference of cytokine expression between lentivirus-infected and lentivirus non-infected 
animal models.
7.4.2 Kinetics and  Cell Fraction Findings
Kinetics of mRNA expressions over time must be interpreted with caution due to possible day- 
to-day variations related to experimental design: samples were tested per day to primarily compare 
groups of animals. However, the results confirm some previous findings and provide some interesting 
insights on the dynamics of cytokine secretion in response to M. leprae inoculations in the skin.
In the skin inoculation sites, when the mean per sampling time point of the ranks of each 
cytokine obtained from each monkey was determined, it was clearly found that IL-4 and IL-10, 
classified as type 2 cytokines secreted by type 2 T cells (Th2), have a maximum of mRNA expression 
both at day 26 whereas the maximum of mRNA expression of IL-2, classified as type 1 cytokines 
secreted by type 1 T cells (Thl), is at day 2. The mean rank of interferon-y mRNA expression in the 
skin is characterized by a peak at day S and a maximum at day 26. It can therefore be concluded that, 
overall, the local cytokine response to M. leprae is initially a type 1 response and then evolves towards a 
type 0 response at around 1 month post inoculation. Interestingly, this very trend has also been observed 
in a murine model of pulmonary tuberculosis, where the initial cytokines secreted in situ were IL-2, 
IFNy and IL-12 followed at ~ 28 days by IL-4 mRNA expression up-regulation (Hemandez-Pando, 
Orozcoe et al. 1996).
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In the regional draining lymph nodes, and in contrast with the inoculation sites, no peaks or 
maxima of mean rank of mRNA cytokine expression over time was noticed. There is a trend towards a 
down regulation of IL-2 and an up-regulation of IL-4 at day 5 post-inoculation. Slight up-regulation of 
IL-10 was present at day 26. No conclusion could be drawn for IFNy mRNA expression using the mean 
rank since the IOD ratrios in most cases were well above 1. The initial ex vivo cytokine milieu in the LN 
was therefore a type 0, without early predominence of the set of cytokines defining the type 1 cytokine 
response, like what was observed in the skin.
In all animals studied, the maximum mRNA expression of IFNy as assessed by IOD ratio was 
noted at day 5 in all fractions of lymph nodes and at day 26 in the skin inoculation sites. Sorted fractions 
in the lymph node indicated that the main source of IFNy was the lymphocytes, since the highest mRNA 
expression and up-regulation at day S were in CD4-enriched and CD8 fractions, without apparent 
preferential expression between these fractions. This finding must be interpreted with caution, however, 
since CD8 fractions were near pure (>95% purity) wheras the CD4 fraction attained on an average only 
(± SD) 74.2 ± 17.7% purity (see chapter 5) with 9.5 ± 16.0% of remaining CD8+ cells. Several lines of 
evidence suggest that CD8+ T lymphocytes can be high producers of IFN-y and have very similar 
capabilities as compared to CD4+ T cells in terms of the array and preferential expression of type 1 and 
type 2 cytokines (Croft, Carter et al. 1994; Sad, Marcotte et al. 1995). In addition, both type 1 and type 
2 cytotoxic CD8+ T cells (Tel and Tc2, respectively) may be able to induce DTH reactions in mice (Li, 
Sad et al. 1997).
At day 5, slightly higher levels of IFN-y were noted in the non-fractionated LNCS and similar 
to slightly lower, but non statistically significant, levels in the CD4-enriched and CD8 fractions of SIV+ 
animals as compared with SIV- animals. This finding, which would need confirmation with larger 
numbers of animals, raises the possibility that other sources of IFN-y production cells such as, for 
example, macrophages and NK cells as early high producers of IFN-y (Billiau, Hermans et al. 1998; 
Gessani and Belardelli 1998; Kos 1998). Such compensatory mechanisms o f IFNy secretion by non- 
CD4 non-CD8 T cells may be important in SIV+ animals responding to a moderately virulent infectious 
challenge such as M. leprae. For example, a murine mice malaria model, has recently shown that NK 
cells producing high levels of IFNy and IL-12 are important, in addition to CD8+ T cells, for the
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adaptive immunity against malaria (Doolan and Hoffman 1999). This underscores the complexity of the 
immune response against intracellular pathogens and addresses the currently poor knowledge about the 
relative importance of adaptive CMI mediated by non-CD4 and non-CD8 T cells in leprosy.
In summary, LN CD4 and CD8 fractions, with the highest expression at day S, were the main 
source of IFNy in regional lymph nodes in response to M. leprae challenge.
7.4.3 C o r r e l a t i o n  o f  C y to k in e  mRNA E x p re s s io n  w ith  M  l e p r a e  P e r s i s te n c e  
O u tc o m e
The outcome of M. leprae persistent infection was assessed in post-mortem samples of nerves, 
skin and nasal mucosa. Persistent infection is compatible with mild leprosy disease or, at least, 
persistent M. leprae carriers with multiple site lesions , and mainly neural involvement (see chapter 5; 
table 5.2).
Significantly higher IL-2 and IFN-y expression at day 2 and day 5 locally in the skin, 
respectively, but not in the LN, were observed in the group of rhesus monkeys which resisted to 
persistent M. leprae infection compared to the group which developped persistent M.leprae infection. 
Higher median level of IL-2, but not IFNy, were observed in the CD4-enriched fraction of lymph node 
cells in animals which resisted to persistent M. leprae infection. The highest relative IL-2 mRNA 
expression was observed at day 2 in the skin of monkeys resistant to M. leprae persistent infection.
These findings strongly support the concept that IL-2 and EFN-y are critical cytokines secreted 
early after re-exposure to a CMI-eliciting agent, in particular after a second challenge with 
mycobacteria. Interferon-y is known to be very important for the successful management of invading 
mycobacteria (Barnes, Fong et al. 1990; Bames, Lu et al. 1993; Cooper, Dalton et al. 1993; Flynn, Chan 
et al. 1993). Our study also re-emphasizes the importance of early vigorous IL-2 secretion in a recall 
immune response against inoculated mycobacteria, although recent emphasis have been on the secretion 
of IL-12 in the primary response (Zhang, Gately et al. 1994; Cooper, Magram et al. 1997). A recent 
study, studying the immune response and disease outcome in a murine model of Mycobacterium 
tuberculosis primary infection in CD4 and MHC class II deficient mice, reported a 2-week delay or an 
absence of a peak of IFN-y mRNA, respectively, at the site of infection (lung); both of these correlated 
with development of disease and death, whereas the wild-type controls successfully managed the 
challenge (Myers Caruso, Serbina et al. 1999). Surprisingly, IL-2 was not detected in this study,
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probably because the first sampling time was at day 7. Our kinetic results are consistent with this 
finding, showing similar delays; a 10 day-delayed secretion of IL-2 and a 24 day-delayed secretion of 
IFN-y in animals that developed persistent or progressive M. leprae infection. Timing of protective 
cytokine secretion is therefore crucial both for M. tuberculosis and M.leprae infection in rodent and 
primate model of infection, respectively.
There was no significant difference in the magnitude and the timing of IL-2 and IFNy mRNA 
expression between the SIV+ and the SIV- groups at day 2 and day 5, suggesting that the SIV+ slow 
progressor animals were able to respond adequately to restrict persistent M. leprae infection. A similar 
proportion o f SIV+ animals compared to SIV-negative monkeys were indeed able to restrict persistent 
M. leprae infection. The low number of SIV+ animals in this study, the fact that the available SIV+ 
animals for re-challenge were slow progressors for SAIDS and that they were leprosy-fiee up to 26 
months after the initial M. leprae inoculation, may explain the difference in the disease outcome results 
compared to previous reports about the interaction of M. leprae and SIV in rhesus macaques (Gormus, 
Murphey-Corb et al. 1989; Gormus, Murphey-Corb et al. 1998). Flow cytometry and immuno- 
histochemistry data both indicated that the 2 SIV + animals that did not develop persistent M. leprae 
infection were different in terms of relative proportions of CD4 and CD8 T cells. Whereas one animal 
had CD4 recruitment at day 2 essentially similar to SIV- animals, the other had weak CD4 and strong 
CD8 cell influx in the skin. These data suggest that the source of type 1 cytokines may be CD8 T cells, 
which compensate for the defective recruitment of CD4 cells in this animal. This hypothesis has been 
very elegantly demonstrated in a model of tuberculosis in CD4 knock out mice, where the main source 
of IFN-y was shown to be CD8 T cells and was a compensatory mechanism, albeit delayed and partly 
inefficient (Myers Caruso, Serbina et al. 1999).
In regional LN, there was little or no cytokine mRNA up-regulation the in SIV-negative, M. 
leprae-KsisxasA animals at day 5, and very little in SIV-positive that had subsequently developed 
persistent M. leprae infection, suggesting that the cytokine component o f the immune response against 
M. leprae, whether protective or not, is essentially local in SIV — animals. In contrast, both resistant and
susceptible SIV+ animals up regulated IFN-y expression at day 5 in the LN. This produced a Thl profile 
at day 5 in the two M. /eprae-resistant SIV+ monkeys and a ThO response in the only M. leprae-
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susceptible SIV+ animal.The higher IFN-y mRNA expression in the unfractionated LN of the SIV+ 
group as compared with the SIV- group, may reflect a compensatory mechanism or it may be a 
consequence of chronic SIV infection in the LN. An earlier up regulation of the cytokine response in 
SIV+ M. leprae-resistant animals compared to SIV- animals (e.g. IFNy at day 5 versus day 26), supports 
the compensatory hypothesis. Also, this regional response could be associated with an intermediate 
level of resistance locally in the SIV+ animals. Persistent chronic SIV infection may also induce 
inflammation in the LN, however, and play a direct role in the regional IFN-y up-regulation in the 
response to M. leprae challenge, regardless of the outcome in terms of persistent progressive M. leprae 
infection. In HIV patients, higher expression of EFN-y in lymph nodes have been described compared to 
controls (Graziosi, Pantaleo et al. 1994). In SIV+ rhesus monkeys, similar results were found in the 
lymph node (Khatissian 1996).
Very importantly, the results of this study suggest for the first time that in leprosy, successful 
containment and destruction of the bacilli resulting in resistance to persistent M. leprae infection (i.e. 
the absence of disease development), is strongly associated with a local, early and strong type 1 cell 
mediated immune response at site of invasion upon re-challenge, and not with early cytokine mRNA 
expression in the LN.
In the lymph nodes, expression of IL-4 and up-regulation of IL10 was present at day 5 in all 
the animals but one that developed persistent M. leprae infection , suggesting that an early type 2/type 
0-cytokine response in the LN is associated with progression to persistent M. leprae infection. This may 
be interpreted in 2 ways: with the sensitivity of RT-PCR, cytokine up-regulation may be detected in the 
regional LN of monkeys that have dissemination of M.leprae there, as an anticipation of future 
persistent disease and inflammation. Alternatively, antigen presentation and an appropriate immune 
response may take place mainly in the skin early (at day S) in M. /eprae-resistant SIV- animals, with 
minimal response in the LN, whereas in susceptible animals, significant antigen presentation and 
inappropriate cytokine secretion may take place in the LN early (~ 5 DPI), regardless o f bacillus 
dissemination.
In SIV+ resistant animals, and in contrast to SIV- resistant animals which had slight up- 
regulation o f any cytokine, type 1 cytokines are up-regulated in the LN wheras all 4 cytokines are
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expressed in the animals which developed disseminated M. leprae infection. Even though these findings 
must be interpreted with caution due to day-to-day variation, the consistency of up-regulation of all 4 
cytokines in the LN of the all S animals that developed persistent M. leprae infection, but in none of the 
SIV-, resistant animals is a positive argument to validate biological relevance of these results.
Re-inoculation was not randomly administered, but involved animals that had not developed 
any evidence of persistent infection with M. leprosy despite inoculation 26 months earlier with large 
doses of armadillo derived M. leprae (Gormus, Xu et al. 1998). It is therefore not very surprising that 
these animals had rather high IFNy expression levels in the skin and in CD4 and CD8 lymphocyte 
fractions in LN. Likewise, the SIV positive group, although showing systemic evidence of impaired 
CMI responses 96 days as assessed by LST and peripheral CD4/CD8 ratios, was composed of slow 
progressor animals. It is therefore somewhat surprising that a high proportion of SIV- animals (4/6) 
developed the disease whereas only 1/3 SIV+ did. Several factors could potentially be responsible, the 
first one being higher selective pressure in SIV+ rhesus macaques challenged by large doses of M. 
leprae compared with control, SIV- animals.
Multiple exposures, occuring in the context of a susceptible genetic background, have never 
been experimentally tested in any animal model of leprosy. It would be the predisposing factor for 
disease development most readily tested in rhesus macaques, in conjunction with rhesus MHC typing 
that is already used to test for SIV disease susceptibility in rhesus monkeys (Baskin, Bontrop et al. 
1997).
7.4.4 T y peI V ersus Type2 Response
Interferon-y was the predominant cytokine expressed locally and regionally in the skin and
lymph nodes of all the animals studied. IL-2 was the earliest cytokine reaching a maximum in the skin.
IL-4 and IL-10 expression either were either absent or minimal and followed later at lower levels the
expression of IFN-y in all animals at all sampling time points in the skin.
Low expression of IL-4 was noted in a few animals studied, both in the skin and lymph nodes.
Interestingly, up to 26 DPI in the sldn, weak IL-4 expression was associated with the animals that
developed the strongest CMI as assessed by histology and immunohistochemistry and the most vigorous
type I cytokine mRNA expression. This suggests that, up to 1 month, IL-4 may act as a physiologic
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down-regulator of a vigorous initial type 1 response in the skin rather than driving an inadequate, strong 
type 2 reaction or a type 0 response. In fact, vigorous early IL-4 secretion and other type 2 cytokine 
production remain to be shown in any mycobacterial infection at the site of disease (Hemandez-Pando, 
Orozcoe et al. 1996). IL-4 and IL-10 expression were not, at any time point, strongly up-regulated either 
in SIV+ animals or among the group that developed persistent M. leprae infection in the skin. At the 
last sampling time point (62 DPI), type I cytokines, represented by IFN-y expression, still dominated 
the response in the skin. In an attempt to extrapolate those results in humans, it may be proposed that 
the type 2 cytokines observed in established lepromatous leprosy lesions in humans (Yamamura, 
Uyemura et al. 1991) would appear after at least several months after exposure. This could also be 
tested in sooty mangabey monkeys that are highly susceptible to lepromatous leprosy (Meyers, Gormus 
etal. 1994).
In the lymph nodes, there was minimal differences between different LN cell fractions with 
respect to expression of IL-10 and IL-2 expression. The response was therefore a type 1 or a type 0 
response in all animals at all time points. In the lymph nodes, it is only after subtraction of the baseline 
levels of IL-10, IL-2 and IFNy expression for each monkey and mRNA up-regulation/down regulation 
analysis that type 2 responses were evident in some animals. The predominant baseline IFN-y 
expression and type 1/type 0 profile may be associated with the species studied. Analysis of T cell 
clones in rhesus macaques have shown that a large majority of Thl and ThO clones predominated 
compared to Th2 clones in SIV- rhesus monkeys (47%, 24% and 4%, respectively). In SIV+ animals, 
this trend is even more pronounced, with relatively more Thl clones (21%, 60% and 9%, respectively) 
(Ansari, Mayne et al. 1994; Rosenberg, Lewis et al. 1994). Whether this is due to genetic or 
environmental factors or a lesser capability of rhesus monkey Th2 clones to survive is not known. It is 
not an artifact, however, since predominant Th2 clones were found in other monkey species, such as the 
sooty mangabey (Ansari, Mayne et al. 1994; Rosenberg, Lewis et al. 1994). Also cytokines do not all 
have the same levels of mRNA expression and protein secretion in an inflammatory focus: IFN-y and 
IL-10 have usually higher mRNA production and quantities of proteins secreted, whereas IL-2 and IL-4 
have lower, more discrete and brief mRNA up regulation and protein secretion.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
In the lymph nodes, when analysis was based on up or down-regulation after adjustment for 
baseline expression, IL-4 and IL-10 signals were detected only in animals that developed persistent M. 
leprae infection, at day S. IFN-y expression levels were either unchanged or down-regulated in these 
animals at the same time (day S).
In conclusion, there is an interesting regional effect observed in IL-4 and IL-10 expression. 
Whereas in the skin, up to day 26, IL-4 and IL-10 seem to act physiologically to down-regulate the 
strongest a type 1 cytokine responses, early (5 DPI) up regulation o f IL-4 and IL-10 in lymph nodes (i.e. 
a type 2 milieu) is predictive of development o f persistent M. leprae infection.
In the case of lymph nodes, it is important to mention that, from unfractionated LN cell 
suspensions, only two out of five animals that developed the persistent M. leprae infection had 
moderate IL-2 and IFNy mRNA expression up-regulation compared with baseline values. These 
findings indicate that those 2 animals most probably develop a type 0 response, whereas the last 3 
developed a type 2 response in the regional LN draining the inoculation sites. Analysis of in vitro 
stimulated PBMCs and LNCSs for cytokine expression and T cell clones at day S in lymph nodes 
draining an M. leprae first and second challenge would be extremely useful to clarify this finding.
To summarize these data with regard of the Thl/Th2 model, in the LN, the detection of a 
signal and up-regulation for IL-4 together with IL-10 may be considered as a strong up-regulation of 
type 2 cytokines, because absent or low up-regulation of type I cytokines were seen regionally at the 
same time. In contrast, in the skin, type 2 cytokine expression consistently lagged in magnitude and 
time behind type 1 cytokines and this was interpreted as physiologic down-regulation locally in the skin 
inoculation sites. Taken together with the known properties of these cytokines, the results of this study 
confirm that a type 1 response occurs in the skin, and that progression to persistent M. leprae infection 
is associated with delayed and weaker type 1 responses in the skin rather than a type 0/ type responses.
7.4.5 LST R e s u lts :  S y s tem ic  V e rs u s  L o c a l  In f lu e n c e  o f  SIV I n fe c t io n
Comparison of results of LST in PBMC and cytokine mRNA expression indicate that 
peripheral blood lymphocytes of the SIV+ rhesus monkeys have a diminished capability to proliferate 
against M.leprae Ag. However, they retained the capability to induce a strong local CMI and strong 
type 1 cytokine mRNA expression in the skin. Even though there was no test performed to assess the
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capability of recmited skin lymphocytes to proliferate against M. leprae antigens, this difference of 
response between the skin and peripheral blood is very similar to the results found in HIV infected 
persons with BT leprosy (Sampaio, Caneshi et al. 1995). We found a similar proportion of SIV+ 
animals able to contain M. leprae inoculation and avoid the development of progressive of M. leprae 
infection in nerves and nose as compared with controls. Due to the low number and the slow progressor 
nature of SIV+ animals, this result should not be generalized, but clearly indicates the possibility of 
adequate response against M. leprae inoculation in the skin among SIV+ rhesus monkeys. In previous 
experiments of inoculation of larger numbers of rhesus monkeys, a higher percentage of SIV+ animals 
developed persistent M. leprae infection (Gormus, Murphey-Corb et al. 1989; Gormus, Murphey-Corb 
et al. 1998). In addition to the compartmentalization observed between the blood and the skin, there is 
also an interesting regional effect observed between cytokine expression in the skin inoculation sites 
and cytokine up regulation in the draining LN in SIV+ monkeys. Whereas IFN-y is present at similar 
levels in the skin up to day 26 between SIV+ and SIV- animals, early (5 DPI) strong up regulation of 
IFN-y that is a type 1 milieu is observed in lymph nodes of all the SIV-infected animals, regardless of 
resistance or persistence of M. leprae infection. Even though, again, the finding does not address M. 
/eprae-specific immune response capabilities between SIV+ and SIV- animals in the LN, this finding 
suggests a compartmentalization of the local and regional responses against M. leprae in SIV+ animals. 
This may be possibly due to a combination of SIV persistent infection in the LN that dysregulate innate 
and acquired immunity capabilities (Pantaleo and Fauci 1995) with recent M leprae re-challenge. In 
contrast, it is improbable that innate defense mechanisms in the skin are impaired in this model. In fact, 
Langerhan’s cells from homozygous twins discordant for HIV-1 infection were shown to mediate 
similar immune responses in humans (Blauvelt, Clerici et al. 1995; Blauvelt, Chougnet et al. 1996).
In summary, our study suggests that, despite lower frequencies of circulating T cells capable to 
specifically respond to M. leprae antigens in SIV+ monkeys, there is a similar local response resulting 
into the adequate management of M. leprae infection in a similar proportion o f SIV+ as compared with 
SIV- animals. This finding also suggests an appropriate or better local recruitment of the fewer 
responding T lymphocytes in SIV+ animals and probably adequate chemoattraction.
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The apparent compartmentalization of the effect of SIV on CMI against M. leprae is intriguing 
and is consistent with observations in humans infected with HIV. There is compelling evidence that the 
effect of lentiviral persistent infection may differ in different tissues. The most striking example of this 
is the discovery that primary replication of SIV in rhesus monkeys shortly after infection is in the 
activated lymphocytes of the gastro-intestinal tract (Veazey, De Maria et al. 1998). In this system, CD4 
depletion is profound and rapid in the intestinal lamina propria whereas the CD4:CD8 ratio and CD4 
counts remains unremarkable in the peripheral blood. Another example is the persistent HIV and SIV 
infection in lymph nodes, in particular germinal centers (Fox, Tenner-Racz et al. 1991; Staprans, 
Hamilton et ai. 1995), during the asymptomatic stage of these lentiviral diseases (Pantaleo, Graziosi et 
al. 1991; Embretson, Zupancic et al. 1993; Pantaleo, Graziosi et al. 1993), (reviewed in (Pantaleo and 
Fauci 1995), (Khatissian 1996). The germinal centers are the privileged sites of immune response with a 
high concentration of activated lymphocytes, which are the main target of HIV and SIV for vims 
replication. It is now well established that concurrent infections and disease, whether successfully 
contained or not, may favor the progression to more advanced clinical features of AIDS by favoring 
vims replication, among other (Pantaleo, Graziosi et al. 1993)(reviewed by (Copeland and Heeney 
1996). Immune activation elicited by vaccination and diseases like influenza and tuberculosis, also 
favor replication and higher HIV-1 mRNA copies in the blood, at least transiently (Ho 1992; O'Brien, 
Grovit-Ferbas et al. 1995; Staprans, Hamilton et al. 1995; Zhang, Nakata et al. 1995; Goletti, Weissman 
et al. 1996; Stanley, Ostrowski et al. 1996; Garrait, Cadranel et al. 1997; Nakata, Rom et al. 1997; 
Honda, Rogers et al. 1998).
The reaction of the lentivirus-infected host to M  leprae is unique when compared to other 
mycobacterial infections such as tuberculosis (reviewed in (Shafer and Edlin 1996) and (Bloom 1994) 
and opportunistic species of mycobacteria such as Mycobacterium avium-intracellulare complex 
infections (Wallace and Hannah 1988; Benson and Ellner 1993; Race, Adelson-Mitty et al. 1998), 
which rank among the main life-threatening secondary infection in HIV-infected and AIDS patients. 
This uniqueness may be related to unique pathogenic properties o f M. leprae, characterized by 
intracellular location and slow growth, among other characteristics. It is as if the SIV-infected animals
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were able to focus the CMI defense apparatus in the very sites o f inoculation, with apparent success, in 
the half of the animals of the group.
In experiments performed in other rhesus monkeys in which SIV was inoculated 8-10 months 
before, M. leprae primary inoculation with resulted in diminished proliferation to Concanavalin A lectin 
stimulus in co-infected animals and an absence of proliferative response to ML-S (Gormus, Murphey- 
Corb et al. 1998). A majority of these animals developed persistent M. leprae infection. This indicates 
that the timing of the relative inoculations of SIV and M. leprae is important when studying the 
interactions between the two. In our model, when M. leprae was inoculated at the time of the SIV 
primary syndrome, we did not find any major difference between the two groups.
7 .4 .6  S u m m a r y  a n d  C o n c l u s io n
In summary, an important finding of this study is that slow progressors, SIV positive animals 
are still capable of mounting an adequate type 1 immune response against M. leprae locally and 
regionally, with similar or higher levels of IL-2 and IFN-y compared with SIV- monkeys. This response 
was present despite significantly lower levels of circulating, significantly lower stimulation indexes of 
peripheral blood mononuclear cells to M. leprae antigens and slightly lower recruited CD4 T cells . The 
patterns of response present in both SIV+ and the SIV- animals correlated quite well with the degree of 
cell infiltration of the skin lesions and the disease outcome. The animals that did not develop signs 
and/or lesions characteristic of a persistent M. leprae infection and an evolution towards leprosy had 
consistently more rapid and more vigorous expression of IL-2 and IFNy locally in the skin, indicating a 
rapid and vigorous Thl response. Th2 cytokines (IL-4, IL-10) do not appear to be important in the skin 
at early time points, but are up-regulated in the lymph nodes in animals which developed persistent M. 
leprae infection, with microscopic lesions as assessed by post-mortem findings. According to our results 
on a limited number of animals, SIV infection appears to have little importance in the type and 
magnitude of the cell mediated immune response to a Mycobacterium leprae re-challenge. The rhesus 
monkey is a useful model in which to explore the causative factors of the defective CMI in leprosy, that 
appears in only a proportion of animals and does not seem to be strongly affected by SIV infection, 
corroborating results of epidemiological studies of leprosy in HIV+ individuals.
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8 SUMMARY AND CONCLUSION
There is a general consensus among leprosy researchers to consider that the disease following 
infection with Mycobacterium leprae is more a consequence of immunopathologic processes than a 
manifestation of the direct action of the agent This mycobacterium is a well-adapted, stealthy, 
minimally toxic pathogen that hides in the host, with a predilection for peripheral nerves and the cooler 
parts of the body (reviewed in (Job 1994)). Another important factor is the apparent genomic 
monomorphism of M. leprae (Williams, Gillis et al. 1990), suggesting that most if not all of the disease 
spectrum is a consequence of the host’s capabilities or inability to react against the parasite.
One central question of leprosy research concerns the pathogenesis of lepromatous leprosy. It 
is still not known, more than a century after the discovery of the etiological agent by Harmauer Hansen, 
whether the primary defect in lepromatous leprosy is an initial failure to recognize and/or process 
antigens from M. leprae or is a progressive down regulation of the cellular arm of adaptive immunity, a 
consequence of uncontrolled replication of the organism (Harboe 1994). Since this non-cultivable 
organism is a slow grower in animal tissues, one is tempted at first analysis to favor the first hypothesis. 
However, as molecular microbiologists are unraveling the complexity of strategies in mycobacteria-host 
relationship (reviewed in (Bloom 1994; Ernst 1998; Aderem and Underhill 1999), the situation might be 
more complicated. It could be a combination of the above, with partial failure to process antigens and 
therefore mount an efficient CMI, subsequent augmentation of the bacterial load and secondary down 
regulation of the CMI. According to the Thl/Th2 paradigm, this down regulation of CMI would then be 
characterized by a shift from a local type 1 (Thl) to a local type 2 (Th2) cytokine possibly mediated by 
type 2 cytokines, such as IL-4 and IL-10. This situation may also be valid for tuberculosis in humans. 
These kinetic aspects o f cytokine responses in mycobacterial diseases, and in leprosy in particular, have 
seldom been tested in animal models.
Whereas individuals exposed to Mycobacterium tuberculosis develop an extremely strong 
CMI, illustrated by a positive tuberculin test that indicates a strong DTH, individuals suffering from 
active, progressive tuberculosis usually have a ThO or Th2 cytokine profile, with occasional tuberculin 
test negativity (Sanchez, Rodriguez et al. 1994; Surcel, Troye-Blomberg et al. 1994) (reviewed in 
(Cooper and Flynn 199S; Lucey, Clerici et al. 1996)). Kinetic studies on a murine model o f progressive
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pulmonary tuberculosis in Balb/c mice have clearly shown a progressive shift from a type 1 to a type 2 
cytokine milieu, that correlates with progression to pneumonia and corroborates the hypothesis of CMI 
down regulation (Hemandez-Pando, Orozcoe et al. 1996).
Another puzzling observation in leprosy research concerns the apparent lack of increased 
incidence of leprosy, severity of lesions and down-grading from tuberculoid to lepromatous in HIV- 
infected Africans and Asians. The reasons of this observation, if true, are not presently understood. The 
apparent ability of individuals immunologically crippled by chronic HIV infection to compensate and 
avoid a worse manifestations of leprosy after chronic M. leprae infection may be related to the apparent 
slow growth of the pathogen. In addition, the often limited, local infection elicited by M. leprae in 
tuberculoid leprosy may still be mastered by a partially impaired host immune response whereas it 
would not be if M. leprae infection was characterized by a rapid overwhelming of the immune system 
(Sampaio, Caneshi et al. 1995). Presently, the situation is as if the general loss of the immune 
capabilities observed in HIV-infected persons evolving towards AIDS had little consequence on how M. 
leprae will behave in the human host. This issue is still not settled and more epidemiological studies 
will be helpful to clarify the situation. This is in any case unique to M. leprae since tuberculosis is 
definitively worse in HTV+ than in HIV- patients and mycobacterial opportunistic infections are highly 
frequent in the former group.
Carefully controlled experimental situations such as rhesus macaques inoculated with M. 
leprae (ML), with or without SIV infection, reveals a higher incidence o f persistent ML infection in 
ML-SIV co-infected animals compared with ML-inoculations alone (Gormus 1989) (Gormus, 
Murphey-Corb et al. 1998). This suggests that sooty-mangabey-derived SIV might have a detrimental 
affect on the outcome of large doses of M. leprae inoculated in rhesus macaques. This detrimental effect 
has been observed in two distinct situations: at the initial time of ML exposure, or later during 
progression towards SAIDS. However, the mechanism of the effect of SIV infection on M. leprae 
persistent infection and disease has not been determined in rhesus macaques. Similarly, the possible 
detrimental effect of SIV infection on M. /eprae-associated persistent infection and disease has not been 
apparently tested when ML was inoculated several months before SIV challenge. Lastly, the effect of
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M  /eprae-associated persistent infection on the primary infectoin complex and the evolution of SIV 
infection and disease in rhesus macaques has not been explored.
Moreover, it is not known yet what type of cytokine milieu is present initially at site of 
inoculation in the skin of rhesus macaques whereas it is already known in humans with established 
leprosy lesions (Yamamura, Uyemura et al. 1991; Modlin 1994). Preliminary studies have been done to 
test the cell recruitment and the cytokine milieu in the primary immune response to M. leprae in rhesus 
macaques (Lathrop, Scollard et al. 1996; Scollard, Gillis et al. 1997). These studies revealed delayed 
recruitment of CD4+ lymphocytes and delayed mRNA expression of IL-2 in SIV+ macaques.
To investigate the memory immune response against a second challenge of M. leprae , we 
inoculated 9 rhesus macaques, 3 of which were SIV positive. Our study hypothesis was that a type 1 
cytokine milieu initially exists in rhesus macaques and that an inadequate local and regional response 
against M. leprae is present in SIV+ animals. Results indicated that there was indeed, in the initial phase 
of host response after challenge, a type 1 cytokine response in the skin with a predominance of IFNy 
and IL-2 mRNA expression locally in the skin, and surprisingly, that there was no significant difference 
between SIV+ and SIV- animals. In the lymph node, a strong Thl response was present at day S when 
sorted lymphocytes were studied for mRNA expression, with notably high levels of IFNy mRNA. In 
contrast, in the unftactionated cell suspension, a proportion o f animal had a type 0 response at day S 
since IL-4 mRNA was detected. As in the skin, there was no significant difference between SIV+ and 
SIV- monkeys. However, when the rhesus macaques were grouped according to persistence of M. 
leprae infection, 4 of 5 animals with persistent infection had IL-4 mRNA in the lymph node at day S, 
suggesting that the early up-regulation of type 2 cytokines in the LN rather that at the site of infection in 
the skin, was predictive of future development of persistent infection in this species.
The results presented in this work, despite low numbers of animals, are the first in any animal 
model of leprosy that clearly indicates that a locally delayed, weaker adaptive cytokine response is 
uniformly present in thee skin of the group of monkeys that subsequently had persistent M. leprae 
infection (ML+). This weaker and delayed response is characterized by lower levels of Thl cytokines, 
such as IL-2 and IFN-y, rather than an initial Th2 response, and reduced recruitment of lymphocytes, 
especially of CD4+ T cells. This is in contrast with the regional response in the LN, where early up-
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regulation of IL-4 is present at day 5 in animals that will subsequently develop persistent ML infection. 
Two notes of caution should be considered in the case of the animals that developed persistent M. 
leprae infection (ML+): (1) One cannot conclude that the development of persistent M. leprae infection 
(ML+) in rhesus macaques was entirely due to the re-inoculation, even though they all appeared 
healthy, since they had been infected previously with M. leprae. (2) Whether these results can be 
applied to humans exposed per-cutaneously to M. leprae remains to be proven, since rhesus macaques 
do not exhibit the same features of leprosy as humans (Gormus, Xu et al. 1998).
A rapid and vigorous secretion of IL-2, and of IFN-y immediately thereafter, was invariably 
present in the 4 animals that failed to develop persistent lesions and M. leprae infection (ML-), 
regardless of their SIV status. These latter monkeys were able to recruit large numbers of CD3+ 
lymphocytes in the skin inoculation sites at 2 DPI, the majority o f which were CD4+ T cells, except one 
SIV+ animal that had a large majority of CD8+ T cells. No statistically significant difference was 
observed between SIV+ and SIV- animals, both in cytokine responses and cell recruitment, reflecting 
similar proportions of ML - animals among the 2 groups.
The possibility that a type 2 cytokine milieu may act as down regulator o f CMI in 
mycobacterial infection, rather than being the motor of early inadequate response, was supported by the 
results of IL-4 expression in the skin: IL-4 was expressed in a very limited, minimal manner, without 
any recognizable pattern, until day 26 in all animals. At day 26, IL-4 mRNA was detected in the skin in 
the ML-negative animals that had had the highest initial Thl response.
The value of performing longitudinal studies stressing the kinetics of cell recruitment and 
cytokine mRNA expression or cytokine protein secretion will probably be the key for a better 
understanding of the innate and adaptive immune response to mycobacteria and other infectious agents. 
Moreover, they will help solve some of the apparent discrepancies observed in studies dealing with a 
single sampling time point from peripheral blood.
Several issues, however, need to be addressed. Our results suggest that there is a group of 
animals with an inadequate secondary anamnestic immune response, regardless of the SIV infection 
status in rhesus monkeys. This latter group o f animals could be characterized with planned breeding and 
further study, and they could give important insights into possible genetic defects in the processing and
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handling of M. leprae antigens and possibly other mycobacteria. They would possibly complement 
quite interestingly the studies in humans and laboratory rodents, where several genes have been 
characterized (de Vries and Young 1994), because these animals are phylogenetically closer to human 
beings. Another avenue of research would be the testing, from this sub-group of rhesus macaques that 
develop persistent infection, of the influence of the lepromatous leprosy on the outcome of acute SIV 
infection, since it has already been proven that tuberculosis has a negative effect on HTV infection 
(Goletti, Weissman et al. 1996; Garrait, Cadranel et al. 1997; Nakata, Rom et al. 1997; Honda, Rogers 
et al. 1998).
In conclusion, this study enabled us to get important insights into the pathogenesis of leprosy 
by stressing the key role of a precocious and strong expression of an adequate type 1 cytokine milieu, 
characterized by early and strong IL-2 and IFNy expression, after re-challenge of M. leprae in the skin 
of rhesus macaques that controlled M. leprae and avoided persistent infection. Animals that developped 
persistent M. leprae infection had delayed and weaker expression of IL-2 and IFNy mRNA, rather than 
an initial inadequate type 2 cytokine environment. There was no significant differences between SIV- 
infected and SIV-non-infccted macaques, corroborating epidemiological studies in human leprosy and 
AIDS. Further studies exploring the basis of this difference of strength and precocity of type 1 cytokine 
expression between resistant and susceptible animals would be highly interesting and of uppermost 
importance.
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APPENDICES
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Appendix 1
Comparison of the results of disease outcome by SIV status between already published data and the present study.
Previous study (Gormus, Xuetal.  1998) Present study (n=9)
_____________ (Sz38)___.________________________________ _
Distrib. % SIV* % Distrib. % SIV5 %
No visible disease 24 63 6 16 4 44 2 22
Disease development 14 37 5 13 5 56 1 11
m 2 5 0 0 0
Neuritic TTU 4 11 0 0 0
TT/IndH 9 24 2 5 0 0
BB1 2 5 2 5 0 0
BL1 1 3 1 3 4 44 0
LL1 3 8 0 1 11 1 11
§ Including SIV positive rhesus macaques
H leprosy immunological classification according to (Ridley and Jopling 1966) modified in (Gormus, Xu et al. 1998).
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APPENDIX 2: PHOTOMICROGRAPHS ILLUSTRATING THE 
HISTOPATHOLOGY AND CYTOLOGY OF INCOMPLETE 
FREUND’S ADJUVENT (IFA) INJECTION SITES
See also page 92 and page 98.
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APPENDIX 3: PHOTOMICROGRAPHS ILLUSTRATING RNA 
ISOLATION FROM IFA INJECTION SITES
See also page 96-97.
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APPENDIX 4: PHOTOMICROGRAPHS ILLUSTRATING M. 
LEPRAE SKIN INOCULATION SITES AND GROSS LESIONS 26 
DAYS POST-INOCULATION (DPI)
See also page 105 and page 108.
209
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 5.2
Figure 5.5
2 1 0
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission
APPENDIX 5: PHOTOMICROGRAPHS ILLUSTRATING CD4 
IMMUNO-HISTOCHEMISTRY IN M. LEPRAE  SKIN 
INOCULATION SITES AT 2 DPI
See also page 137.
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APPENDIX 6: PHOTOMICROGRAPHS ILLUSTRATING 
TOPOGRAPHICAL HISTOPATHOLOGY AT 62 DPI IN SIV 
NEGATIVE RHESUS MACAQUES
See also page 138.
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APPENDIX 7: PHOTOMICROGRAPHS ILLUSTRATING 
TOPOGRAPHICAL HISTOPATHOLOGY AT 62 DPI IN SIV 
POSITIVE RHESUS MACAQUES
See also page 139.
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VITA
Thomas Xavier D. Lemarchand was bom in 1967 in Caen, Normandy, France. In 1974, His 
parents decided to move in Brittany and he had the luck to be raised in the countryside in Locmariaquer, 
a village along the Morbihan Gulf, a beautiful and touristic area in southern Brittany. His child wish 
were to become a farmer and biologist. He attended the “ecole Saint Gildas” catholic private school 
from the 4lh grade to the 7* grade, then “Le Verger” public college (highschool) in the 8* and 9lh grade 
in Auray. At that time, he realized that biology and geology was most interesting and importantly that it 
was easy to be bold in this discipline with moderate studying, a situation not present in other disciplines 
such as languages and mathematics! He then moved for three years to the “Lycee Benjamen Franklin”, 
Auray, France, a lycee named after the great American scientist and politician, who landed there after a 
long travel through the Atlantic Ocean in the late 18th century to discuss alliances with the young French 
Republic against the British Crown. There, he focused his efforts on Experimental Sciences and 
Mathematics and finished his highschool curriculum by taking and passing the “Baccalaureat serie C” in 
the spring of I98S. Shifting from his initial wish of farming, he decided to become a veterinarian and 
enrolled in pre-veterinary preparation in Lycee Chateaubriand, Rennes, France and took the competition 
in the spring of 1986. He luckily passed the written and oral part of the competition and was accepted as 
a veterinary student in “The Ecole Nationale Veterinaire de Nantes” (ENVN) in fall 1986. While 
focusing on the harsh theory courses of the first 2 years, he gradually got involved in a non-lucrative 
association founded by students known as the “Ferme Experimental des eleves de l’ENVN” (ENVN 
students’ Experimental Farm) dealing with many aspects of small ruminant and poultry medicine and 
zootechniques. Noticing the recent isolation of feline immunnodeficiency virus (FIV) by Dr Pedersen in 
Davis, California, he got involved in 1989 on research investigating the lesions associated with the 
natural disease caused by this virus, and decided in 1990 to leam further veterinary pathology by 
enrolling in a 3 year residency in veterinary anatomic pathology. He defended his veterinary thesis 
entitled “Etude anatomo-pathologique de 25 chats naturellement infectes par le virus de 
I’immunodeficience feline” (Pathology of 25 cats naturally infected with FIV) in the fall of 1992 and 
focused, for his residency research project, on the neurologic changes associated with natural FIV
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infection. Meanwhile, in an attempt to learn more in large animal pathology and achieve excellence in 
pathology, he decided, for the third year of his residency, to follow a practical training after the kind 
invitation of Dr Michel Morin from the University of Montreal, Quebec, Canada. He completed his 
training there in the early summer of 1993, and took and passed successfully the requirements for 
receiving the recently created “Diplome d’etudes specialises en anatomie pathologique veterinaire” 
from the French Ministry of Agriculture. He then moved to Albuquerque, New Mexico, United States of 
America, to fiillfill a one year temporary position in the New Mexico Department of Agriculture’s 
Veterinary Diagnostic Services. Seeking for further knowledge and competency, he decided in 1994, 
with the warm support of his wife Christine, to diversify his previous training and devote himself to 
learning research philosophy and techniques in pathology and immunology, and to accept an 
assistantship in the Department of Veterinary Pathology, Louisiana State University. His career goals 
are to continue further developments in the understanding of the mechanisms of disease and practice the 
expertise acquired in the last 9 years in diagnosing animal diseases and in counceling his colleagues and 
veterinarians.
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